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Abstract
Central to the humoral immune response is the commonly observed improvement of
antibody affinity over time, a phenomenon referred to as affinity maturation.
Affinity maturation takes place in so-called germinal centers (GC) that are tran-
siently formed in secondary lymphoid tissues (e.g. spleen) following immunization
with T cell-dependent antigens. Within GC, B lymphocytes are subjected to a
micro-evolutionary process that includes multiple rounds of diversification of their
B cell receptors (BCRs) by somatic hypermutation (SHM) and subsequent selec-
tion of those B cells showing improved binding characteristics towards the antigen.
However, despite recent advances in defining the mechanisms contributing to di-
versification of B lymphocytes within GC, the dynamics, mechanisms and forces of
their selection are poorly understood. The current thesis aims at providing new
insights into the evolution of B cells within GC by assessing the overall GC growth
behavior (Chapter 4), by documenting changes of the cellular composition of GC
over time (Chapter 5) and by, for the first time, specifying the kinetics (Chapter 5)
and sequence properties (Chapter 6) of negative selection occurring within GC.
The results obtained during cross-sectional evaluation of spleen sections revealed a
robust average growth kinetics of GC, that was, however, based on a notable size
distribution of GC within individual sections. This could not be explained by ran-
dom sectioning of GC. However, simulations of random sectioning of hypothetical
ensemble kinetics have shown that the experimentally recorded cross-sectional pro-
file of GC growth is consistent with others than the accepted notion. To solve this
problem, GC growth was subsequently addressed by three-dimensional volumetric
evaluation of splenic GC, that finally contradicted the accepted notion by revealing
non-synchronized formation and growth of GC as characterized by ongoing new for-
mation and marked, broad volume distributions of GC. According to these findings,
a revised model of affinity maturation was proposed that involves recirculation of
GC emigrant B cells and a multilevel selection strategy (intercalation of local and
global selection).
It was further shown that the kinetics of GC T cells and macrophages follow the
overall growth kinetics of GC. However, whereas T cells populated B cell zones not
until antigenic challenge, macrophages already represented a constituent cell pop-
ulation of primary B cell follicles. Noteworthy, the number of macrophages was
found to strictly correlate with the underlying size of B cell zones. In this context,
an acquired imbalance due to phagocytosis-induced macrophage death was further
shown to be associated with disease progression in the NZB/W autoimmune mouse
model of systemic lupus erythematosus (SLE). Furthermore, costaining of macro-
phages and apoptotic cells revealed that cell death occurs throughout GC, thereby
indicating that selection takes place in both, dark and light zones of GC.
The establishment of a reliable method for recovery of primary BCR sequences of
phagocytosed GC B cells has proven to be powerful, in that it provides new insights
into the selection process of GC B cells by, for the first time, allowing for access
to yet unexplored negatively selected GC B cells. In this context, the tradition-
ally proposed molecular signatures - as for instance the distribution of mutations
within framework (FR) and complementary determining regions (CDRs), ratios of
replacement (R) to silent mutations (S) and the incidence of key mutations - were
all shown to fail to demarcate winners and losers of selection. The obtained results
indicated that the survival fate of GC B cells is governed by the cumulative effect of
replacement mutations within CDRs, though, in which the as yet proposed positive
effect of R mutations turned out to be overemphasized. By contrast, R mutations in
CDRs turned out to possess marked deleterious effects, thereby lending support to
the proposition that survival of GC B cells is particularly driven by the absence of
excess mutations within CDRs that have an adverse effect with respect to antigen
binding. Moreover, the high interclonal diversity of phagocytosed B cell fractions
demonstrated that interclonal competition is sustained throughout the GC response
most probably incited by ongoing replenishment of the pool of interacting B cells.
Finally, this finding closes the circle to the central asssumption of the revised model
of affinity maturation, that is recirculation of GC emigrant B cells.
In conclusion, the current thesis provides new insights into the evolution of B cells
within GC by proposing:
• non-synchronized GC formation and growth
• a multilevel selection strategy (intercalation of local and global selection by
recirculation of GC emigrant B cells)
• a central role for macrophages in retaining germinal center B cell homeostasis
and preventing autoimmunity
• the failure of commonly supposed molecular signatures to demarcate positively
and negatively selected B cells
• survival fate of GC B cells is particularly driven by absence of excess mutations
within CDRs that have an adverse effect with respect to antigen binding
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Zusammenfassung
Ein zentrales Merkmal der humoralen Antwort ist die im Laufe der Zeit ansteigende
Affinität der Antikörper gegenüber dem Antigen, ein Phänomen, das man generell
als Affinitätsreifung bezeichnet. Die Affinitätsreifung von Antikörpern ist an
die transiente Ausbildung von Keimzentren gebunden, die man nach Immuni-
sierung mit einem T-Zell-abhängigen Antigen in sekundär lymphatischen Geweben
wie der Milz beobachtet. Innerhalb der Keimzentren durchlaufen B-Zellen einen
mikro-evolutionären Prozess, in dessen Verlauf es zu einer Diversifizierung der von
den B-Zellen kodierten B-Zell-Rezeptoren durch somatische Hypermutation und an-
schließender Selektion derjenigen B-Zellen mit den besten Bindungseigenschaften
gegenüber dem Antigen kommt. In den letzten Jahren waren große Fortschritte hin-
sichtlich der Aufklärung der molekularen Mechanismen die zur Diversifizierung der
B-Zell-Rezeptoren beitragen zu verzeichnen, wohingegen die Dynamik, der Mecha-
nismus und die treibenden Kräfte der Selektion bisher weitgehend unverstanden
sind. Das Ziel dieser Arbeit ist es zum Verständnis der Evolution von B-Zellen in
Keimzentren beizutragen. Aus diesem Grund wurden das Wachstumsverhalten von
Keimzentren (Kapitel 4) und die Veränderung der zellulären Zusammensetzung von
Keimzentren (Kapitel 5) untersucht. Des Weiteren wurde in dieser Arbeit zum ers-
ten Mal auch die Kinetik der negativen Selektion (Kapitel 5) aufgenommen sowie
die B-Zell-Rezeptor Sequenzen von negativ selektierten Keimzentrums B-Zellen ana-
lysiert (Kapitel 6).
Anhand der Auswertung von Milzschnitten konnte eine robuste mittlere Größen-
kinetik von Keimzentrumsflächen nachgewiesen werden, die jedoch auf einer aus-
geprägten Größenverteilung von Keimzentren innerhalb der einzelnen Schnitte be-
ruhte. Diese ließ sich nicht durch zufälliges Anschneiden der Keimzentren erklären.
Des Weiteren wurde anhand von Simulationen gezeigt, dass das Profil der experi-
mentell aufgenommenen Größenverteilungen von Keimzentren nicht nur mit dem
traditionell angenommenen synchronisierten Wachtumsverhalten von Keimzentren,
sondern auch mit anderen hypothetischen Wachstumskinetiken übereinstimmt. Die
anschließend durchgeführte dreidimensionale, volumetrische Analyse hat gezeigt,
dass das Wachstumverhalten von Keimzentren - anders als bisher angenommen -
nicht-synchronisiert ist und sich durch fortgesetzte Neuformation und beträchtliche
Volumenverteilungen von Keimzentren auszeichnet. Auf Grundlage dieser Ergebnis-
se wurde ein neues, überarbeitetes Modell der Affinitätsreifung entwickelt, dessen
Hauptmerkmale die Rezirkulation von ausgewanderten Keimzentrums-B-Zellen so-
wie die zusätzliche Einführung eines globalen Selektionsprozesses sind.
Es wurde weiterhin gezeigt, dass die Kinetiken von Keimzentrums-T-Zellen und
Makrophagen der mittleren Gesamtwachstumskinetik der Keimzentren folgen. Die
Besiedlung der B-Zell-Zonen durch T-Zellen setzte erst nach der Immunisierung ein,
dagegen waren Makrophagen bereits in B-Zell-Zonen naiver Mäuse nachweisbar. Da-
zu konnte nachgewiesen werden, dass die Anzahl der Makrophagen strikt mit der
Größe der B-Zell-Zonen korreliert. Ein durch Zelltod von Makrophagen erworbenes
Ungleichgewicht zwischen Makrophagen und B-Zellen konnte mit dem Fortschrei-
ten der Erkrankung in NZB/W Mäusen, einem Mausmodell für systemischen Lupus
erythematodes (SLE), in Verbindung gebracht werden. Die Analyse der Kinetik und
der Lokalisation von apoptotischen Zellen hat des Weiteren gezeigt, dass Selektion
sowohl in der dunklen als auch in der hellen Zone von Keimzentren stattfindet.
Die Etablierung einer Methode zur Gewinnung von B-Zell-Rezeptor Sequenzen von
phagozytierten B-Zellen hat sich als sehr effektiv erwiesen, da sie zum ersten Mal die
Betrachtung von bis dahin völlig unerforschten negativ selektierten Keimzentrums-
B-Zellen zuließ und auf diesem Weg zu neuen Erkenntnissen bezüglich des Selekti-
onsprozesses geführt hat. In diesem Zusammenhang konnte gezeigt werden, dass die
bisher angenommenen molekularen Signaturen wie z.B. die Verteilung der Muta-
tionen in den Gerüst (FR)- und komplementaritätsbestimmenden Regionen (CDR),
das Verhältnis von Austauschmutationen zu stillen Mutationen (R/S) sowie das Vor-
kommen von Schlüsselmutationen, keine Unterscheidung bzw. Identifizierung von
Gewinnern und Verlierern der Selektion zulassen. Dahingegen hat sich die kumu-
lative Wirkung von Austauschmutationen in den CDRs als ein für das Überleben
von Keimzentrums-B-Zellen sehr wichtiges Kriterium herausgestellt, wobei jedoch
nicht wie bisher angenommen der positive Effekt, sondern die schädliche Wirkung
von Austauschmutationen entscheidend ist. Das Überleben von Keimzentrums-B-
Zellen ist demnach von der Abwesenheit überschüssiger, nachteiliger Mutationen
in den CDRs abhängig. Die hohe interklonale Diversität der phagozytierten B-
Zellen hat zusätzlich gezeigt, dass es einen andauernden interklonalen Wettbewerb
von Keimzentrums-B-Zellen gibt, der wahrscheinlich durch ständiges "Äuffüllen"des
Pools interagierender B-Zellen angetrieben wird. Hier schließt sich der Kreis zum
Kernpunkt des überarbeiteten Models der Affinitätsreifung, der Rezirkulation von
ausgewanderten Keimzentrums-B-Zellen.
In Kürze zusammengefasst trägt diese Arbeit durch folgende Erkenntnisse zum Ver-
ständnis der Evolution von B-Zellen in Keimzentren bei:
• nicht-synchronisiertes Wachstumsverhalten von Keimzentren
• mehrstufige Selektionsstrategie (Verknüpfung von lokaler und globaler Selek-
tion durch Rezirkulation von ausgewanderten Keimzentrums-B-Zellen)
• zentrale Rolle von Makrophagen für die Homöostase von Keimzentren und die
Verhinderung von Autoimmunität
• bisher angenommene molekulare Signaturen sind unzulänglich, um posititv
und negativ selektierte B-Zellen zu unterscheiden
• das Überleben bzw. positive Selektion von Keimzentrums-B-Zellen ist von der
Abwesenheit überschüssiger, nachteiliger Mutationen in den CDRs abhängig
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Chapter 1
Introduction
1.1 The immune response
The immune system is permanently challenged with myriads of foreign substances,
pathogens of different nature and origin. The most prominent pathogens comprise
bacteria, viruses, fungi and parasites - in their entirety referred to as antigens. In
order to guarantee protection against exogenous pathogens, the immune system is
build upon diverse modules that comprise barriers, soluble substances and cellular
constituents. The demand on the immune system to act globally is warranted by
the distribution of its components across the whole organism. Besides circulation of
"loose" immune cells, immune cells also constitute an integral part of various tissues
and preferentially accumulate in specialized immune organs. These immune organs
are classified as generative (primary) tissues, where immune cells are generated and
attain maturity and as peripheral (secondary) tissues where the response of immune
cells proceeds. The primary immune organs are bone marrow and thymus, whereas
spleen, lymph nodes, the cutaneous and the mucosal immune system are among
secondary immune organs and tissues.
The immune system is made up of three pillars that are immune barriers, innate
immunity and adaptive immunity. Potential pathogens first have to trespass the im-
mune barriers of an organism, such as physico-mechanical (e.g. epidermis, mucosa),
biochemical (e.g. pH, enzymes) and microbiological (e.g. intestinal flora) restraints.
After penetrating the immune barriers, invading pathogens are recognized by the
innate immune system. As the evolutionary oldest arm, the innate immune sys-
tem comprises germline coded immune mediators (e.g. cytokines, complement) and
immune cells (e.g. macrophages, granulocytes, NK cells). Activation of the innate
system typically evokes local immune reactions that prelude the rapid and effective
elimination of pathogens by either phagocytosis or cell lysis. In addition, the innate
immune system also stimulates the adaptive immune system that represents a highly
evolved defense mechanism, taking advantage of exquisite specificity, pronounced di-
versity and the capacity to establish immunological memory. The components of the
adaptive immune system are specialized immune cells named lymphocytes and their
products. There are two types of adaptive immunity that are mediated by differ-
ent components of the immune system. Cell-mediated immunity relies on cytotoxic
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T lymphocytes that promote elimination of intracellular pathogens like viruses and
some bacteria by either inducing the destruction of the residing pathogens or the ly-
sis of affected cells. Humoral immunity is mediated by blood-borne proteins, termed
antibodies, that are derived from B lymphocytes. Because antibodies are secreted
and thereby highly mobile they account for the major defense against extracellular
pathogens and their toxins. Binding of antibodies marks their targets for elimina-
tion and subsequently activates adequate effector mechanisms.
This thesis deals with a feature of humoral immunity that is to adapt to an infection
by a process referred to as affinity maturation of antibodies. Affinity maturation
takes place in specialized structures called germinal centers (GC), that transiently
develop in the B cell areas of secondary lymphatic tissues such as the spleen. Before
giving a detailed survey on the cells and mechanisms involved in the rather complex
affinity maturation machinery, the following sections will first introduce the proper-
ties of B cells and antibodies as well as the architecture and migratory pathways of
the murine spleen.
1.2 Mission of B cells and their antibodies
The adaptive immune system uses three classes of molecules for recognition of anti-
gens: major histocompatibility complexes (MHC), T cell antigen receptors (TCR)
and antibodies. Within these three classes of molecules, antibodies display the
highest specificity and capability to discriminate among antigenic structures. An-
tibodies institute a family of structurally related glycoproteins that participate in
both the recognition and effector phase of the humoral immune response. In their
membrane-bound form, antibodies are referred to as B cell antigen receptors (BCR).
The interaction of antigen and BCR initiates the B cell response and therefore ac-
counts for the recognition phase. In the effector phase, binding of secreted anti-
bodies masks the antigens and thereby triggers various effector mechanisms that
finally result in the elimination of the antigen. Due to their migrational behavior
in electrophoresis, antibodies are classified as gamma globulins and are commonly
named immunoglobulins (Ig). Therefore, antibody and immunoglobulin are used
interchangeably throughout this thesis.
1.2.1 The molecular structure of antibodies
The entirety of antibodies share the same basic structure but exhibit high variability
regarding the antigen binding region. The symmetric core structure of an antibody
is a heterodimer, composed of two heavy and two light chains that are covalently
connected via disulfide bonds (see Figure 1.1). Each heavy and light chain consists
of an amino terminal variable (V) and a carboxy terminal constant region (C). Due
to differences in the constant part, antibodies are subdivided into Ig classes (IgM,
IgD, IgA, IgG and IgE). The constant region of an antibody assigns the molecule its
Ig class and thereby permits different effector functions, such as complement activa-
tion and mediation of cell cytotoxicity. By contrast, the variable region designates
the antigen specificity to the antibody and thereby accounts for the recognition re-
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spectively binding of antigens. The antigen binding sites of an antibody are formed
by juxtaposing the V region of one heavy (VH) and one light chain (VL). The vari-
able regions feature three highly divergent stretches termed hypervariable segments
that are positioned by rather conserved framework regions (FR) (see Figure 1.1).
In three-dimensional space, the three hypervariable segments of the (VH) chain and
the three hypervariable segments of the (VL) chain are brought together to form the
antigen binding surface. Because the antigen binding surface is complementary to
the three-dimensional structure of bound antigen, the hypervariable segments are
also referred to as complementarity-determining regions (CDR).
Figure 1.1: Schematic depiction of the Ig molecule exemplified for IgG. The antigen binding sites
are formed by juxtaposition of variable light chain (VL) and variable region heavy chain domains
(VH). C; constant region, CDR; complementarity determining region, Fab; fragment antigen
binding, Fab; fragment antigen binding, Fc; fragment crystallizable, FR; framework, H; heavy
chain, L; light chain, V; variable region. Modified according to [1].
1.2.2 Antibody diversity
The enormous diversity of the antibody repertoire is generated by somatic recom-
bination - also referred to as rearrangement - of Ig genes during the development
of B lymphocytes in the bone marrow (see Section 1.2.3 and Figure 1.2). Three
separate loci encode the two Ig light chains (IgL; Igκ, Igλ) and the Ig heavy chain
(IgH). Each light chain locus is composed of three different clusters of gene seg-
ments, referred to as variable (V), constant (C) and joining (J) gene segments. The
IgH locus bears an additional cluster of diversity (D) gene segments. The repertoire
analyses performed for the current thesis are exclusively related to the murine light
chain loci. Therefore, the germline organization of the Igκ locus on chromosome
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6 is exemplarily depicted in the appendix (Figure A.1). The nomenclature of the
Igκ locus and a detailed description of its organization is given by Martinez-Jean
et al. [2]. Each cluster of gene segments comprises a defined number of functional
genes, for example the murine Igκ locus features a V segment cluster of 93 genes, a
J segment cluster of 5 genes and a C segment cluster of 1 gene. The genes within
a cluster are each separated from one another by regions of non-coding DNA that
vary in length. The somatic recombination of gene segments within each Ig locus is
a requisite for the production of a functional antibody molecule and follows a precise
order (reviewed in Krangel [3]). The first recombination, occurring in the IgH locus
results in joining of one of the D to one of the J gene segments. Thereafter, one of
the V gene segments is joined to the DJ complex. Due to the lack of D gene segments
within the light chain loci, somatic recombination directly joins one of the V to one
of the J gene segments. The somatic recombination of gene segments within each
locus occurs randomly. Therefore, the diversity that can be generated at each locus
depends on the number of genes within its clusters. In case of the murine Igκ locus -
by multiplying the number of Vκ (93) and Jκ (5) genes - the combinatorial diversity
adds up to 93·5=465 possible combinations. The overall combinatorial diversity of
antibodies - calculated by multiplication of the combinatorial diversities of the IgH,
Igκ and Igλ loci - ranges in an order of magnitude of about 106.
The diversity of antibodies is further enhanced by the so-called junctional diversity
that is due to "non-precise" joining of gene segments. During somatic recombi-
nation, nucleases may remove nucleotides of the recombining gene segments. In
addition, the enzyme terminal deoxyribonucleotidyl transferase (TdT) mediates the
random addition of up to 20 non-germline encoded nucleotides (n-nucleotides) at
the junctions. The junctional diversity raises the overall diversity of antibodies by
a factor of approximately 107 [4]. Taken together, the theoretical murine antibody
repertoire comprises marvelous 1013-1014 different specificities. Because formation
of the B lymphocyte repertoire in the bone marrow is antigen independent, it is also
referred to as pre-immune repertoire.
1.2.3 Development and maturation of B lymphocytes
In mammals, the B lymphocyte ontogeny starts in the fetal liver and spleen and
proceeds in the bone marrow of adult individuals [5]. The "B" in B lymphocyte
refers to bursa-derived. This is because proliferating foci of newly generated B lym-
phocytes were first defined in the bursa fabricius (latin: Bursa cloacalis or Bursa
fabricii) of birds [6], nicely reviewed in Ribatti et al. [7]. Almost a decade after the
description of the bursa, research discovered that the development of B lymphocytes
of mammals - that do generally not possess a bursa equivalent organ - takes place
in the bone marrow. The B cell lymphopoiesis and maturation can be divided into
an antigen-independent and an antigen-dependent phase (outlined in Figure 1.2).
The antigen-independent development of B-lymphocytes takes place in the locale of
the bone marrow, where hematopoietic stem cells differentiate to immature B lym-
phocytes. During this developmental phase, the Ig loci are subjected to somatic
recombination (reviewed in Section 1.2.2). B cells that do not succeed in generating
a functional BCR undergo apoptosis. Immature B lymphocytes that express func-
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tional BCRs are subsequently subjected to a selection process that preserves useful
but eliminates potentially harmful self-reactive cells. A powerful description of the
maturation of B lymphocytes in the bone marrow and in particular the selection
events operating at the various developmental stages is given by Melchers et al. [8]
and Rolink et al. [9]. Apart from instant elimination, self-reactive B lymphocytes
may also undergo active genetic correction of their receptors by secondary recom-
bination of the DNA (referred to as receptor editing, reviewed by Nemazee [10]).
Due to the cell death occurring at various stages of the development of B lympho-
cytes, less than 10% of the originally generated B lymphocytes acquire functional
competence and leave the bone marrow. In the late stages of B cell development
the immature B lymphocytes emerging from the bone marrow have to migrate to
the spleen, where they may finally differentiate to mature B cells [11].
Figure 1.2: B lymphocyte development and maturation. Illustrated are both, the developmental
stages of a B lymphocyte and the status of Ig gene rearrangement and expression during maturation
in the bone marrow. µH; µ heavy chain protein, VpreB; pre-B cell receptor. Modified according
to [1].
1.3 The architecture of the spleen and migratory
pathways
The spleen constitutes the largest secondary lymphatic organ of mammals and com-
bines the implementation of two important functions: filtration of blood and de-
fense against pathogens. Its effectiveness is based on the organization of functional
compartments, each featuring adapted microarchitecture (Figure 1.3). The splenic
red pulp is characterized by a specialized network of open sinuses that facilitates
filtration of the blood and removal of old or damaged erythrocytes. Due to the
high abundance of erythrocytes, it is macroscopically tinged red - to which the red
pulp owes its name. The red pulp is intermingled with white pulp cords that lack
erythrocytes but instead mostly consist of white blood cells such as lymphocytes,
macrophages and dendritic cells. Within the white pulp, T and B lymphocytes
accumulate in well separated compartments. Whereas T lymphocytes are located
within the periarteriolar sheaths (PALS) surrounding the incoming central arteri-
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oles, B lymphocytes reside in adjacent B cell follicles. The white pulp is further
encompassed by the so-called marginal zone that harbors specialized macrophages,
dendritic cells and a particular subset of B lymphocytes referred to as marginal
zone B cells (for further reading about marginal zone B cells, see Lopes-Carvalho
and Kearney [12]). Within the marginal zone, the blood leaks from the terminal
arterioles into the open sinuses resulting in a slow-down of the blood flow. This
facilitates the marginal zone, in particular its residing macrophages, to act as an
important trap for particulate antigens [13].
The initial organization and maintenance of the splenic architecture is supervised by
a set of factors that includes cytokines, chemokines and adhesion receptors. Studies
in lymphotoxin (LT) as well as tumor necrosis factor (TNF) deficient mice support
a pivotal role of signals transmitted by LTα for the correct formation of secondary
lymphoid tissue [14]. As shown by Kim et al. [15], local LTα expression is capable
to provoke basic lymphoid organogenesis even in the absence of functional B and
T lymphocytes. Reconstitution experiments further demonstrate that LTα is re-
quired for the segregation of B and T lymphocytes in the splenic white pulp. LTα
expression by B cells on the one hand causes the recruitment of follicular dendritic
cells (FDC) towards B cell areas [16] and on the other hand provides a signal that
is essential for retention of the T cell zones [17].
Even though the splenic compartments are well-established, they are subjected to
a permanent flux of lymphocytes - within and between compartments, in and out.
Lymphocytes enter the white pulp via the blood that is released in the marginal
zone. The transit of lymphocytes from the marginal zone towards white pulp cords
depends on both the presence of adhesion molecules such as leukocyte function-
associated antigen (LFA-1) and very late antigen (VLA)-4 [18] and chemokine re-
ceptor signaling. The importance of chemokine receptor signaling was first pointed
out by Cyster and Goodnow [19] who observed accumulation of lymphocytes that
fail to enter the white pulp due to uncoupling of chemokine receptor signaling follow-
ing pertussis toxin treatment. Since then, the gain in knowledge steadily increased
and meanwhile, the lymphoid chemokines that control attraction of lymphocytes to
their respective compartments are identified. B lymphocytes are directed towards
B cell follicles due to CXCL13 (chemokine (C-X-C motif) ligand 13) expression by
FDC and adjacent stromal cells. The migration of B cells relies on the expression
of the chemokine receptor for CXCL13 by B lymphocytes, that is CXCR5 [20, 21].
On the other hand, T lymphocytes are attracted to the T cell areas due to stromal
cell derived delivery of the chemokines CCL19 and CCL21, both interacting with
the chemokine receptor CCR7, expressed by T lymphocytes [22, 23].
B lymphocytes first encounter antigen in the marginal zone or outer part of the
T cell zone (bridging area). In response to antigen engagement, B lymphocytes
downregulate CXCR5 but instead upregulate CCR7 expression that facilitates their
migration towards the B-T border. Interaction with T lymphocytes at the B-T bor-
der, finally activates B lymphocytes that afterwards may either become antibody
secreting plasma or GC precursor cells [24, 25, 26]. The B lymphocytes committed
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to GC upregulate CXCR5 and migrate back towards a B cell follicle. Alike, a subset
of T cells acquires CXCR5 expression that makes it enter the B cell follicles or GC,
respectively [27].
Figure 1.3: Architecture of the murine spleen. The murine spleen is composed of two major com-
partments that are referred to as red pulp and white pulp. The red pulp is characterized by a
network of open sinuses that facilitate filtration of the blood and in particular removal of old ery-
throcytes. The red pulp is intermingled with white pulp cords that mostly harbor white blood cells.
Within white pulp cords, B and T lymphocytes are confined to well-separated subcompartments.
T lymphocytes are located within the PALS, B lymphocytes reside in adjacent follicles. Red pulp
and white pulp are separated by the marginal zone. PALS; periarteriolar lymphoid sheath. Scale
bar 0.5 mm.
1.4 The formation of germinal centers (GC)
The term germinal center (GC) was introduced by Walther Flemming - a pioneer
in the field of cytogenetics - more than 120 years ago. While studying cell division
in lymph nodes, he observed strong proliferation of lymphocytes within the follicles
and suggested that these sites constitute the origin of lymphocyte generation or ger-
mination, respectively [28]. Flemming assigned the term germinal center to these
structures according to their supposed function (discussed in Berek [29]). The term
outlasted until today although we now know that not Flemming’s GC but bone
marrow and thymus are the primary lymphoid organs and sites of lymphocyte dif-
ferentiation. Nevertheless, Flemming’s interpretation was not quite wrong, because
GC are indeed the source of generation of unique B cells (GC B cells) featuring
high affinity B cell receptors. The process leading to high affinity B cell receptors is
referred to as affinity maturation and was first assigned to the locale of GC about
20 years ago [30, 31, 32, 33]. In addition, the formation of B cell memory as well as
immunoglobulin (Ig) isotype class-switching are likewise associated with the GC re-
action. The importance to elucidate GC formation, progression and not least mode
of operation is stressed by the fact that malfunction or deregulation is linked to
the onset of severe diseases, most prominent cancer and autoimmunity (reviewed in
Section 1.4.5).
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1.4.1 Commitment of B cells to GC
Appropriate immunization with T cell dependent (TD) antigens typically results in
the transient formation of GC in secondary lymphoid tissues. The sites and dy-
namics of responding antigen-specific B cells in a primary immune response were
first revealed in a series of seminal in situ studies by Kelsoe and colleagues as
well as Liu et al. in the early 1990’s. Via their migratory pathway, B cells are
believed to first interact with antigen in the marginal zone or outer parts of the
interfollicular T cell zones, that are - in context of the spleen - referred to as peri-
arteriolar lymphoid sheath (PALS). After initial B cell activation, B lymphocytes
either commit to an extrafollicular proliferative focus response or to enter primary
B cell follicles and found GC. The basis of direction towards one of these pathways
is still under discussion. Initial experiments performed with hapten-carrier conju-
gates (NP-CGG) suggested that recruitment of B cells to either of the pathways is
essentially a stochastic process [34, 35]. In contrast, very recent studies based on
the adoptive transfer of B cells, that express defined anti-hen egg lysozyme (HEL)
BCRs, and subsequent immunization with HEL coupled to SRBC indicate that the
direction towards one of the pathways is not stochastic but rather determined by
the strength of the initial interaction between BCR and antigen. In this scenario,
B cells featuring a strong initial interaction with antigen contribute to the early T
dependent response by rapidly differentiating to extrafollicular plasma cells. B cell
clones of weak antigen reactivity are primarily drawn to found GC and thereby to
undergo affinity maturation [36]. In either case, becoming a GC precursor B cell and
above all propagation of GC requires adequate T cell help. The need for adequate
T cell help is underlined by the both, rare and abortive formation of GC observed
in response to T cell independent type 2 (TI-2) antigens such as NP-Ficoll. TI-2
antigens evoke an immune response with a strong bias towards an extrafollicular
focus response and GC are only generated if antigen dose and precursor frequencies
are sufficiently high [37].
1.4.2 Cellular players of GC
Besides GC B cells, at least three other cellular players participate in the GC reac-
tion: follicular dendritic cells (FDC), GC T cells and GC macrophages (GC Mφ).
Follicular dendritic cells (FDC)
The dendritic processes of FDC form dense networks (FDC networks) that are al-
ready detectable in the primary B cell follicle and provide a follicular niche for the
formation of GC. Therefore, the maximal number of GC is predetermined by the
limited number of follicular niches [38]. FDC present non-processed antigen in form
of either antigen-antibody or antigen-complement complexes, collectively referred to
as immune complexes.
GC T cells
As aforementioned, T cells are a requisite for formation and progression of GC.
The T cell help required for antibody production has long been considered a Th2
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property [39, 40] but was recently shown to rely on a third class of effector-type
T cells referred to as follicular B helper T cells (TFH) [41, 27, 42]. Homing of
TFH cells to B cell follicles occurs after gain of responsiveness to the chemokine
CXCL13 that is expressed by follicular stromal cells. CXCL13 binds to the CXC
chemokine receptor (CXCR)5 that is expressed by T cells upon T cell activation in
the T cell zone. Indeed all T cells that localize in B cell follicles are CXCR5+. The
relationship of TFH to Th1 and Th2 cells - in particular the question if TFH cells
represent a separate subset or if they are derived from either Th1 or Th2 cells - is
still unresolved.
GC macrophages (Mφ)
Noteworthy, GC macrophages represent the earliest identified cellular players of
GC. In 1885, Walther Flemming did not only discover GC but yet he additionally
reported the emergence of tingible bodies within GC for the first time [28]. Already
suggested by Flemming and finally proven by Swartzendruber and Congdon [43],
the tingible bodies of GC represent phagocytosed nuclear debris of lymphocytes.
Accordingly, the macrophages of GC were referred to as tingible body macrophages.
Although well-known for more than a century, the macrophages of GC somehow
got neglected. The rather marginal knowledge of macrophages within GC solely
attributes to a series of publications of Smith et al. [44, 45, 46]. They suggest
that the macrophages within GC represent a unique, vigorously phagocytic subset
of mature macrophages. Furthermore, they claim that these macrophages are not
a requisite for the induction of GC, because they are absent from B cell follicles
prior to the GC reaction. On the other hand, Smith et al. [44] propose that GC
macrophages may be specialized in downregulating the GC reaction. In the recent
past, the discussion of GC macrophage origin and function was revived, actuated by
their malfunction being associated with development of autoimmune diseases such as
systemic lupus erythematosus(SLE). The contribution of GC and GC macrophages
to autoimmunity is reviewed in a discrete section (Section 1.4.5).
1.4.3 Affinity maturation
A striking phenomenon of humoral immune responses is the progressive improve-
ment of binding properties of antibodies. This so-called affinity maturation is due
to further diversification of B lymphocytes after antigen engagement of their BCR,
realized by introduction of somatic mutations into the sequences encoding the vari-
able regions of the BCR. Subsequently, an efficient selection process ensures the
detection and promotion of the B lymphocytes featuring the highest affinity for the
antigen.
How does the immune system accomplish affinity maturation on the cellular and
mechanistical level? Basically, affinity maturation is confined to the presence of
follicular GC, albeit GC-like structures were discovered outside of B cell follicles or
even outside lymphatic tissues under certain conditions (ectopic GC) [47, 48, 49].
There is a standard view on the GC reaction even propagated by immunology text
books that was entitled as textbook GC response in an innovative review by Manser
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[50]. The need for such a label is emphasized by the fact that the transitions between
experimental certainty and deductive theoretical assumptions are often obliterated
with respect to the GC reaction. The following paragraphs will concentrate on affin-
ity maturation in the light of textbook GC (schematically illustrated in Figure 1.4),
disclosing only some of the discrepancies of recent studies and textbook behavior (a
full review is given by Manser [50]).
After commitment (Section 1.4.1), GC precursor B cells migrate towards B cell fol-
licles, settle down in the stromal environment created by FDCs and commence an
expansion phase characterized by brisk proliferation [51, 52]. The vigorously prolif-
erating GC B cells (also referred to as centroblasts) then give rise to formation of the
so-called dark zone of GC. Subsequently, centroblasts are subjected to mutational
activity of their Ig genes, implemented by the induction of a mechanism referred to
as somatic hypermutation (SHM).
Diversification by mutation of Ig genes was already suggested more than 40 years
ago [53, 54]. However, it was first experimentally validated by sequencing of Ig genes
of λ light chains of murine myeloma cells [55]. Although the mechanisms underlying
SHM - briefly, deamination of cytidines due to an enzyme referred to as activation
induced cytidine deaminase (AID) [56, 57, 58, 59] followed by excision mismatch
repair - were identified in the last years, both, the induction and regulation of SHM
constitute an enduring enigma [60]. The rate of somatic mutation in Ig genes is
about 103 to 104 higher than the spontaneous rate of mutation in other genes, a fact
that somatic hypermutation owes its name. Merging the estimated rate of SHM
(10−3/bp per cell/generation) [61] and the total number of base pairs that encode
the variable region of an antibody (n=700) results in an average rate of accumula-
tion of mutations of almost 1 per cell division.
As a consequence of mutations in their Ig genes, many of the GC B cells feature
declined or even annihilated antigen binding properties. However, some of the cells
are likely to acquire useful mutations generating high affinity antibodies. The next
pivotal step of affinity maturation comprises the preferential selection and prop-
agation of the very GC B cells that have acquired mutant BCR of high affinity.
Selection is attributed to the so-called light zone of the GC that is rich in FDC
and additionally harbors GC T cells. The centroblasts are believed to exiT cell
cycle and to migrate towards the light zone of GC. The henceforth non-proliferating
GC B cells within the light zone (also referred to as centrocytes) vastly compete
for survival signals provided by engagement of their BCR with antigen on FDCs.
Unless they do not receive these survival signals, all centrocytes are prone to apop-
tosis. This disposition ensures that only the centrocytes that feature high affinity
towards the antigen are retained. The remainder centrocytes undergo apoptosis by
default. Within GC, apoptotic cells are immediately recognized, engulfed and finally
degraded by macrophages. Surviving centrocytes are thought to internalize, process
and afterwards present the antigen to GC T cells resulting in IgH class-switching
and terminal differentiation to either pre-antibody forming cells (AFC) or memory
B cells that subsequently exit GC.
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Although the basis of the outlined textbook selection procedure seems quite com-
prehensible, it should be interpreted as a hypothesis, because direct experimental
validation is still missing. Although FDC are certainly capable of retaining antigen
for extended periods of time [62], their impact on the selection process is quite ar-
guable. Recent studies of mice, deficient in mounting secreted antibodies and thus
incapable of deposition of immune complexes on FDC, point out that formation of
GC as well as the first stages of SHM and subsequent selection may occur even in
the absence of detectable levels of antigen on FDC [63]. Additionally, Vora et al. [64]
demonstrate that enhanced deposition of immune complexes on FDC does not result
in relaxed stringency of selection, as anticipated from the textbook model. Besides
their questionable involvement in the selection process, FDC seem to be essential for
maintaining the response, by providing an indispensable niche for B cell clustering,
proliferation, survival and differentiation [65, 66].
The central dogma of textbook GC is the spatial separation of processes by in-
stalling two compartments: proliferation and hypermutation are confined to the
dark zone, whereas selection and differentiation occur in the FDC-rich light zone
of GC. This concept was initially inspired by analysis of chronically inflamed hu-
man tonsils. However, as demonstrated by Camacho et al. [67], it does not hold
true in case of murine de novo arising GC. Although acutely induced GC develop
two compartments - one rich and one poor in FDC - the cellular composition of
these compartments is subjected to a rather complex time evolution (schematically
outlined in Figure 1.5). As a result, the installment of a typical textbook dark and
light zone structure turns out to be constricted to a rather late and short time-
frame - at a time when selection is known to already have been deployed. As a
hallmark, proliferating GC B cells were detected in the FDC-rich compartment at
all times. Furthermore, murine GC B cells display a rather uniform histological
phenotype and the vast majority stays in cell cycle throughout the response [68, 69].
Taken together, these data indicate that besides selection and differentiation also
proliferation and hypermutation may take place in the FDC-rich compartment of
GC. Moreover, hypermutation and selection seem to act on a rather homogeneous
GC B cell population, thereby challenging the concept of centroblasts and centro-
cytes.
1.4.4 Assessing the transient nature of germinal centers
As aforementioned, the formation of GC in response to TD antigens is not stable
but transient. Independent studies applying various antigens demonstrate in unison
that GC are detectable within an interval of 3 to 4 weeks after antigenic challenge.
In each case, the overall growth kinetics - comprising appearance, expansion and
decay of GC - was deduced from evaluation of planar tissue sections of either spleen
or lymph node (cross-sectional evaluation). Besides counting the actual numbers of
GC per tissue section [70], a more precise measure was introduced by either record-
ing the relative volume of all GC [24] or the distribution of volumes of individual
GC [45] at different time points after immunization. In either of the latter two cases
the volume represents an extrapolated quantity, derived from evaluation of planar
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Figure 1.4: Illustration of a textbook GC reaction. Committed B lymphocytes enter GC and
there undergo affinity maturation. While proliferating in the dark zone (DZ), B lymphocytes are
subjected to somatic hypermutation. After migration towards the light zone (LZ) of the GC,
high affinity B lymphocytes are selected due to engagement of their BCR and immune complexes
deposited on FDC. B lymphocytes featuring low or annihilated affinity become apoptotic and are
immediately engulfed and degraded by macrophages. Positively selected B lymphocytes interact
with T cells, resulting in IgH class-switching and final differentiation to either pre-AFC or memory
cells that exit the GC.
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Figure 1.5: Illustration of the time evolution of de novo arising murine splenic GC, according to
Camacho et al. [67]. Proliferating GC B cells are first detected in the FDC poor compartment and
subsequently move to the FDC network. Around days 7-9 after immunization the FDC network is
completely filled with proliferating GC B cells. Afterwards a typical dark and light zone structure
is installed, characterized by non-proliferating GC B cells within the FDC network. By day 15 the
dark zone is absent and proliferating and non-proliferating GC B cells are scattered throughout
the FDC network.
tissue sections. Nevertheless, the course of the recorded overall growth kinetics is
concordantly characterized by an initial expansion phase of GC - peaking at around
day 10 - thereafter followed by gradually decay phase. At the peak of the response,
GC harbor a maximal number of a few thousand GC B cells [71]. Taken together,
the above cited works provide the basis for assuming a lifetime of GC of about 3
weeks.
Another yet puzzling feature of GC is their termination. Due to the lack of direct
experimental proof, the factors that govern the termination of a GC reaction remain
unidentified until now. Nevertheless, scientists put forward various hypothesis re-
garding the termination of the GC reaction that will be outlined in the following.
One explanation for the termination of the GC reaction is the gradual antigen de-
pletion due to extraction and uptake of antigen from FDCs by GC B cells. Although
the mathematical model proposed by Kesmir and De Boer [72] demonstrates that
such a phenomenon may result in termination of GC, it is rather unlikely that it
contributes to the decay of GC in vivo, because considerable amounts of antigen
are retained on FDC, even after the response has waned [73]. Tarlinton and Smith
[74] suggested that a declined antigen accessibility - due to the successive masking
of antigen by secreted antibodies - may account for the termination of GC. In con-
trary, Meyer-Hermann et al. [75] envisioned a scenario, where increased emigration
of GC B cells results in the termination of GC. In a very recent publication Moreira
and Faro [76] propose yet another model, that is based on the decay of a hypothetical
proliferation signal, thereby limiting the number of cell divisions.
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1.4.5 Contribution of germinal centers to autoimmunity
The significance to study and to eventually understand GC is emphasized by the
strong association of its malfunction with the onset of severe disease. In case of
B lymphocytes, the generation of specifities is not restricted to the primary lymphoid
organ or bone marrow, respectively, but is reinstalled within the environment of GC
after antigen exposure. Figuratively, GC can be understood as insular "generative"
microstructures, therefore necessitating tight regulation. Basically, somatic hyper-
mutation of B lymphocytes within GC poses two risks: emergence of self-reactivity
and B cell malignancy (lymphoma, leukemia) [77]. The following paragraphs will
concentrate on the aspect of autoimmunity, in particular on the generation of anti-
DNA antibodies. Nevertheless, an informative review on the contribution of GC to
B cell malignancy is given by Kuppers [78].
The emergence of activated autoreactive B lymphocytes always indicates a func-
tional loss of central or peripheral tolerance, respectively. In the healthy state,
B lymphocytes featuring self-reactivity are eliminated from the repertoire at vari-
ous checkpoints during B cell development. Concordantly, failure of either one or
even several of these checkpoints during B lymphocyte development results in the
accumulation of potentially harmful B lymphocytes.
In systemic autoimmune diseases, the major targets of self-reactive B lymphocytes
comprise a limited set of autoantigens, such as ribonuclein, IgG and chromatin
[79, 80]. As a hallmark, autoimmune disorders are generally not driven by single
but rather by a medley of self-epitopes. In addition, the targeted epitopes often
alternate during a response, a phenomenon referred to as epitope-spreading. Never-
theless, there is evidence for predominance of certain epitopes in different autoim-
mune diseases. Whereas rheumatoid arthritis (RA) and Sjogren’s syndrome feature
high titers of anti-IgG (rheumatoid factor (RF)) autoantibodies, RF are less frequent
in systemic lupus erythematosus (SLE). Lupus-like diseases are rather characterized
by the high prevalence of anti-nuclear autoantibodies. In SLE, autoantibodies to
double-stranded DNA (anti-dsDNA) typically have a IgG isotype and their serum
titer correlates positively with disease activity. In addition, progressive deposition
of the very autoantibodies in glomeruli of the kidney causes fatal lupus nephritis.
The generation of anti-dsDNA antibodies in lupus-like diseases is of special interest
for the current thesis, because studies performed by Wellmann et al. [81] point out
that anti-DNA reactivity is generated during a normal immune response. Figura-
tively, once harmless non-autoreactive B lymphocytes acquire de novo anti-DNA
specificity during somatic hypermutation within GC. Due to the failure of a GC-
confined tolerance checkpoint, the autoreactive cells are not eliminated but give rise
to antibody secreting plasma cells.
How do anti-DNA reactive GC B cells manage to bypass negative selection, or the
other way round why do they become positively selected? As an answer to this ques-
tion, Gaipl et al. [82] propose an elegant model. They suggest that as a consequence
of impaired uptake by macrophages, apoptotic cells accumulate and undergo sec-
ondary necrosis within GC, thereby releasing danger signals and modified autoanti-
gens. These "free" autoantigens become accessible due to binding to FDC, most
14
probably through complement receptor (CR) 2/CD21 [83]. Consequently, autore-
active GC B cells are positively selected because their BCR engages the henceforth
accessible autoantigen on FDC. In case of SLE, chromatin - that is well-known to
activate complement [84] - is believed to represent the triggering antigen for positive
selection of anti-DNA reactive GC B cells. After being positively selected, autoreac-
tive B lymphocytes finally exit the GC and may give rise to autoantibody secreting
plasma cells.
The outlined model is affirmed by a set of experimental findings. Histological exami-
nation of lymph node biopsies reveals that SLE patients indeed feature accumulation
of apoptotic cells within GC. Furthermore, the number of GC macrophages is signif-
icantly decreased in GC of SLE patients [83]. A crucial function for the removal of
apoptotic cells in GC is assigned to milk fat globule epidermal growth factor (EGF)
factor 8 (MFG-E8), that is strongly expressed by GC macrophages. Notably, MFG-
E8 deficient mice develop a lupus-like disease, featuring high titers of anti-DNA
antibodies and glomerulonephritis. The same applies for wildtype mice, if MFG-E8
function is impaired due to administration of anti-MFG-E8 antibodies [85, 86]. Al-
though there is strong evidence that the pathogenesis of SLE-like diseases is related
to disturbances in the macrophage compartment, the cause of altered clearance ca-
pacities of macrophages is still ill-defined. As reviewed by Gaipl et al. [87], intrinsic
defects of macrophages as well as defects of serum factors may contribute to im-
paired uptake of apoptotic cells. As already stated by Zullig and Hengartner [88],
tickling macrophages is a serious business.
Just recently, two novel GC-related tolerance checkpoints - both engaged only af-
ter initial activation of autoreactive B lymphocytes - were reported by [89]. One
checkpoint prevents AFC but allows GC formation of autoreactive RF-expressing
B lymphocytes. The other checkpoint impairs selection of RF-expressing B lympho-
cytes within GC. Both of these checkpoints are shown to fail in autoimmunity.
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Chapter 2
Objectives
There has been continuous progress in understanding the micro-evolutionary pro-
cess resulting in affinity maturation of B cells over the last decades, which lead to a
general conception of the GC reaction that is now found in immunology textbooks.
However, the gain in knowledge mostly applies to particular subprocesses occurring
within GC, as for instance somatic hypermutation and the signaling involved in
differentiation of GC B cells along either, the plasmacytoid or memory pathway.
By contrast, the actual crux of the matter, that is how GC B cells that gained
heightened affinity are selected within GC, remains rather elusive, in that experi-
mentally validated verities often mingle with theoretical hypotheses. The current
thesis aims at providing new insights into the evolution of B cells within GCs by
particularly addressing the when, where and how they are selected and not least
propagated during the primary immune response. A major approach to this prob-
lem is to overcome the unilateral winner-sided view on B cell evolution by placing
special emphasis on the "dark side" of the GC reaction, that is negative selection
and cell death of GC B cells.
Specific aims
• Documentation of overall GC growth behavior and changes of cellular composi-
tion of GC/GC subcompartments following immunization, regarding all major
players of GC, namely GC B cells, macrophages and T cells. This should help
to answer questions of tempo-spatial organization and regulation of affinity
maturation. Moreover, such analysis might reveal new aspects regarding the
interplay of the cellular players of GC.
• In-depth analysis of the kinetics of cell death/negative selection occurring
within GC (where, when and how much?). This should provide new insights
regarding the temporal and spatial extent of the selection process.
• Comparative analysis of positively (living) and negatively selected (dying)
GC B cells by means of their BCR sequences in order to explore why or by
which criteria/molecular signatures GC B cells are selected.
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Chapter 3
Material and methods
Chemicals were purchased from Merck unless otherwise noted. The sources of supply
are documented in the appendix (Table A.5).
3.1 Applied software and databases
Software/Database Version
Amira Version 3.0 (Mercury Computer Systems)
Analyze-It Version 1.7.2
Arivis browser Version 1.6
CLC Free Workbench Version 2.5.2 (CLC)
Chromas Lite Version 2.01
FCS Express Version 3 (De Novo Software)
ImageJ Version 1.35q (NIH)
IMGT database/IMGT/V-Quest [90]
Leica LCS Version 2.6.1
MatLab (The MathWorks)
Photoshop CS Version 8.0.1
R Version 2.4.1
SigmaPlot Version 9.0 (Systat)
VBase2 http://www.vbase2.org/
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3.2 Solutions and buffers
Buffer/solution Components
50x TAE buffer 242 g/L Trisbase, 57.1 mL/L 96% acetic acid,
10% EDTA 0.5M pH 8.6
Blocking buffer PBS, 3% BSA (Fraktion V, Sigma)
Erythrocyte lysis buffer 10 mM KHCO3, 155 mM NH4Cl, 0.1 mM EDTA
FACS buffer PBA, 4 mM EDTA, pH 8.0
Fixation buffer (FACS) 2% paraformaldehyde (PFA)
Fixation buffer (TUNEL) 1% PFA
LB medium (Bio101) 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl
LB agar LB medium + 15 g/L Selekt Agar (Sigma)
Sodium phosphate buffer 1 M Na2HPO4, 1 M NaH2PO4
PBA PBS, 0.5% BSA (Fraktion V, Sigma)
PBS 130 mM NaCl, 10 mM sodium phosphate buffer
Permeabilization buffer (FACS) 0.5% (w/v) Saponin (Sigma) in PBA
Permeabilization buffer (TUNEL) 1% sodium citrate, 1% Triton X-100 (Promega)
YT medium (Bio101) 16 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl
YT agar YT-Medium + 15 g/L Selekt Agar (Sigma)
3.3 Consumables supplies
Consumables Source of supply
Centrifuge tubes 50, 15 mL (Corning)
Imject Alum (Pierce)
Microtome blades SEC35 (Microm)
Mini lancets (Braun)
Petri dishes ∅ 10 cm (Greiner)
Reaction tubes 0.5, 1.0, 2.0 mL (Eppendorf)
Superfrost Plus slides (Roth)
Cover slips (Roth)
Cryomolds (Sakura)
Paint brushes
3.4 Mice, antigen and immunization
BALB/c mice were bread and maintained in the facilities of the BgVV Marienfelde
and used between the age of 6-10 weeks. Immunization was performed by a sin-
gle intraperitoneal (i.p.) injection of 100 µg alum precipitated 2-phenyloxazolone
(Sigma) coupled to chicken serum albumin (phOx-CSA) in a ratio of 10:1 [91].
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3.5 Tissue collection and cell preparation
Mice were sacrificed by cervical dislocation and subsequently the spleens were dis-
sected. For immunohistology purposes spleens were embedded in cryoprotective
Tissue-Tek OCT compound (Sakura), cautiously frozen in liquid nitrogen and stored
at -70◦ C until cryosectioning. By default spleens were bisected giving rise to two
cryopreserved tissue specimens except for the spleen tissue intended for the three
dimensional reconstruction experiments.
Spleen sections of NZB and (NZB/W)xF1 mice were kindly provided by Katrin
Moser and Daniel Panne (Research Groups Humoral Immunology and Autoim-
munology, DRFZ, Berlin).
For flow cytometry, single cell suspensions were prepared from dissected spleens.
Spleens were mechanically disaggregated by pressing through 70 µm cell strainers
(Becton Dickinson) using flattened pestles and the cell strainers were subsequently
washed with PBA. Thereafter, the cell suspensions were filled-up with PBA to a
volume of 50 mL and centrifuged at 400 x g for ten minutes. The supernatant
was discarded and the cell pellet was resuspended in 5 mL erythrocyte lysis buffer.
Lysis of erythrocytes was stopped after one minute by addition of 10 mL PBA.
Afterwards, the cell suspensions were centrifuged at 400 x g for ten minutes, the
supernatant was discarded and the cell pellet was resuspended and washed in PBA.
The cell pellet was again collected by centrifugation at 400 x g for ten minutes and
discarding the supernatant. The cell count was determined by using the Casy Cell
Counter. The pellet was finally resuspended in PBA to a cell concentration of 106
cells per mL.
3.6 Immunohistology
A major part of this thesis deals with high-throughput immunofluorescence staining
and subsequent evaluation of cryopreserved spleen sections for different purposes.
On this account, the applied protocols differ in order to serve the respective purpose.
A comprehensible representation of this protocols is given by first introducing the
standard protocol and afterwards specifying the modifications for each application.
3.6.1 Cryosectioning of spleen tissue
Cryosectioning was performed applying a Microm HM 500 OM cryostat adjusted to a
box temperature of -20◦C and an object temperature of -17◦C. Frozen tissue samples
were first allowed to adjust to the box temperature by leaving them untouched in the
box for about fifteen minutes. Cryosections of a thickness of 8 µm - corresponding
to one cell layer - were cut and picked up onto Superfrost Plus glass slides (Roth).
For the three dimensional reconstruction experiments sections of 25 µm thickness
were cut. Tissue sections were air-dried for about one hour at room temperature and
subsequently fixed in fresh cold acetone for ten minutes. After complete evaporation
of acetone, slides were stored at -70◦C.
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3.6.2 Standard protocol for immunofluorescence staining
Splenic cryosections were allowed to thaw at room temperature for about five to
ten minutes before they were encircled with a grease pen (Dako pen, Dako). Prior
to staining with various antibody combinations (Table 3.1), unspecific binding was
prevented by blocking the sections in PBS/3% BSA. Likewise, all antibodies were
diluted in PBS/3% BSA. For direct immunofluorescence staining sections were in-
cubated with diluted fluorescent dye conjugated primary antibodies for about thirty
minutes, extensively washed in PBS and then mounted with FluoromountG (South-
ern Biotech). In case of indirect immunofluorescence staining, unconjugated anti-
bodies were detected using fluorescent dye conjugated secondary antibodies (Table
3.1) and incubated in the dark for another thirty minutes. Sections were washed in
PBS and coverslips were mounted with FluoromountG (Southern Biotech). Before
examination mounted sections were allowed to air-dry for at least two hours.
Specificity Source Dilution
α-B220:bio rat, clone RA3.6B2 (DRFZ)X 1:100
α-B220:Cy5 rat, clone RA3.6B2 (DRFZ)X 1:100
α-CD3:A488 rat, clone KT3 (Serotec) 1:10
α-CD4:Cy5 clone GK1.5 (DRFZ)X 1:100
α-CD4:FITC clone GK1.5 (DRFZ)X 1:50
α-CD68:A488 rat, clone FA-11 (Serotec) 1:100
α-F4/80:Cy5 rat, clone F4/80 (DRFZ)X 1:100
α-FDC-M2:bio rat, clone FDC-M2 (ImmunoK) 1:250
α-Ki67 rat, clone TEK3 (DAKO) 1:50
α-MOMA-2 rat, clone MOMA-2 (Southern Biotech) 1:100
PNA:bio(*) 5 mg/mL, B-1075 Vector 1:200
PNA:FITC(*) 5 mg/mL, FL-1071, (Vector) 1:500
PNA:Rho(*) 5 mg/mL, RL-1072 Vector 1:500
α-rat IgG:A647 goat, 2 mg/mL, A21247 (Molecular Probes) 1:800
α-A488 rabbit, 1 mg/mL, A11094 (Molecular Probes) 1:100
α-rabbit IgG:A594 goat, 2 mg/mL, A11012 (Molecular Probes) 1:400
SA:A546(*) 2 mg/mL, S11225 (Molecular Probes) 1:250
SA:A555(*) 2 mg/mL, S32355 (Molecular Probes) 1:250
SA:A647(*) 2 mg/mL, S32357 (Molecular Probes) 1:800
Table 3.1: Survey of antibodies applied for immunofluorescence staining. All listed antibodies
are α-mouse antibodies unless otherwise noted. (*) labeled items represent non-antibody proteins
that are used for detection. X labeled antibodies were purified from B-cell hybridoma culture
supernatants and conjugated to fluorescent dyes in the DRFZ.
3.6.3 Detection of apoptotic cells applying TUNEL techno-
logy
In situ detection of apoptotic cells in splenic tissue sections was performed apply-
ing TUNEL technology (TdT-mediated dUTP nick-end labeling) [92]. The TUNEL
technology is based on the enzymatic labeling of free 3’-OH ends of fragmented
DNA, that accounts for a hallmark of apoptosis. The enzyme TdT catalyzes the
incorporation of either directly fluorescent dye coupled (In situ cell death detection
kit, Roche) or biotinylated nucleotides (DeadEnd Colorimetric TUNEL System,
20
Promega). The latter are detected in a further step by binding of streptavidin con-
jugated to a fluorescent dye.
The TUNEL assay requires pretreatment of the tissue sections by fixation and per-
meabilization that lead to accessibility of the fragmented DNA for the TdT enzyme.
An unrequested side effect of this pretreatment is the degradation of other epitopes
resulting at the best in poor staining of the same tissue section with additional
antibodies. By testing different fixation and permeabilization conditions a protocol
that ensures consistent detection of apoptotic cells applying TUNEL in combination
with high quality immunofluorescence staining of further epitopes was established,
that is specified in the following.
Cryosections were directly encircled with a grease pen (Dako pen, Dako) and fixed
in 1% PFA for thirty minutes. Afterwards sections were washed three times three
minutes with PBS and subsequently permeabilized in 1% sodium citrate/1% Triton
X-100 at 4◦C for two minutes. The sections were washed in PBS again, in the mean
time the TUNEL reaction mixture was prepared (Tables 3.2 and 3.3). Applying the
In situ cell death detection kit the TUNEL reaction mixture was directly added to
the sections, the DeadEnd colorimetric TUNEL system required a preceding equili-
bration step carried out by incubating the sections with provided equilibration buffer
for five to ten minutes at room temperature. After addition of the TUNEL reaction
mixture sections were covererd with plastic coverslips to ensure even distribution of
the reagent and to minimize evaporative loss. The slides were incubated at 37◦C for
one hour inside a humified chamber. Afterwards, sections were either directly washed
in PBS (In situ cell death detection kit) or first immersed in 2x SSC buffer for ten
minutes to terminate the reaction and then washed in PBS (DeadEnd colorimetric
TUNEL system). Staining of the same tissue sections with additional antibodies
was performed following the standard protocol (see Section 3.6.2). In case of the
DeadEnd colorimetric TUNEL system, incorporated biotinylated nucleotides were
detected using streptaviding conjugates SA:A546 or SA:A647 (Molecular Probes),
respectively.
Component Volume per reaction [µL]
Labeling solution 45
Enzyme solution 5
Table 3.2: Composition of the TUNEL reaction mixture applying the In situ cell death detection
kit provided by Roche.
Component Volume per reaction [µL]
Equilibration buffer 98
Biotinylated nucleotide mix 1
rTdT enzyme 1
Table 3.3: Composition of the TUNEL reaction mixture applying the DeadEnd colorimetric
TUNEL system provided by Promega.
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3.6.4 Improvement of Ki-67 staining
The Ki-67 antigen is a large nuclear protein (about 350 kDa) present only in the
nuclei of cycling cells. Detection of this antigen by the α-Ki67 antibody could be
dramatically enhanced by pretreatment of tissue sections by fixation and perme-
abilization as described for TUNEL technology (Section 3.6.3). Most likely, the
accessibility of the nuclear Ki67 antigen is likewise improved.
3.6.5 Immunofluorescence staining of thick spleen sections
The 25 µm thick spleen sections were fixed and permeabilized prior to staining as
described for TUNEL technology (section 3.6.3). This pretreatment improved the
depth of penetration of antibodies into the tissue and reduced incubation times. All
antibodies were applied in a two times higher concentration compared to the stan-
dard immunofluorescence staining protocol and the incubation time was extended
to one hour. Additionally, the washing steps were prolonged to ten minutes. To
avoid squashing of tissue section during the mounting process, sellotape was affixed
to the slides serving as a spacer.
3.6.6 Establishment of four color immunofluorescence stain-
ing of macrophages, T cells, proliferating cells and
FDC networks
In order to reduce time and effort of data acquisition, a four color immunofluores-
cence staining protocol was established for three dimensional reconstruction experi-
ments. The chosen dye combination was A488, A555, A594 and A647, the absorption
and emission spectra of these dyes are listed in the appendix (A.1).
The initial problem was the unavailability of any of the applied antibodies con-
jugated to A594, even worse the antibodies detecting macrophages (α-CD68) and
T cells (α-CD3) both were conjugated to A488. Therefore, we chose an unortho-
dox "recolor" approach by first labeling T cells with the α-CD3:A488 antibody and
directly afterwards quenching the fluorescence by addition of a rabbit α-Alexa488
antibody that is finally detected by a α-rabbit IgG:A594 antibody. Macrophages,
proliferating cells and FDC network could then be labeled as usual. The chronology
of the staining is given below.
1. rat α-Ki67
2. α-rat:A647
3. α-CD3:A488
4. rabbitα-A488 + α-FDC-M2:bio
5. α-rabbit IgG:A594 + SA:A555 + α-CD68:A488
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3.7 Confocal microscopy
Immunofluorescence stained tissue sections were typically analyzed applying the
Leica DM Ire2 confocal laser scanning microscope provided by the DRFZ. Data
acquisition, processing and analysis are specified in Section 3.7.1 and 3.7.2. The
sole exception was the acquisition of images for the three dimensional reconstruction
experiments that were performed using the Leica TCS SP2 with IRBE2 of the
group of Werner Zuschratter at the Leibnitz Institute for Neurobiology (IFN) in
Magdeburg. The latter microscope was additionally equipped with a motorized
xy-stage (Merzhäuser), allowing the implementation of meander scans. Because
data acquisition, processing and analysis was much more complex in this case it is
described in a discrete section (Section 3.7.3).
The basics of confocal microscopy are not explained here in detail, for interested
readers the book Confocal Laser Scanning Microscopy is recommended [93].
3.7.1 Image acquisition Leica DM Ire2
All images were acquired using the LEICA LCS software, applied settings are sum-
marized in the appendix (Table A.2). Images were scanned in sequential mode, that
is each channel was scanned separately. In the following, channel 0 (ch0) always
corresponds to stainings with FITC or A488, channel 1 (ch1) to A546 and chan-
nel 2 (ch2) to Cy5, APC or A647. Each channel was assigned a RGB pseudocolor:
ch0=green, ch1=red, ch2=blue). Images of individual GC were typically acquired
at x400 magnification. In rare cases, images were also acquired at x100 for overview
purposes or at x630 magnification for detailed inspection of cellular interactions. For
the analysis of macrophage morphology images were additionally magnified beyond
x630 applying an electrical zoom factor.
3.7.2 Image processing and quantitative analysis
The first step of image processing comprised merging of the images obtained sepa-
rately for each channel to one image, henceforth referred to as overlay image. Auto-
mated batch RGB merge of images as well as subsequent quantitative analysis of GC
overlay images were implemented with the support of ImageJ based macros, that
are listed in the appendix (Table A.4). ImageJ macros were developed with the help
of Anke Klein, an undergraduate student of the Systems Immunology Group group.
Macro source codes are available on request (n.wittenbrink@biologie.hu-berlin.de).
3.7.3 Image acquisition, processing and analysis for three
dimensional reconstruction of murine spleens
Images of serial whole spleen sections were acquired using the Leica TCS SP2 con-
focal microscope operated by the group of Werner Zuschratter (IFN, Magdeburg).
The settings for image acquisition are listed in the appendix (Table A.3). Images
of whole spleen sections were obtained by performing meander scans (more pre-
cisely comb scans) at x100 magnification. The meander scan technology facilitates
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scanning of regions that are much larger than the optical field specified through
the chosen objective by segmentation of the defined region into overlapping tiles.
Each tile is scanned individually and afterwards, the images of overlapping tiles are
aligned to one assembly image. The Leica TCS SP2 microscope was equipped with
a motorized xy-stage (Merzhäuser) that was automatically actuated by the Arivis
browser software. This software was also used to configure the settings of the mean-
der scans as overlap and alignment of tiles (appendix, Table A.3). Serial images of
whole spleen sections obtained for each analyzed tissue were integrated as separated
layers into a Photoshop file. Within the first layer of the Photoshop file the entirety
of follicular niches (FDC networks) was marked by consecutive numbering and the
status of each follicular niche - either empty or occupied by a GC - was recorded.
The mask containing the consecutive numbering was projected onto the next layer
and newly arising follicular niches were added to the mask. Again the status of
each follicular niche was recorded. This procedure was repeated for all layers of the
photoshop file.
3.8 3-D reconstruction
Following a manual segmentation (ImageJ) of the GC as defined by the Ki-67 stain-
ing and a binarization of the segmented outline (ImageJ based macro MacroROIVol-
umes, developed by Armin Weiser, a fellow member of the Systems immunology
group, for further details see Appendix A.4), the individual GC have been slice wise
aligned according to their center of mass, both with and without allowing rotation.
After the alignment a principal component analysis (Matlab) was performed on the
filled outlines, resulting in three orthogonal eigenvectors, ensuring a right hand sys-
tem. The length and angles (yaw, pitch, roll) of the eigenvectors were visualized
(Amira) as ellipsoids, using the volume of the manual segmented data as constraint.
3-D reconstructions of murine spleens were assisted by Dr. Michael Sibila, University
of Technology, Berlin, Institute for Software Engineering and Theoretical Computer
Science and Armin Weiser, a fellow member of the Systems Immunology Group.
3.9 Flow cytometry
For FACS (fluorescence activated cell sorting) analysis single cell suspensions were
stained for surface and intracellular markers applying fluorochrome conjugated an-
tibodies (Table 3.4) and measured employing a BD FACS Calibur flow cytometer.
In the flow cytometer, single cells move past an excitation source (laser) and the
light hitting the cells is either scattered or absorbed and then re-emitted (fluores-
cence). This scattered or re-emitted light is collected by a detector. The pattern
of light-scattering is dependent on the size and shape of cells and thereby gives a
relative measure of the cellular characteristics. Fluorescence-based detection relies
on the capacity of fluorescent dyes to adsorb light of an appropriate wavelength and
subsequently re-emit light of a different wavelength. Detection of the intensity of
the emitted wavelength is used as an indicator of the presence of a fluorescent dye
on the cell and therefore the component it is labeling.
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Specificity Source Dilution
surface markers
α-B220:PE rat, clone RA3.6B2 (DRFZ)X 1:200
α-F4/80:Cy5 rat, clone F4/80 (DRFZ)X 1:200
PNA:FITC(*) 5 mg/mL, FL-1071, (Vector) 1:2000
rat IgG2a:FITC clone R35-95, isotype control, (Becton Dickinson) 1:100
intracellular markers
α-CD68:A488 rat, clone KT3 (Serotec) 1:5
Table 3.4: Survey of antibodies applied in flow cytometry. All listed antibodies are α-mouse
antibodies unless otherwise noted. (*) labeled items represent non-antibody proteins that are used
for detection. X labeled antibodies were purified from B-cell hybridoma culture supernatants and
conjugated to fluorescent dyes in the DRFZ.
3.9.1 Extracellular staining of cells for analysis by flow cy-
tometry
For each staining a volume of the single cell suspensions (Section 3.5) equally to
106 cells was transferred to a 1.5 ml reaction tube and cells were collected by cen-
trifugation at 400 x g at 4◦C. The supernatant was discarded, pelleted cells were
resuspended in 100 µL of the respective antibodies diluted in FACS buffer followed
by a twenty minute incubation at 4◦C in the dark. The staining was stopped by
addition of 1 mL FACS buffer and centrifugation at 400 x g for ten minutes. The
supernatant was discarded, cells were washed and finally resuspended in 500 µL
FASC buffer. Just prior to analysis 1 µL of propidium iodide (PI, 1 mg/mL, Sigma)
was added to allow exclusion of dead/necrotic cells.
3.9.2 Intracellular staining of cells for analysis by flow cy-
tometry
In case of cells that were stained for both, surface and intracellular markers, the
extracellular staining was carried out first in order to prevent disintegration of
membrane-bound molecules due to fixation and permeabilization. The latter are
required for the intracellular staining. For intracellular staining cells were first fixed
in 500 µL 2% PFA for twenty minutes at room temperature. Fixation was stopped
by addition of 1 mL PBA and centrifugation at 400 x g for ten minutes. The su-
pernatant was discarded and cells were permeabilized in 50 µl PBA/0.5% Saponin
at 4◦C. After twenty minutes 50 µL of antibody diluted in PBA/0.5% Saponin was
added and incubated for another twenty minutes at 4◦C. Staining was stopped by
addition of 1 mL PBA/0.5% Saponin and centrifugation at 400 x g for ten minutes.
The supernatant was discarded and the cells were repeatedly washed in PBA/0.5%
Saponin at 4◦C before they were finally resuspended in 500 µL FACS buffer.
3.9.3 FACS sorting of germinal center B cells and follicular
Mφ
Splenic single cell suspensions were prepared as described in Section 3.5. B cells were
rapidly isolated from these preparations by magnetic negative depletion. Therefore,
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B cells were first stained with α-B220:PE and afterwards, magnetically labeled using
α-PE MicroBeads (diluted 1:5) provided by Miltenyi Biotec. Separation of B cells
was carried out applying the "DeplS" program of the autoMACS separator (Miltenyi
Biotec). After autoMACS separation the cell counts of the B220+ and B220− frac-
tions were determined using the Casy cell counter (Schärfe System). Aliquots of
both fractions were taken (about 105 cells) and their purity was checked by FACS
analysis. For identification of GC B cells, the B220+ fraction was counterstained
with PNA:FITC. The B220− fraction was first stained with α-F4/80:Cy5 and was
afterwards stained intracellulary with α-CD68:A488. Both fractions were finally
resuspended in FACS buffer adjusted to a concentration of 5×107-1×108 cells/mL.
Within the B220+ fraction germinal center B cells were identified as B220+ PNAhigh.
Follicular macrophages were identified within the B220− fraction as CD68+ F4/80−
B220−, the latter to exclude any remaining B cell contamination. GC B cells and fol-
licular macrophages were collected separately following multicolor cell sorting using a
FACSAria cell-sorting system (Becton Dickinson). The RNA of collected GC B cells
and follicular macrophages was isolated directly after cell sorting (Section 3.10.1).
3.10 Molecularbiology
3.10.1 Isolation of RNA
Isolation of RNA from sorted cells was performed in a RNAse-free environment
using the PicoPure RNA isolation kit (Arcturus, Biozym). To avoid RNAse con-
tamination certified RNAse-free buffers and reagents were used. Lab benchtops,
tube racks and pipettors were routinely treated with the RNAse decontamination
reagent RNAseZap (Ambion) and gloves were changed frequently during the isola-
tion process. FACS sorted cells were first resuspended in 100 µL extraction buffer
and incubated for thirty minutes in a heatblock adjusted to 42◦C. Afterwards RNA
was isolated according to the manufacturers’ instructions. During isolation an op-
tional DNAse treatment was performed in order to remove DNA from the prepara-
tions (RNAse-free DNAse Set, Qiagen). The isolated RNA was immediately stored
at -70◦C. RNA concentrations were determined using the Nanodrop ND-1000 spec-
trophotometer (Witec).
3.10.2 Amplification of Ig light chain rearrangements
Primers
All primers were synthesized by TIBMolBiol. The supplied lyophilisates were resus-
pended in DEPC H2O (Roth) to a final concentration of 100 pmol per µl. Overall IgL
chain rearrangements (IgL) were amplified using a primer set that was originally set
up for the assembly of a mouse derived phage display library at the MRC Centre for
Protein Engineering (for further information see http://www.mrc-cpe.cam.ac.uk/).
These primers were designed to amplify the whole spectrum of variable region re-
arrangements of murine IgL. To simplify the working procedure and to save time,
three primer mixes were prepared: VL-mix, JL-mix and CL-mix, respectively. These
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mixes contained the primers listed below in a final concentration of 10 pmol per µL
each (Table 3.5). The first round RT-PCR used the primer combination VL-mix,
CL-mix. In case of follicular macrophage derived RNA, a second round PCR was
carried out, using the semi-nested primer combination VL-mix, JL-mix.
PhOx specific IGKV4-59 (VκOx1) IgL rearrangements were amplified by RT-PCR
using the primer combination Vκ77, CL-mix (Table 3.5). The binding site of the
Vκ77 primer is interrupted by a long intron sequence on the DNA level. There-
fore, the Vκ77 primer cannot bind to and amplify genomic DNA. On RNA level
the intron is missing due to splicing of mRNA. Again, the amplification of follicular
macrophage derived RNA required a second round of PCR, that was carried out
using the primer combination Vκ77, JL-mix.
The optimal annealing temperature of primer mixes (62oC) was determined in tem-
perature gradient PCRs (data not shown). For a map off the used primers see
Figure 3.1.
1. VL-mix: Vκ-1 to 8 and Vλ-1
2. JL-mix: Jκ-1/2, 4, 5 and Jλ-1, 2/3
3. CL-mix: Cκ and Cλ
Primer Sequence Length [nt] Tm [oC]
Vκ-1 gatattgtgatgacBcagDc 20 58
Vκ-2 gatRttKtgatgacccaRac 20 57
Vκ-3 gaaaatgtgctcacccagtc 20 60
Vκ-4 gaYattgtgatgacacagtc 20 57
Vκ-5 gacatccagatgacacagac 20 60
Vκ-6 gaYattgtgctSacYcaRtc 20 59
Vκ-7 gacatccagatgacYcartc 20 60
Vκ-8 caaattgttctcacccagtc 20 58
Vλ-1 gctgttgtgactcaggaatc 20 60
Jκ-1/2 gtttKatttccagcttggtgc 21 62
Jκ-4 gttttatttccaactttgtc 20 52
Jκ5 ccagcttggtcccagcaccg 20 68
Jλ-1 ggacagtcagtttggttc 18 54
Jλ-2/3 ggacagtgaccttggttc 18 56
Cκ gttcactgccatcaatcttc 20 58
Cλ ggaaggtggaaacaBggtg 19 60
Vκ77 gctaatcagtgcctcagtcataata 25 63
Table 3.5: Primers used in amplification of Ig light chain rearrangements.
Figure 3.1: Primer map. Illustrated are the locations of primers used for amplification of overall
IgL (VL-mix, CL-mix, JL-mix) and IGKV4-59 (VκOx1) (Vκ77, CL, JL-mix).
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OneStep RT-PCR and second round PCR
The reverse transcription of RNA and subsequent amplification of the resulting
cDNA was performed applying the OneStep RT-PCR kit (Quiagen). This kit fea-
tures the primer-specific transcription of RNA into cDNA, that is not the whole RNA
but only RNA matching the used primer(s) is transcribed into cDNA. By virtue of
the specially formulated enzyme blend provided with the kit reverse transcription
and subsequent PCR amplification are feasible in one step i.e. in one reaction tube.
The composition of RT-PCR samples is depicted in Table 3.6. RT-PCRs were per-
formed in Biometra thermocyclers, according to the following temperature profile:
reverse transcription, 50◦C, 30 minutes 7−→ initial denaturation, 95◦C, 15 minutes
7−→ 40 cycles of PCR amplification: denaturation, 94◦C, 1 minute 7→ annealing,
62◦C, 1 minute 7→ elongation, 72◦C, 1 minute 7−→ final elongation, 72◦C, 10 min-
utes 7−→ Cool off, 4◦C, ∞.
Second round PCRs were performed using Amplitaq Gold DNA Polymerase pro-
vided by Applied Biosystems, the composition of samples is given in Table 3.7. PCRs
were performed in Biometra thermocyclers, according to the following temperature
profile: initial denaturation, 94◦C, 9 minutes 7−→ 40 cycles of PCR amplification:
denaturation, 94◦C, 1 minute 7→ annealing, 62◦C, 1 minute 7→ elongation, 72◦C,
1 minute 7−→ final elongation, 72◦C, 10 minutes 7−→ Cool off, 4◦C, ∞.
Component Volume per reaction [µL]
Mastermix
RNAse-free water 19
5x RT-PCR buffer 10
5x Q-Solution 10
dNTP mix (10 mM of each dNTP) 2
Enzyme mix 2
Primer
3’Primer (10 pmol/µl) 3
5’Primer (10 pmol/µl) 3
Template
RNA template (5-50 ng/µl) 1
Total volume 50
Table 3.6: Composition of RT-PCR samples applying the OneStep RT-PCR kit provided by Qia-
gen.
3.10.3 Analytical and preparative agarose gel electrophore-
sis
For visualization and separation of DNA amplificates analytical and preparative
submarine horizontal agarose gel electrophoresis was conducted. For analytical pur-
poses gels made from standard agarose were prepared (Roth), for preparative pur-
poses NuSieve GTG agarose (FMC) featuring a low melting temperature was used.
In general, 100 mL agarose gels (1.5-2% in TAE) containing 1 µL ethidiumbromide
(1 mg/mL, Biorad) were poured. The added ethidiumbromide intercalates into the
DNA double helices and can be later on vizualized by UV-illumination (λ=302 nm).
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Component Volume per reaction [µL]
Mastermix
DNAse-free water 34.75
10x PCR Gold buffer 5
dNTP mix (10 mM of each dNTP) 2
MgCl2 (25 mM) 4
AmplitaqGold DNA polymerase 1.25
Primer
3’Primer (10 pmol/µl) 1
5’Primer (10 pmol/µl) 1
Template
First round RT-PCR sample 1
Total volume 50
Table 3.7: Composition of second round PCRs samples, AmpliTaq Gold DNA Polymerase, Applied
Biosystems.
In case of each sample 18 µL were mixed with 2 µL of loading buffer (Invitrogen)
that contained the tracking dyes bromphenol blue and xylene xyanole. The electro-
phoresis was performed in 1xTAE buffer applying a constant voltage of 100-120 V.
The size dependent separation of DNA fragments is based on the migration of DNA
after conducting an electric field. Positively charged DNA migrates towards the
negative pole with a velocity that is reciprocally proportional to the log10 of its size.
A molecular size weight marker (Track-It 100 bp DNA Ladder, Invitrogen) was used
to identify the size of amplificates run on the agarose gel. After electrophoresis gels
were photographed applying an UV-illuminator and fragments of interest were dis-
sected using disposable micro lancets (Braun). Single bands at 350 bp and 290 bp
were expected for first round RT-PCRs and second round PCRs, respectively.
3.10.4 Extraction of DNA from agarose gels
Following preparative agarose gel electrophoresis, fragments of interest were excised
from the gel using mini lancets (Braun). The DNA of excised amplificates was
then extracted applying the QIAQuick gel extraction kit (Qiagen) according to the
manufacturers’ instructions. The QIAQuick system is based on the combination
of spin-column technology and selective binding of DNA to silica-gel membranes in
the presence of high salt concentrations while contaminants pass through. Extracted
DNA was finally eluted with 50 µl DEPC H2O (Roth) and was stored at 4◦C.
3.10.5 Cloning of IgL amplificates
Cloning of Ig light chain amplificates was performed applying the TOPO TA Cloning
Kit (with pCR2.1-TOPO vector) with One Shot TOP10F’ Chemically Competent
E. coli cells (Invitrogen). TOPO TA cloning provides a one-step cloning strategy for
Taq polymerase-amplified PCR fragments by taking advantage of the nontemplate-
dependent terminal transferase activity of the enzyme that results in the addition of
single deoxyadenosines (A) to the 3’ ends of PCR amplificates. Such amplificates lig-
ate with the linearized pCR2.1 vector, that bears overhanging 3’ single deoxythymi-
dine (T) residues. Identification of successfully transformed cells resulted from using
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ampicillin resistance as selection marker. Insert carrying vectors were detected by
blue/white screening of recombinant bacterial clones that is based on the insertional
inactivation of the enzyme β-galactosidase (LacZ). Functional β-galactosidase con-
verts the substrate X-Gal into a colored product resulting in blue colonies. Cloning
inserts disrupt the β-galactosidase activity and yield in white bacterial colonies.
Ligation
The composition of the ligation mixture is displayed in Table 3.8. After gentle mix-
ing, the ligation mixture was incubated for five to ten minutes at room temperature
and placed on ice until transformation.
Component Volume per reaction [µL]
DEPC H2O 3
Salt solution 1
PCR amplificate (20 ng/µL) 1
TOPO pCR2.1 vector 1
Total volume 6
Table 3.8: Composition of the ligation mixture applying the TOPO TA Cloning kit provided by
Qiagen.
Transformation
Competent cells were allowed to thaw by incubating for about ten minutes on ice.
Precautiously, 2 µL of the ligation mixture were added to the competent cells and
mixed gently by stirring with the pipet tip. Then, competent cells were incubated
on ice for thirty minutes and thereafter, uptake of vector DNA was launched by
heat-shock (42◦C, thirty seconds). Afterwards competent cells were placed on ice,
supplemented with 250 µL S.O.C medium and shaken horizontally (200 rpm) at
37◦C for one hour. 25 to 50 µL of each transformation were spread on prewarmed
selective agar plates (see Table 3.9) and incubated overnight at 37◦C. Transformants
were then isolated from agar plates and incubated overnight in 2 mL LB medium
containing 50 µg/mL ampicillin.
Component Quantity
LB medium (Bio101) 8 capsules
Select agar (Roth) 4.5 g
H2O 300 [µL]
autoclaving
Ampicillin [100 mg/mL] (Roth) 150 µL
IPTG [1 M] (Roth) 80 µL
X-Gal [20 mg/mL Dimethylformamide] (Roth) 700 µL
Table 3.9: Composition and preparation of selective agar plates.
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3.10.6 Plasmid minpreparation
Plasmid minipreparations were performed using the NucleoSpin Plasmid kit ac-
cording to the manufacturers’ instructions (Macherey-Nagel). The kit is based on
SDS/alkaline lysis of harvested bacteria, followed by DNA binding to a silica mem-
brane and removal of contaminants by employing spin column technology. The plas-
mid DNA was finally eluted with 50-100 µl DEPC H2O (Roth) and was afterwards
stored at 4◦C.
3.10.7 Sequencing of IgL amplificates
Sequences of cloned IgL rearrangements were obtained using the DNA sequencing
service offered by MWG Biotech (for further information see the website of the com-
pany http://www.mwg-biotech.com/html/all/index.php). For sequencing, a volume
equivalent to 1 µg of the isolated plasmid DNA was transferred to a new 1.5 ml re-
action tube, vacuum dried and then send to MWG Biotech.
Sequence analysis was performed using the IMGT database and IMGT/V-Quest.
Sequence alignments were done in CLC Free Workbench.
3.11 Mathematical simulations
All mathematical simulations presented in this thesis were compiled using the R soft-
ware (http://www.r-project.org/). Specifications and explanations of simulations
are given directly in the text of the results part. Simulations were assisted by my
supervisor Dr. Michal Or-Guil and Dr. Johannes Schuchhardt (MicroDiscovery
GmbH, Berlin, Germany).
3.12 Statistical analysis
Statistical analysis was performed using the Analyze-It software add-in for Microsoft
Excel. Statistical significance was assessed using Student’s t test, Wilcoxon rang
sum test (Mann-Whitney U test) or χ2 test unless otherwise noted. Values of p
were considered statistically significant at p<0.05. Linear and power regressions
were calculated in Sigmaplot.
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Revising the kinetics of germinal center
growth
Chapter 4
Revising the kinetics of germinal
center growth
The current state of knowledge on the kinetics of GC growth following immunization
with hapten-carrier conjugates is basically attributed to a series of distinguished
articles, published by the groups of I.C. MacLennan [24], G. Kelsoe [70] and A.K.
Szakal, J.G. Tew [45] in 1991. Nevertheless, just this kinetics became a major
challenge for the present thesis, as initial results revealed a much more complex
picture than anticipated so far.
4.1 Assessing the kinetics of GC growth by 2-D
cross-sectional evaluation
The kinetics of GC growth was assessed by studying the de novo formation of GC
within the murine spleen following intraperitoneal (i.p.) immunization of BALB/c
mice with 2-phenyloxazolone (phOx) coupled to chicken serum albumin (CSA).
Spleens of challenged mice were collected at frequent intervals of two to three days
over a period of three weeks and were subsequently subjected to cross-sectional
immunohistological analysis.
4.1.1 2-D cross-sectional evaluation of GC size and geome-
try
To save time and effort, the cross-sectional size of GC was not recorded separately
but by means of triple immunofluorescent stainings that were carried out to assess
either kinetics of GC T cells (Section 5.1) or GC macrophages (Section 5.2). Since
these stainings were performed on consecutive sections, the resultant kinetics of GC
growth turned out to be identical. In the following, the kinetics of GC growth is
given according to the evaluation of stainings performed for recording the kinetics
of GC T cells. GC were identified as Ki-67 positive cell clusters and by anatomical
location in triple immunofluorescence stainings of proliferating cells (Ki-67), T cells
(CD3) and FDC networks (FDC-M2) (Figure 4.1, A). For the quantitative analy-
sis, GC boundaries, referred to as regions of interest (ROIs), were first manually
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assigned to all acquired images. Subsequently, the size of cross-sectional GC was
recorded by measuring the areas of assigned ROIs [µm2]. In addition, the geometry
of cross-sectional GC was captured by parameterization of ROIs applying an ellipse-
fitting algorithm that outputs the major (r1) and minor radii (r2) of fitted ellipses
(Figure 4.1). As a further indicator for GC size, the number of Ki-67+ proliferating
cells per cross-sectional GC was determined by automated batch processing of image
stacks applying an adapted version of the Nucleus Counter Plugin of the ImageJ
software (Figure 4.1, B).
Figure 4.1: Quantitative analysis of acquired GC images exemplified by representative images of
a GC at day 12 after immunization. (A) GC were identified by reactivity to Ki-67 and anatomical
location in triple stainings of proliferating cells (Ki-67, blue), T cells (CD3, green) and FDC (FDC-
M2, red). GC boundaries were manually assigned (yellow) and saved as regions of interest (ROI).
ROIs were parametrized by an ellipse fitting algorithm and resultant areas of ROIs as well as major
(r1) and minor radii (r2) of the fitted ellipses (white) were recorded. (B) Automated detection and
measurement of Ki-67+ proliferating cells for the GC depicted in (A) applying an adapted version
of the Nucleus Counter plugin of the ImageJ software. Scale bar 100 µm.
The work of Camacho et al. [67] first pointed out a less pronounced subcomparti-
mentalization of murine splenic GC by means of Ki-67 staining compared to human
tonsillar GC. This observation was further confirmed by others, revealing a rather
phenotypically homogeneous proliferating GC B cell population throughout the re-
sponse. In spite of that, Ki-67 was affirmed as convenient marker for identification
and measurement of GC in an initial experiment. This was realized by comparison of
measurements of GC that were identified by reactivity to Ki-67 to GC visualized in
adjacent sections using PNA. Such analysis reveals a strict concordance of recorded
cross-sectional GC areas assessed by Ki-67 and PNA reactivity at all tested time
points (Figure 4.2). For the large scale analysis Ki-67 was preferred to PNA because
it both facilitates the manual assignment of ROIs due to a more distinct contour
of GC and potentiates automated detection and counting of Ki-67+ cells within as-
signed ROIs. The number of Ki-67+ cells is further shown to strictly correlate with
the cross-sectional area of GC (Figure 4.3), therefore both modes of measuring GC
size can be employed interchangeable.
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Accordingly, the mutual dependence of cross-sectional GC size and numbers of Ki-
67+ cells can be inferred from the data set. As a result, 1 µm2 cross-sectional GC
area is equivalent to 0.0116 Ki-67+ cells, respectively one Ki-67+ cell corresponds to
86 µm2 cross-sectional GC area.
Figure 4.2: Verification of Ki-67 as consistent marker for detection and measurement of GC.
The scatter plot demonstrates the strict correlation of cross-sectional areas recorded by means
of reactivity to Ki-67 (vertical axis) and PNA (horizontal axis). GC were stained with PNA on
adjacent sections (not shown) and acquired images were processed as illustrated in Figure 4.1 for
Ki-67. Data is representative of in each case one splenic tissue section at day 6, 12 and 18 post
immunization. Regression lines and correlation coefficients (R2) are specified for the scatter plots.
Figure 4.3: The number of Ki-67+ cells within cross-sectional GC is determinated by the size of
GC. Vertical axis represents the number of Ki-67+ cells of cross-sectional GC plotted against the
cross-sectional area of these GC. Data is representative of a splenic tissue section at day 12 post
immunization. Regression line and correlation coefficient (R2) are specified for the scatter plot.
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4.1.2 Robust overall GC growth kinetics is based upon no-
table size distribution of GC within individual sections
The kinetics of GC growth was assessed by quantitative analysis of GC size and
geometry as described above. In total, 1136 GC out of 45 sections derived from
23 mice were evaluated, a detailed survey of all analyzed sections and evaluated
GC is given in Section 5.1, Table 5.1. The resultant kinetics of the average size
of GC by means of recorded cross-sectional GC areas is resumed in Figure 4.4.
Well-established GC, typically of very small size, are first detectable at day 4 after
immunization. The average size of GC afterwards steeply increases and reaches
its maximum at day 10, thereafter, it gradually declines. The deviation of mean
values, both for sections of the same and different individuals, turns out to be
rather moderate (Figure 4.4, A).
Converse to the fairly robust kinetics of the mean size of GC, discrete mean values are
shown to be representative of a notable size distribution of GC within the individual
spleen sections, reflected by substantial intra-section standard deviations (Figure
4.4, B). The kinetics of GC growth, given by the numbers of Ki-67+ cells per cross-
sectional GC, leads to conforming results. Moreover, displaying the entirety of
recorded values for each time point demonstrates that the size distribution of cross-
sectional GC emerges as early as day 6 and becomes most pronounced between day
8 to 12 after immunization. A striking feature of the broad size distribution of GC is
the sustained high frequency of cross-sectional GC of rather small size (Figure 4.5).
Figure 4.4: Kinetics of GC growth in spleens of phOx-CSA immunized mice. GC were identified
and measured as illustrated in Figure 4.1. (A) Mean kinetics and inter-section variance of GC
size. Vertical axis represents the slope of the mean area of GC with the standard deviation plotted
against the time after immunization. The data were obtained from two sections per mouse (n=2-4)
that were at least 50 sections apart. The two values obtained per mouse are each depicted by the
same symbol. The analysis reveals low inter-section variation within and between individual mice.
(B) High intra-section variance of GC size. Data is representative of the splenic tissue section at
day 12 post immunization highlighted by a box in (A). The scatter plot represents recorded GC
areas (vertical axis) for all detected GC, sorted by their size (horizontal axis). The solid line depicts
the intra-section mean, dashed lines indicate the range of the intra-section standard deviation.
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Figure 4.5: Kinetics of GC growth displayed as numbers of Ki-67+ cells per cross-sectional GC.
The depicted values are representative of the entirety for measured GC for each time point. The
course of the mean is given by the blue curve, gray curves illustrate the median (thick line) as well
as lower and upper quartile (thin lines).
4.1.3 Mathematical simulation of virtual random sectioning
fails to explain the high intra-section variance of GC
size.
The broad size distribution of cross-sectional GC within individual spleen sections
most likely reflects random sectioning of GC. Nevertheless, it can also be indicative
of a real size distribution of GC in the original 3-D spleen sample or even attributes
to both. The problem of anticipating the distribution and extension of objects in
the original 3-D space based on cross-sectional profiling is a general one, referred
to as Wicksell’s corpuscle problem (schematically illustrated in Figure 4.6). To as-
sess the influence of random sectioning on the obtained data, R-based mathematical
simulations of virtual random sectioning of various shaped ellipsoids were performed
(Figure 4.7). Briefly, ellipsoids were allowed to freely rotate in the 3-D space and
virtually random sectioned 20,000 times. The resultant radii (r1, r2) as well as
the frequencies (f) of areas and radius ratios (r1/r2) of cross-sectional ellipses were
plotted and compared to the experimentally obtained data. Such analysis explic-
itly rules out that random sectioning of spheres (Figure 4.7, A) accounts for the
experimentally recorded cross-sectional profiles of GC (exemplified for day 10 after
immunization in Figure 4.7, C). Likewise, neither of the further tested ellipsoids
succeeds in reproducing the experimentally obtained data. Figure 4.7, B illustrates
the simulation of random sectioning of an oblong shaped ellipsoid that bears the
closest resemblance to the experimental data. The most striking divergence of sim-
ulations occurs at the level of recorded cross-sectional GC areas, as all simulations
failed to reproduce the experimentally recorded high frequencies of rather small
cross-sectional GC areas.
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Figure 4.6: Schematic illustration of Wicksell’s corpuscle problem. The Wicksell’s corpuscle prob-
lem deals with the dilemma of inferring the volume distribution of a population of particles, using
a lower dimensional sampling probe. As illustrated, rather different populations of particles (A
and B) give rise to the very same cross-sectional profile.
Figure 4.7: Random sectioning fails to explain the high intra-section variance of GC size. Various
shaped ellipsoids were virtually sectioned in R-based mathematical simulations. Briefly, ellipsoids
were allowed to freely rotate in the 3-D space and randomly sectioned 20,000 times. The resultant
radii (r1, r2) as well as the frequencies (f) of areas and radius ratios (r1/r2) of cross-sectional
ellipses were plotted and compared to experimentally obtained data. (A) Simulation of random
sectioning of a sphere (rx=ry=rz=1). (B) Simulation of random sectioning of an oblong ellipsoid
(rx=4, ry=2, rz=1). (C) Experimentally obtained data exemplified for the total number of cross-
sectional GC recorded at day 10 after immunization (see Table 5.1), symbols indicate individual
mice (n=3). Simulations were assisted by Dr. Michal Or-Guil and Dr. Johannes Schuchhardt.
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4.2 A theoretical approach to GC ensemble ki-
netics
The finding that the broad size distribution of cross-sectional GC does not solely
attribute to random sectioning of GC (Section 4.1.3) but potentially also reflects a
real size or volume distribution of GC has some major implications for the interpre-
tation of GC growth kinetics. According to the current notion, the growth behavior
of individual GC obeys the average kinetics of the ensemble of GC within the ob-
served lymphatic tissue. The existence of a real size distribution of GC challenges
this view, since it allows for non-uniform growth of individual GC within an ensem-
ble. To check if others than the established ensemble kinetics are consistent with
the experimental data, different predefined GC ensembles were therefore subjected
to simulation-based random sectioning.
4.2.1 Formulation of hypothetical growth kinetics of indi-
vidual GC
As a first step, hypothetical growth kinetics of individual GC, that later serve as
templates for the composition of GC ensembles, are formulated according to the
mathematical model given below. In the model scenario, a fraction of proliferating
GC B cells halts proliferation and is subjected to selection as given by the selection
rate. Selected GC B cells do not further take part in the GC reaction but disappear
from the system by either undergoing apoptosis or emigration. Due to this lack
of internal iteration, the modeled kinetics is independent of affinity of the B cell
receptor. Therefore, the time course and lifetime of an individual GC solely rely on
the chosen rates of proliferation and selection. Two examples of hypothetical growth
kinetics of individual GC that substantially differ with regard to their lifetimes are
illustrated in Figure 4.8. In the former case, the life time of individual GC is
equivalent to the established life span of the GC ensemble of about 3 weeks (Figure
4.8, A), whereas the latter case features a significantly shorter lifetime of individual
GC of about 6 days (Figure 4.8, B). In the following, these two cases are referred to
as the long-lived and short-lived kinetics, respectively.
Model equations
The model scenario outlined above is specified by the following set of ordinary
differential equations:
b˙ = p · b(t)− r(t) · b(t) (4.1)
c˙ = r(t) · b(t)− δ · c(t) (4.2)
r(t) = r02 · (1 + tanh((t− t0)/τ)) (4.3)
A population GC B cells (b) proliferates with the rate constant p. A fraction of
this population then halts proliferation and is subjected to selection according to
the selection rate function r(t). The GC B cells undergoing selection (c) disappear
from the system with the rate constant δ. The chosen selection rate function r(t)
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fulfills the premise of a gradually increasing selection rate, starting from zero and
finally reaching its maximum rate constant r0.
Figure 4.8: Formulation of hypothetical long-lived (A) and short-lived (B) growth kinetics of
individual GC according to the mathematical model described in Section 4.2.1. Illustrated are the
simulated time plots of the populations of proliferating B cells (b), B cells undergoing selection
(c), total B cells (b+c) and the selection rate function (r). Applied parameter values and initial
conditions are depicted for each plot. Modeling was assisted by Dr. Michal Or-Guil and Dr.
Johannes Schuchhardt.
4.2.2 Simulation of random sectioning of different GC en-
semble kinetics
The long-lived and short-lived growth kinetics of individual GC now serve as tem-
plates for composition of kinetics of ensembles of many individual GC of which 500
are allowed to coexist. Albeit there is no limit to conceivable ensemble scenarios, the
consideration is first confined to the 3 rather "simple" instances represented in the
left panel of Figure 4.9. With respect to the ensemble kinetics illustrated in Figure
4.9, A and B the time course of individual GC is given by the long-lived kinetics.
Since GC are unlikely to be launched all at exactly the same time, these ensemble
kinetics additionally allow for a small variation in the seeding time point. Neverthe-
less, seeding of GC is restricted to a short period of time, in which the maximum
seeding rate is reached within 1.5 days and afterwards rapidly decays. Since seeding
of GC is virtually absent from day 4 after immunization onwards, the ensembles
of GC are seeded "almost" simultaneously, thereby promoting virtually synchronous
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GC growth progression. The ensemble kinetics represented in Figure 4.9, A and B
finally diverge in that the latter additionally allows for pronounced variation of max-
imal attained GC size. Regarding the ensemble kinetics illustrated in Figure 4.9, C,
each individual GC obeys the short-lived kinetics. Moreover, compared to the afore
described ensemble kinetics, the maximum seeding rate is attained at a later time
point (day 4 after immunization) and only decays slowly afterwards. Since seeding
is confined to a extended period of time, it provides for asynchronous seeding and
progression of GC.
To facilitate comparison of the hypothetical ensemble kinetics represented in Figure
4.9, A, B and C with the experimentally recorded ensemble kinetics of cross-sectional
GC size (Figure 4.5), simulations of planar random sectioning were performed. To
this end, the generic shape of GC is specified as oblong ellipsoid (diameter ratios
4:1:1), and GC are assumed to possess no preferential orientation but to be dis-
tributed randomly within the spleen. During simulations, sectioning of GC ellipsoids
occurs according to their individual probability of being cut at all, which strictly
depends on their size. The resultant cross-sectional profiles are depicted in the
right panel of Figure 4.9. Strikingly, the simulation of random sectioning of any of
the three highly divergent ensemble kinetics results in the very same cross-sectional
profile that in turn closely resembles the experimentally attained data (Figure 4.5).
Therefore, cross-sectional evaluation of GC size just suffices to infer the average
kinetics of the ensemble but does not allow for inference of the underlying kinetics
of individual GC. In conclusion, the accepted notion of GC growth including syn-
chronous seeding and progression of long-lived GC (Figure 4.9, A) turns out to be
not the only conceivable scenario.
4.3 Assessing the kinetics of GC growth by 3-D
volumetric evaluation
The cross-sectional evaluation of GC size has proven insufficient for inferring the
kinetics of individual GC. Moreover, simulation-based random sectioning revealed
that others than the accepted notion of GC ensemble kinetics are consistent with the
experimental data, allowing for asynchronous formation and progression of GC and
a lifetime of individual GC that is much shorter than previously thought. To further
elucidate the growth kinetics of individual GC, the evaluation was upgraded from
cross-sectional to volumetric profiles of splenic GC. The 3-D evaluation of splenic
volumes shall be capable of distinguishing the introduced hypothetical GC ensemble
kinetics (Section 4.2.2, Figure 4.9), by means of two measures:
1. Time course of occupation of follicular niches by GC
Regarding the two ensemble kinetics featuring synchronous GC formation and progression
(Figure 4.9, A and B), the number of follicular niches occupied by GC do not increase from
day 4-6 onwards, since seeding of GC is merely restricted to a short period of time. By con-
trast, the asynchronous ensemble kinetics of short-lived GC (Figure 4.9, C) is characterized
by increasing numbers of follicular niches occupied by GC even after day 6, since the period
of seeding is extended.
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Figure 4.9: Simulation of random sectioning of different GC ensemble kinetics. Left panel: GC
ensembles kinetics were compiled using the hypothetical growth kinetics of individual GC shown
in Figure 4.8 as templates. Each ensemble is composed out of many individual GC of which
500 are allowed to coexist (GCn, gray curves). For readability, only every tenth individual GC
kinetics is illustrated, in which one is highlighted (GCi, red curve). The distribution of GC seeding
events is given by the seeding density, that follows a cusp like shape (dark gray curve, arbritary
units). The illustrated ensemble kinetics (A), (B) and (C) represent combinations of different
individual GC growth kinetics and seeding events. The resultant average kinetics of each ensemble
is indicated by the blue curve. Right panel: Simulated cross-sectional profiles of the respective
ensemble kinetics. Simulations were performed assuming that GC are distributed randomly, have
the shape of oblong ellipsoids (rx=4, ry=1, rz=1), and that ellipsoids are sectioned by a plane cut,
in which their individual probability of being cut at all, is dependent on their size. Cross-sectional
profiles are displayed as numbers of B cells per cross-sectional GC (open circles), the mean size of
cross-sectional GC (blue circles) as well as the median lower and upper quartile (gray curves) of the
simulated size distribution are highlighted. (A) Synchronous ensemble kinetics of long-lived GC.
The maximum seeding rate is reached within 1.5 days and decays rapidly within half a day. (B)
Ensemble kinetics of long-lived GC featuring high variation in attained maximum size. The seeding
rate is the same as in (A). (C) Asynchronous ensemble kinetics of short-lived GC. The seeding
rate increases for four days and decays only slowly afterwards, implementing an ongoing series of
seeding events. Simulations were assisted by Dr. Michal Or-Guil and Dr. Johannes Schuchhardt.
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2. Volume distribution of GC
In contrast to the synchronous ensemble kinetics of long-lived GC of fixed maximal size
(Figure 4.9, A), both the ensemble kinetics of long-lived GC featuring high variation in
maximal attained size (Figure 4.9, B) and the asynchronous ensemble kinetics of short-lived
GC (Figure 4.9, C) are characterized by a profound volume distribution of GC.
4.3.1 3-D volumetric evaluation of GC growth kinetics
The approach to 3-D evaluation of GC growth kinetics is graphically illustrated in
Figure 4.10, a detailed survey of analyzed spleen specimens is given in Table 4.1.
Briefly, spleens of cohorts of BALB/c mice (n=3) were analyzed at day 6, 10 and
14 after phOx-CSA challenge. With respect to each spleen specimen, 7 serial tis-
sue sections (s01-s07), spaced at intervals of 50 µm, spanning a total thickness of
300 µm were quadruple stained for proliferating cells (mAb Ki-67), FDC-networks
(mAb FDC-M2), T cells (mAb CD3) and macrophages (mAb CD68). Images of en-
tire spleen sections were afterwards obtained by performing meander scans at x100
magnification (exemplary depicted for a spleen specimen obtained at day 10 after
immunization in Figure 4.10, A.
Evaluation of spleen specimens was performed both separately for each individual
section (2-D cross-sectional evaluation) and integratively for the whole series of sec-
tions (3-D volumetric evaluation). The results of the 2-D cross-sectional evaluation
are summarized in Table 4.1. Both the recorded total number of follicular niches
and the number of follicular niches occupied by GC show only little variation among
each series of serial sections. The mean area of the analyzed sets of serial sections
ranges from 30.8 to 49.5 mm2, correspondingly the estimated volume ranges from
9.2 to 14.9 mm3.
The 3-D volumetric evaluation was accomplished by tracing follicular niches through-
out the analyzed splenic volume or the series of images sections, respectively. During
tracing, follicular niches were denoted as either empty or occupied by virtue of con-
comitant existence or absence of GC. The tracing of follicular niches is exemplary
illustrated for one empty and three occupied niches at day 10 after immunization
in Figure 4.10, B. Notably, the numbers of sections spanned by occupied follicular
niches show pronounced variation. Regarding empty follicular niches, this variation
turns out to be rather moderate since their range generally tends to be smaller
(Figure A.3).
4.3.2 The 3-D volumetric evaluation of occupation of fol-
licular niches indicates continuous new formation of
GC throughout the immune response
The time courses of the numbers of total, occupied and empty follicular niches - as
revealed by 3-D volumetric evaluation - are graphically illustrated in Figure 4.11.
Values are quoted as numbers of follicular niches per 12 mm3, corresponding to
the average volume comprised by the series of 7 serial sections analyzed per spleen
specimen (see Table 4.1). Notably, the total number of follicular niches per splenic
volume is fixed in BALB/c mice and does not change during the progression of
the immune response in these mice (231±13, 234±35, 225±24 at days 6, 10 and
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Number of follicular niches occupied by GC/total number of follicular nichesa)
day 06 day 10 day 14
 ~ }    ⊕ ⊗ 	
s01 33/119 49/128 100/162 75/90 97/126 89/112 80/90 68/94 56/106
s02 38/124 60/140 96/158 80/106 88/117 100/125 90/101 73/104 79/102
s03 26/127 49/148 80/161 80/108 87/110 97/129 90/112 81/101 80/122
s04 32/130 40/122 98/166 84/116 89/110 90/123 92/112 74/89 77/117
s05 38/121 48/111 95/178 80/113 85/117 92/135 89/119 74/99 83/148
s06 27/118 37/105 99/165 86/115 92/117 92/125 84/99 81/118 82/145
s07 21/89 48/106 97/164 90/112 88/130 90/130 88/113 77/97 81/136
Mean area of spleen sections [mm2]
35.8 44.4 49.5 30.8 46.9 45.1 37.7 34.7 45.9
Estimated volume [mm3]b)
10.8 13.3 14.9 9.2 14.1 13.5 11.3 10.4 13.8
Table 4.1: Survey of spleen specimens analyzed for 3-D evaluation of GC growth kinetics. Specified
are both the number of follicular niches occupied by GC and the total number of follicular niches
detected within each of the serial sections (s01-s07) analyzed per spleen. Additionally, the mean
area of each series of serial sections and the estimated volume comprised by the very sections are
indicated. Three spleens were analyzed at each time point (day 6, 10 and 14), and different symbols
refer to individual mice. a Listed values refer to the independent evaluation of single sections. bThe
volume comprised by the analyzed sections was estimated through multiplying their mean area by
the total thickness spanned by them (300 µm).
14, respectively) (Figure 4.11). With regard to follicular niches occupied by GC,
numbers significantly increase from 128±25 at day 6 to 189±27 at day 10 (p=0.04 in
Student’s t test). Naturally, the numbers of empty follicular niches decrease to that
effect, from initially 103±32 at day 6 to 45±9 at day 10. Thereafter, the numbers
of occupied niches only slightly decrease to finally 177±29 at day 14, accordingly
the numbers of empty niches increase to 48±17. Since the frequency of occupied
follicular niches significantly increases from day 6 (55%) to day 10 (81%) and is
rather stable until day 14 (79%), the 3-D volumetric evaluation indicates continious
new formation of GC, even after day 6, thus favoring asynchronous GC ensemble
kinetics. Noteworthy, the frequeny of empty follicular niches is unexpectedly high
even at day 10 and 14 (19% and 21%, respectively) (Figure 4.11).
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Figure 4.11: 3-D evaluation of occupation of follicular niches indicates continuous formation of
new GC throughout the response. Follicular niches were identified and traced as described in
Figure 4.10. The bar graphs illustrate the mean numbers of total (light gray), occupied (dark
gray) and empty follicular niches (white) per splenic volume recorded at each time point. Values
of individual mice (n=3 for each time point) are further indicated by different symbols. In order to
improve interpretability values are quoted as numbers of niches per 12 mm3, corresponding to the
mean estimated volume analyzed per spleen (see Table 4.1). Significant differences as calculated
by Student’s t test are indicated.
4.3.3 3-D reconstructions reveal that GC possess an ellip-
soid shape and cover a wide range of volumes
3-D reconstructions were performed on serial sections of each 3 spleen specimens at
day 6, 10 and 14 after immunization (see Table 4.1) as described in the materials
and methods Section 3.8. For reasons of feasibility and facility of inspection, 3-D
reconstructions were in either case confined to those GC that were wholly contained
within the serial sections. Lateral views, detail enlargements of lateral views and top
views of 3-D reconstructions of each one representative spleen specimen at day 6, 10
and 14 are showcased in Figure 4.12, A, B and C, respectively. As an aside, the 3-D
reconstruction shown for day 10 after immunization pertains to the series of meander
scans illustrated in Figure 4.10, A. The actual numbers of wholly contained GC as
well as their mean, range and total volume are summarized for all spleen specimens
in Table 4.2. The numbers of wholly contained GC are fluctuating with respect to
the three spleen specimens analyzed per time point (e.g. 23, 27 and 42 at day 10)
(Table 4.2). However, no striking differences are detected regarding the different
time points analyzed. As a matter of course, the fluctuation of numbers of wholly
contained GC is reflected by the total volume comprised by the very GC (e.g. 55.0,
80.8 and 112.9 ×106 µm3 at day 10), though the total volume at day 6 (21.2, 23.1
and 41.1×106 µm3) is evidently lower compared to day 10 and 14. Likewise, the
mean volume is minor for day 6 GC (0.5±0.6, 0.6±0.8, 1.4± 1.8 ×106 µm3) com-
pared to day 10 (2.4±3.5, 3.0±4.4, 2.7± 3.7 ×106 µm3) and day 14 GC (2.6±2.8,
2.0±2.1, 1.6±1.9 ×106 µm3). The particularly high standard deviations of mean GC
volumes are due to the omnipresent wide range of GC volumes. The smallest and
largest GC differ by a maximal factor of 220 at day 6, 1180 (!) at day 10 and 555
at day 14 (Table 4.2). But whereas the lower value limit of GC volumes is rather
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retained during the progression of the immune response (0.01, 0.01, 0.02 ×106 µm3
at days 6, 10 and 14), the upper value limit increases from day 6 to day 10 and
14, respectively (4.0, 11.8, 11.1 ×106 µm3) (Table 4.2). Hence, GC of rather small
volume are not restricted to the early phase but are also found at the peak of the
immune response. In contrast, the existence of GC of large volumes is confined to
the peak (day 10) and early decay phase (day 14).
The concomitance of different sized GC is subsidiary spotlighted in Figure 4.13 by
focusing on 3-D reconstruction of the detail enlargement shown for tracing of fol-
licular niches throughout series of serial sections at day 10 after immunization in
Figure 4.10, B. The positions of the occupied follicular niches GC105, GC108 and
GC112 are marked in the 3-D reconstruction image by arrows. Not only that the
very GC span different numbers of serial sections (1, 5 and 7 respectively), but they
are of quite different volume, as the largest (GC112, 10.0 ×106 µm3) differs from
the smallest (GC105, 0.5 ×106 µm3) by the factor of 20. By using the previously
recorded density of Ki-67+ cells per cross-sectional GC area (0.0116/µm2, see Sec-
tion 4.1.1) the numbers of cells comprised by the very GC are estimated as 12,500
(GC112) and 630 (GC105). Albeit the highlighted GC show a pronounced variation
in size, their geometrical shape - as given by the radius ratios of fitted GC ellipsoids
- turns out to be rather uniform. 3-D reconstruction confirms the results of virtual
random sectioning (Section 4.1.3) in that GC do not possess a spherical but ellipsoid
shape.
The 3-D reconstructions only constrictively allow for predication of the orientation
of GC within spleen because the chosen alignment mode (slicewise alignment of in-
dividual GC due to their center of mass, Section 3.8) causes straightening of GC.
The impression of perpendicular stringed GC therefore, at least partially, attributes
to a bias generated during alignment. However, comparison of 3-D reconstructions
performed with and without alignment suggest that GC may possess a preferential
spatial orientation in the spleen (Figure 4.14). GC appear to be predominately posi-
tioned upright (vertical) within the spleen, in which the axis of their major extension
is quasi-perpendicular to the longitudinal section plane. Horizontal or "lying" GC
(axis of major extension parallels the section plane) are observed rather occasionally.
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Spleen specimen Number of GC Volume of GC [106 µm3]
(wholly contained) mean ± SD range ∑
 43 0.5 ± 0.6 0.01-2.2 21.2
day 06 ~ 37 0.6 ± 0.8 0.03-3.7 23.1
} 30 1.4 ± 1.8 0.06-4.0 41.1
 23 2.4 ± 3.5 0.02-11.7 55.0
day 10  27 3.0 ± 4.4 0.01-20.7 80.8
 42 2.7 ± 3.7 0.01-11.8 112.9
⊕ 41 2.6 ± 2.8 0.02-11.1 107.4
day 14 ⊗ 20 2.0 ± 2.1 0.04-9.4 40.8
	 50 1.6 ± 1.9 0.02-8.1 80.9
Table 4.2: Survey of numbers and volumes of GC resulting from 3-D reconstructions. Specified are
the number, mean volume, range of volumes and total volume (
∑
) of GC wholly contained within
the reconstructed splenic volumes specified in Table 4.1. Different symbols refer to individual mice.
Figure 4.13: 3-D reconstruction of splenic volumes reveals a broad volume distribution of geometri-
cally uniform GC. Detail enlargement of the 3-D reconstruction of the splenic volume depicting day
10 GC illustrated in Figures 4.10 and 4.12, (middle panels). The staining of the respective region
of serial section s03 is superimposed (upper right corner), for orientation purposes the position of
s03 is likewise displayed in the 3-D reconstruction. The positions of the occupied niches GC105,
108 and 112 are indicated with arrows. The volumes and estimated numbers of B cells comprised
by reconstructed GC are each quoted. The geometry of GC is pointed out by specifying the ratios
of the radii of fitted ellipsoids, in which R1E , R2E and R3E always refer to the largest, medial
and smallest radius, respectively. Staining, imaging and 3-D reconstruction were carried out as
described in Figure 4.12.
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Figure 4.14: Spatial orientation of GC within the spleen. Albeit the straightening bias due to slice-
wise alignment of individual GC during 3-D reconstruction, GC turn out to possess a preferential
spatial orientation within the spleen. Within spleen, ellipsoid GC appear to be predominately
positioned upright, in which the the axis of their major extension is quasi-perpendicular to the
section plane. (A) Lateral view of 3-D reconstruction of a splenic volume representative for day
10 after immunization. 3-D reconstruction was performed by slicewise alignment of individual GC
as described in Figure 4.12 (aligned mode). (B) The same as in (A), except for 3-D reconstruction
was performed without the slicewise alignment of individual GC (unaligned mode).
4.3.4 GC possess an uniform ellipsoid shape that is pre-
served upon GC growth and progression
As aforementioned, the pure inspection of 3-D reconstructions give the impression
that GC possess a rather uniform ellipsoid shape. To further elucidate the shape
of GC and in particular its variation over the time course of the immune response,
the geometrical data on fitted GC ellipsoids are subjected to closer examination.
On that account, the recorded radii of fitted GC ellipsoids (R1E, R2E, R3E) are
separately plotted versus each other for each of the time points analyzed (days 6,
10 and 14), in which R1E, R2E and R3E always refer to the largest, medial and
smallest radius, respectively. The plots thus obtained show a settled linear depen-
dency between R1E and R2E, R1E and R3E as well as R2E and R3E (Figure 4.15).
As a tendency, the largest radius (R1E) appears to be most susceptible to varia-
tions as indicated by lower squared correlation coefficients (R2). The variation seen
in (R1E) most likely attributes to straightening of GC during 3-D reconstruction
(Section 4.3.3, Figure 4.14), that effectuates compression of the very radius. Fur-
thermore, the inter-individual variation of the linear dependency of radii of fitted
GC ellipsoids is low, since linear regression lines of individual mice almost coincide
at either of the time points.
In order to disclose potential dependencies with respect to shape and size, radii of
fitted GC ellipsoids are separately plotted against the underlying volume of the very
GC (Figure 4.16). Since the inter-individual variation turns out to be low (see above
and Figure 4.15), data obtained for individual mice (n=3) are each merged for days
6, 10 and 14, respectively. Such analysis reveals strict dependencies of either of the
radii (RE) and the underlying volume (V ) (Figure 4.16). These dependencies are
specified by best-fit curves resulting from power regressions that obey to the formula
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RE=a·Vb. All three radii of fitted GC ellipsoids virtually show cube root dependency
on the volume as indicated by the calculated values for the exponent b (e.g. b=0.33,
0.30, 0.36 for R1E, R2E, R3E at day 6). Noteworthy, the formal dependency of
either of the radii on the volume is almost invariable with respect to days 6, 10
and 14 (e.g. R2E=63·V0.30 at day 6, R2E=62·V0.33 at days 10 and 14). The high
squared correlation coefficients (R2≥0.80 for R1E, R2≥0.90 for R2E and R2≥0.91
for R3E) furthermore substantiate the visual impression of uniformly shaped GC.
Consequently, GC turn out to possess a uniform shape that is notedly preserved
upon GC growth and progression of the immune response (Figure 4.16). In synopsis,
the radii of GC ellipsoids roughly obey to the following formulas: R1E=91· 3
√
V ,
R2E=62· 3
√
V , R3E=44· 3
√
V . Accordingly, the approximate shape of GC is given by
the radii ratios R1E : R2E : R3E that are 2.1 : 1.4 : 1.
Figure 4.16: The 3-D shape of GC is preserved upon GC growth and progression of the immune
response. Illustrated is the interrelation of shape and size of GC as revealed by 3-D reconstruction
of in each case three spleens at day 6, 10 and 14 after immunization (see Figure 4.12). The radii of
fitted GC ellipsoids (R1E , R2E and R3E) are plotted separately against the underlying volumes of
the very GC. Best-fit curves resulting from power regression analysis (RE=a·Vb) are depicted as
solid lines. The respective values of constants (a), exponents (b) and squared correlation coefficients
(R2) are shown next to the curves.
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4.3.5 The 3-D evaluation of GC size reveals a considerable
volume distribution that is not consistent with the
accepted notion of GC growth kinetics
As argued before, the volume distribution of GC - and in particular its time course -
shall be capable of providing insight into the ensemble kinetics of GC growth. Since
3-D reconstructions were confined to GC that are wholly contained within the set of
7 serial sections (s01-s07), volume distributions are initially biased towards GC of
small size. To correct for this bias, volume distributions were further restricted to
GC intersecting the central section (s04), in which the probability is higher for large
compared to small sized GC. When displayed as linear histograms of the frequencies
of GC belonging to binned size classes, data thus corrected indicate the existence
of a distribution of GC volumes at days 6, 10 and 14 (Figure 4.17, A). Nonetheless,
the volume distribution of GC at day 6 is rather narrow, in that 91.1% of all GC
belong to the smallest linear binned size class (between 0.01 and 3.5 ×106 µm3 or
15 and 4.400 GC B cells, respectively). At day 10 after immunization the volume
distribution broadens and shifts towards larger size GC. But, the frequency of GC
assigned to the smallest linear binned size is still high, albeit decreased (58.6%). To
gain better resolution of the very GC comprising up to 4.400 GC B cells, the data are
additionally displayed as semi-logarithmic histograms, in which logarithmic binned
size classes are plotted versus their frequencies (Figure 4.17, B). Consequential plots
emphasize the shift towards larger GC between days 6 and 10. Finally, the volume
distribution of day 14 GC resembles the data obtained at day 10 after immunization,
albeit it slightly tends to shift back towards small sized GC (71.4% of GC fall into
the smallest linear binned size class).
Taken together, the data indicate a volume or size distribution of GC that becomes
most pronounced at day 10 after immunization. This volume distribution is pro-
found, since it reveals the concomitance of GC within the spleen that differ by a
maximal factor of about 1,000 (Section 4.3.3). The existence of a such defined vol-
ume distribution is not consistent with the accepted notion of synchronous ensemble
kinetics of long-lived GC, that is characterized by a rather constricted volume distri-
bution of GC (see Figure 4.9, A). Besides refuting the accepted notion, the volume
distribution is not sufficient to provide unambiguous predicates on the ensemble ki-
netics of GC, as it may attribute to either variation of maximal attained size of GC
(see Figure 4.9, B), asynchronous ensemble kinetics (see Figure 4.9, C) or even both
or scenarios just more complex.
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Figure 4.17: The 3-D evaluation of GC size reveals a considerable volume distribution that is not
consistent with the accepted notion of GC growth kinetics. (A) Depicted are the size distributions
of fitted GC ellipsoids at day 6, 10 and 14 after immunization as revealed by 3-D reconstruction
of splenic volumes. 3-D reconstructions were performed by means of in each case seven serial
spleen sections (s01-07), spaced at intervals of 50 µm as illustrated in Figures 4.10 and 4.12. The
frequencies of GC sizes refer to merged data sets of three mice at each time point and include
all GC that cross the central section (s04) and are wholly contained within the analyzed splenic
volumes. GC sizes are represented as volumes and estimated numbers of B cells comprised by these
volumes. The underlying total numbers of GC are indicated (
∑
), in which values of individual mice
are given in parentheses. (B) Semi-logarithmic application of the volume distribution specified in
(A) featuring improved separation of small GC volumes.
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4.4 Discussion
A major part of the investigations presented in this thesis involves the in-depth
contemplation of the kinetics of GC growth within spleen. This effort is motivated
by two major circumstances: (i) the enduring lack of understanding of some rather
basic aspects of affinity maturation, in particular with respect to the tempo-spatial
organization and regulation of the implied processes, namely expansion, SHM and
selection [94] and ii) the increasing number of experimental findings reported in the
primary literature that may challenge the prevailing notion of GC growth kinetics.
The assessment of GC growth kinetics is generally hampered by shortcomings in
feasibility of real-time observation of GC, as modern imaging techniques do not
allow for observation of time scales longer than a few hours. Furthermore, as yet
an adequate in vitro system mimicking spleen or lymph node is still missing [95].
Thus, the current standard of knowledge is a combined result of direct ex vivo
flow cytometric [96, 97] and immunohistological monitoring of GC cell populations
[70, 24, 45]. Albeit lacking any experimental validation, the core statement of the
consequently established or traditional conception of GC growth kinetics (Section
1.4.4) implies that all GC within an ensemble behave rather uniformly synchronous.
The investigation of GC growth in phOx-CSA challenged BALB/c mice refutes this
prevailing notion by negating this "uniformity presumption" (Figures 4.11-4.13, 4.17,
Table 4.2). Cross-sectional profiling reveals a robust average kinetics of GC growth
that is based upon a notable size distribution of GC within individual spleen sections
(Figures 4.4-4.5) that is farther shown not to solely attribute to random sectioning
(Figure 4.7). Moreover, the recorded cross-sectional profile turns out to be consistent
with both the established and unfamiliar conceptions of GC growth (Figure 4.9),
the latter including variegation in terms of seeding (synchronous/asynchronous),
life-time (long-lived/short-lived) and maximum size of GC (fixed/variable). Finally,
3-D volumetric evaluation lends support to non-uniform, asynchronous growth of
GC, given that seeding of GC is an ongoing process (Figure 4.11), and GC display a
profound volume distribution (Figures 4.12-4.13, 4.17, Table 4.2). Together theses
results allow the proposal of a revised model of affinity maturation in such way as
depicted in Figure 4.18.
4.4.1 2-D cross-sectional evaluation of GC growth kinetics
Due to facilitation of manual assignment of GC boundaries and determination of
actual cell counts, GC were generally identified by using the proliferation marker
Ki-67 that stains cells during all active phases of the cell cycle (G1/S/G2/M) but
not resting cells (G0) [98]. Ki-67 was initially reported to reveal a far-less striking
subcompartimentalization of murine GC than is typical of human GC [67], a finding
that was yet sharpened by Rahman et al. [69], claiming that Ki-67 is ubiquitously
expressed by murine GC B cells as identified by GL-7 reactivity. Nevertheless, since
the staining patterns of GL-7 and PNA slightly differ [99, 68, 96], Ki-67 remained
a controversial marker for measurement of GC. Therefore, potential distortion of
results owing to the use of Ki-67 was excluded at the outset of experiments (Section
4.1.1) by demonstrating that cross-sectional areas of GC as revealed by Ki-67 reac-
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tivity are consistently equivalent to those obtained by PNA-reactivity (Figure 4.2).
Consequently, proliferation is not restricted to any subcompartment of murine GC,
and the majority of GC B cells is in an active phase of the cell cycle and does not
enter the resting state. These findings were just recently confirmed by real-time in
vivo imaging of GC [100, 101].
The available data on growth kinetics of GC are not standardized as they are derived
from differently immunized mice (NP-CGG, SRBC, HSA) or rats (DNP-MSH), refer
to different lymphoid tissues (lymph node, spleen) and include different measures
for GC size that usually represent either indirect or extrapolated quantities (num-
ber of GC, volume estimated by cross-sectional diameter of GC, relative volume)
[102, 70, 24, 69, 103, 68, 45]. Despite direct data comparison is impeded by the
divergence of applied protocols, the identified mean time course of GC is surpris-
ingly similar to the above cited works. Since the growth kinetics of splenic GC
following phOx-CSA challenge (Figures 4.4-4.5) shows the very mean time course,
it is considered representative. Moreover, categorizing recorded GC into three size
classes (small, medium, large) following the convention introduced by the group of
T. Manser [104, 69, 68], leads to consistent results (data not shown). Consequently,
the observed profound size distribution of GC (Figure 4.5) is not exceptional to
phOx-CSA challenged BALB/c mice but constitutes a general phenomenon. To-
gether these result prove a robust induction of GC responses following phOx-CSA
challenge.
Simulations of random sectioning of various shaped ellipsoids (Figure 4.7) first sug-
gested that the observed size distribution of GC does not solely attribute to random
sectioning but may reflect a real size distribution of GC. By then, a stereological
approach to estimate the volumes of GC by means of their cross-sectional pro-
files turns out to be impracticable, since building of fair assumptions are impeded
by the unknown 3-D shape and shape distribution of GC. Stereology (from greek
stereos=solid) is an interdisciplinary research field devoted to the three-dimensional
interpretation of planar sections of either tissues or materials [105]. Initially defined
as the "spatial interpretation of sections", stereology is recently referred to as the
science of estimating higher dimensional information from lower dimensional sam-
ples. Albeit their steady advancement, stereological techniques do not apply to all
problems as they commonly share the need to make certain assumptions about the
object of interest that is to be estimated [106]. As by now, the 3-D volumetric
evaluation has revealed that splenic GC possess a preserved uniform shape that is
specified as ellipsoid with diameter ratios 2.1 : 1.4 : 1 (Section 4.3.4, Figure 4.15-
4.16), it shall be worthwhile to resume and advance a stereological approach.
4.4.2 Theoretical approach to GC ensemble kinetics
The simulation of random sectioning of hypothetical ensemble kinetics of GC is an
inverse approach to overcome the "deadlock situation" arising from cross-sectional
evaluation and stereology, that is, the volume distribution/ensemble of GC cannot
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be inferred by means of cross-sectional profiles (Section 4.4). The idea behind was
to simulate cross-sectional profiles of conceivable kinetics of ensembles of GC and to
subsequently identify the best-fit to the experimentally obtained profile (Figure 4.5).
In these premises, the inverse approach fails, as it demonstrates that the kinetics
of the experimentally obtained cross-sectional profile is consistent with various en-
semble kinetics of strikingly different nature (Figure 4.9). This finding is unlikely
to attribute to configuration of simulations, since involved assumptions were as well
fixed and experimentally supported: (i) each ensemble is composed of 500 randomly
distributed individual GC [70], (ii) the generic shape of GC was specified as prolate
ellipsoid (Figure 4.7, 4.16, Section 4.1.3, 4.3.4) and (iii) the probability of sectioning
through an individual GC is defined by its size.
To aid subsequent discussion of internal GC processes, the kinetics of individual GC
are gathered from a purposely simply-kept mathematical model (Figure 4.8, Section
4.2.1), that is similar to models established by Iber and Maini [107] and Meyer-
Hermann et al. [75]. Following a proposition of Oprea et al. [108], the model omits
iteration in that once selected cells do not further take part in the progression of the
respective GC. Due to the lack of internal iteration (recycling), the modeled kinetics
is independent of BCR affinity and both time course and lifetime of individual GC
solely rely on the rates of proliferation and selection. The recycling hypothesis was
proposed by Kepler and Perelson [109] as one implementation of an optimal muta-
tion schedule in which periods of rapid mutation alternate with periods of mutation-
free growth, hence referred to as phasic mutation schedule. Recycling is generally
committed to the conception of cell migration within two-compartmental GC (pro-
liferation and mutation act on centroblasts in the dark zone, whereas centrocytes
are subjected to selection in the light zone of GC) [109, 110]. Actually, migration of
GC B cells in both directions was recently shown by real-time in vivo observation of
GC [100, 101]. However, whether spatial separation of processes applies to murine
GC remains to be rigorously addressed. Anyhow, proliferation is observed in both
dark and light zones (Section 4.4.1) [100, 101], and it seems that selection rather
affects a phenotypically homogeneous population of proliferating GC B cells [69, 68].
Since recycling remains rather speculative it is not included within the current model
of individual GC growth kinetics. However, non-consideration of recycling does not
affect the outcome of simulations, as yet appointing the geometrical shape of growth
curves is sufficient for the current purpose.
In the first instance, the simulation-based inverse approach demonstrates that cross-
sectional profiling of GC does not allow for categorical inference of neither the kinet-
ics of the ensemble nor the underlying kinetics of individual GC (Figure 4.9, Section
4.2.2). Furthermore, by signifying that rather unfamiliar hypothetical ensemble ki-
netics that forgo the "uniformity presumption" are consistent with the cross-sectional
data, it compels reconsideration of the conception of GC growth kinetics. In fact,
hypothetical ensemble kinetics were composed in an nonarbitrary fashion but by
taking into account some rather novel experimental findings:
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(i) There is increasing evidence that the initial phase of GC formation is rather
similar to all GC [111], whereas the further progression of GC is susceptible to fac-
tors as the presence of accessory T cells [37], FDC [112] and the fitness of seeder
cells [113, 114]. Consequently, within an ensemble, GC may as well differ in their
maximum attained size and individual lifetimes, or even both (Figure 4.9, C). Ac-
cording to this conception, the time course and outcome of individual GC may
signify their quality or efficiency, respectively. Interestingly enough, the lifetime of
individual GC might differ from the persistence of the ensemble of GC, in that it
is much shorter. (Whether the volume distribution of GC observed at the peak of
the immune response (Figure 4.17) attributes to "differently successful" GC is under
current investigation by the help of Atĳeh Valai. Briefly, light chain V genes are
PCR amplified and cloned from microdissected GC of different but known volumes).
(ii) In vivo imaging reveals that GC are dynamic open structures, continually vis-
ited by naive follicular B cells, thus indicating germinal center seeding is an ongoing
process [101]. Continual recruitment of B cells into the GC reaction is further sub-
stantiated by the identification of a stable population of splenic B cells displaying a
GC founder phenotype following immunization [96, 97]. It is easily conceivable that
such recruitment is not only confined to already existing GC but may also apply
for yet empty follicular niches, thus leading to sustained new formation of GC. Ac-
cordingly, seeding of GC might indeed constitute a process of marked asynchronicity
(Figure 4.9, C).
4.4.3 3-D volumetric evaluation of GC growth kinetics
The motive force to proceed to volumetric evaluation (Section 4.3.1) was the accu-
mulating evidence that GC growth kinetics might be quite different than previously
accepted. The data presented here, are the first time that GC growth has been di-
rectly assessed by monitoring the real size of GC, to wit their volume. Prior to the
actual analysis determined efforts were made to establish optimal cryosectioning and
staining protocols that both ensure constant quality and ideal 3-D alignment of serial
whole spleen images (this work was assisted by a student assistant of the Systems
Immunology group, Anke Klein, who gives a full record of these pilot experiments
in her student research thesis [115]). Briefly, in order to facilitate identification and
especially tracing of follicular niches throughout serial sections, a complex quadru-
ple staining of proliferating cells, FDC, T cells and macrophages was established
(Section 3.6.6, Figure 4.10). The effectivity of manual tracing of follicular niches
was further improved (≥95%) by using sections of 25 µm thickness that turned out
to least susceptible to tissue ruptures and wrinkles [115].
Based upon tracing of follicular niches throughout serially sectioned splenic tissues
at days 6, 10 and 14, the number of follicular niches estimates to about 600-800 per
spleen, irrespective of the time point analyzed, thereby reconfirming the formation
of primary follicles including the FDC reticulum prior to antigenic stimulation [116].
However, as a consequence of GC formation, FDC networks seem to expand, most
probably reflecting "maturation" of FDC [117, 118, 68]. It is hard to know, whether
FDC networks are passively stretched by growing GC or if FDC even actively pro-
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liferate. At the height of the immune response to phOx-CSA no more than 450-650
GC are estimated to be present in the spleen. This estimate is slightly higher than
previously quoted for NP-CGG challenged C57BL/56 mice (300-500 GC) [70]. This
disparity between the two studies may be related to either different immunogenicity
of phOx-CSA and NP-CGG and the higher challenging dosage of antigen (100 µg
phOx-CSA vs. 50 NP-CGG µg) [45, 119, 120] or different detection of GC (quadru-
ple immunofluorescent staining vs. single immunoenzymatic staining with PNA).
Moreover, GC account for as much as 0.2-0.4%, 0.6-1.0% and 0.4-1.0% of the total
splenic volume at days 6, 10 and 14 after phOx-CSA challenge, which is consistent
with the relative volumes of GC during the primary DNP-MSH response in rats
reported by Liu et al. [24]. Likewise, the course of the mean volume of GC (Table
4.2) is in agreement with previously described extrapolated GC volumes in lymph
nodes [45]. Taken together, these results signalize very robust average kinetics of
the volume comprised by splenic GC. Noteworthy, such behaviour was already pre-
dicted by simulations of hypothetical ensemble kinetics that are, albeit strikingly
differing in underlying time courses of individual GC, reflected by the very same
average kinetics of GC volumes (Figure 4.9).
By means of 3-D reconstructions GC are shown to be randomly distributed through-
out the spleen, irrespective of their size, that is GC related to individual PALS
regions vary in volumes (Figures 4.12, 4.13). Thus, neighboring GC rather seem
to represent discretely acting entities, a finding further supported by genetic non-
relatedness of neighboring GC [121]. As argued before, it is difficult to assess the
spatial orientation of GC, since slicewise alignment of individual GC during 3-D
reconstruction causes an artifact, to wit, the impression of perpendicular stringed
GC. Likewise, the informative value of 3-D reconstructions obtained by alignment
of whole spleen sections is limited, as yet minimal wrinkles and fissures within sec-
tions heavily interfere with the spatial orientation of individual GC. Nevertheless,
GC tend to be arranged "upright" (vertical) with respect to the section plane, lying
(horizontal) GC are observed rather occasionally (Figure 4.14).
In terms of geometry, GC are found to possess marked ellipsoid shape, as empha-
sized by accurate ellipsoid fitting results (Section 4.3.4, Figures 4.12, 4.13, 4.16). In
fact, the general belief in spherical GC - routinely used to extrapolate the volume
of GC - certainly does not apply to the herein well-studied splenic GC. Perfectly
unexpected, GC are shown to not only possess ellipsoid but indeed an uniform el-
lipsoid shape that is fairly specified by the radius ratios 2.1:1.4:1 (Figure 4.16).
Substantial distortion of this result owing to straightening of GC during slicewise
alignment is finally ruled out by the data obtained when alignment was performed
for whole sections rather than individual GC (radius ratios turn out as 2.65:1.45:1,
appendix Figure A.2).
Perhaps the most thrilling conclusion to 3-D volumetric evaluation is that it ex-
plicitly refutes the central proposition of the traditional conception of GC growth
kinetics, that is the "uniformity" presumption. The finding that numbers of GC
significantly increase from day 6 to day 10 after antigenic challenge (about 30%)
(Section 4.3.2, Figure 4.11) attests continual "birth" of new GC, that is, formation
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of GC is not confined to an initial phase limited in time, as generally believed. The
observed increase does not attribute to "overlooking" day 6 GC that tend to be
smaller, and therefore have a lower probability of being cut compared to day 10 GC,
since (i) imaged splenic volumes are spaced at close intervals (the non-imaged inter-
space each accounts for one section) and (ii) the frequency of day 6 GC intersecting
only one section is low (5%), and rather decreased compared to day 10 GC (10%)
(appendix Figure A.3).
Based upon in vivo imaging of GC, Schwickert et al. [101] propose ongoing seeding
of pre-existing GC by naive follicular B cells that contributes to the stringency of
affinity maturation. Indeed, the data presented here point out that ongoing seeding
is not solely restricted to pre-existing GC but additionally entails continual "birth" of
new GC. Sustained new formation of GC provides a rational explanation for the sub-
stantial proportion of late GC showing little or even no evidence of somatic mutation
[122] in particular, and the well-documented high frequency of unmutated sequences
comprised by GC B cell populations (25-30%, Table 6.1) in general [123, 124, 125].
Asynchrononous formation of GC is also consistent with the very broad range of GC
volumes observed at all sampled time points (Section 4.3.5, Figure 4.17, Table 4.2).
It is tempting to speculate that small volumes account for "young" GC, only recently
formed, whereas large volumes signify already fully established "old" GC. However,
a direct link between volume and age of GC is rather unlikely, since the size of GC
is probably influenced by other factors such as efficiency and lifetime of individual
GC (discussed in Section 4.4.2). Affinity maturation based upon somatic hypermu-
tation is generally considered a game with few winners and many losers, since most
mutations are deleterious [126]. Kepler and Perelson [109] point out that, given the
actual rate of somatic hypermutation, accumulation of random mutations is likely
to render B cells incapable of binding the antigen, thereby compromising affinity
maturation. Nevertheless, affinity maturation is efficient as revealed by recurring
key mutations that increase the affinity of the antibody for its antigen by a factor
of 10 [127, 32, 128]. To solve such ambivalence, concepts as the phasic mutation
schedule and recycling were introduced [109, 110]. Asynchronous formation of GC
alleviates the seriousness of deleterious mutations in that failing of individual GC
may not compromise overall affinity maturation, because the very GC are likely to
"die fast" thereby vacating follicular niches for a "next round" of GC. In this scenario,
the lifetime of GC is not fixed but may vary among individual GC. The presented
results also have implications for molecularbiological approaches to study affinity
maturation and in particular its underlying selection process. In all probability, the
crux of evaluation of GC growth kinetics also applies for exploration of selection
within GC by means of sequence analysis of B cells. Albeit such sequencing data
provide insights into global selection, they presumably fail to specify the local se-
lection process operating within individual GC. This may explain why there is still
uncertainity about how B cells are selected on the mechanistical level [94, 129]. To
put in a nutshell: the presented data reveal that we are comparing apples to oranges,
even when examining GC comprised by one spleen. But there is more to it than
that: Who are the apples? Who are the oranges? The missing link to this dilemma
is an adequate GC-age marker.
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4.4.4 Revised model of affinity maturation
The essence of the presented results is that the GC reaction turns out to be of like-
wise robust and variable nature. In an imposing review on textbook GC, Manser [50]
emphasized that one hallmark of GC responses is their inherent plasticity. So far,
myriads of intervening approaches to the function of GC were applied, for the most
part targeting factors that are attributed to play a role for the operation of GC, to
name but a few: bcl-2, bcl-xl, BAFF/BAFF-R, CD19, CD40/CD40-L, CXCR-4, Fas,
FcgammaRIIB, Msh-2, T cells [130, 102, 113, 69, 103, 68, 131, 132, 37, 104, 129].
Strikingly, such interventions hardly ever fully abrogate but result in an "altered
version" of the GC response. By all means, it is beyond the power of the linear, uni-
form textbook conception of the GC response to explain such plasticity. The results
presented in this thesis best support a new concept of affinity maturation (Figure
4.18) that is based upon three principal components: i) formation of splenic GC is
both, asynchronous and sustained over the overall response, ii) GC continuously
generate emigrant B cells released into the periphery, a fraction of whom recircu-
late to the splenic white pulp, and iii) GC are open structures that continuously
recruit B cells from the pools of recirculating and naive follicular B cells.
In this conception, once established GC instantly start to produce emigrant B cells
that are released into the circulation, in which the requisite step to become an emi-
grant B cell is to succeed in the local selection process operating in GC. This idea is
consistent with the early appearance of antigen specific [133] B cells in the blood that
display a post-GC memory-like phenotype, that is isotype switched and shows V re-
gion mutation [133]. Since it is not clear if these cells are true memory B cells [134],
they are referred to as recirculating emigrant B cells in the following. As recirculat-
ing emigrant B cells apparently do not accumulate in the blood, and their population
is continuously renewed over the time course [133], it is tempting to speculate what
happens to the surplus cells. One possibility is that they differentiate to AFC that
subsequently settle in the bone marrow. Nevertheless, this is unlikely to attribute
to all of the surplus cells for two reasons: i) the frequency of AFC in blood is low
compared to bone marrow and ii) this would generate an excess of AFC [133]. Addi-
tionally, a fraction of the emigrant B cells may differentiate to the recently identified
B220− memory population that is found in the splenic red pulp and bone marrow
[135]. The other options, if not differentiation, are death or re-entrance into GC.
The revised model favors a combination of the latter by proposing a global selection
process that acts on the level of re-entrance into follicular niches. In this scenario,
recirculating short-lived emigrant B cells [133, 134] compete for recruitment into al-
ready established GC, since otherwise they will die. Indeed, recirculating emigrant
B cells are shown to be responsive to the chemokine CXCL-13, strongly suggesting
a migratory pathway that returns these cells to follicular niches. Moreover, transfer
experiments performed by Schwickert et al. [101] reveal that pre-existing GC recruit
antigen-specific B cells, as far as the transferred cells possess an competitive ad-
vantage in antigen-binding affinity. Recirculation of GC emigrant cells and global
selection are further supported by the analysis of mice that feature improved B cell
survival due to the transgenic expression of the anti-apoptotic protein bcl-2. The
immune response in these mice is characterized by accumulation of B cells displaying
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a post-GC memory-like phenotype in the spleen, including an excessive number of
low-affinity B cells [136]. Such abundance of low affinity B cells likely attributes to
curtailment of the global selection process, in that competition for reentrance into
GC is strongly reduced. Expression of the bcl-2 transgene prevents cell death of the
low affinity variants and thereby distorts affinity maturation. Strikingly, bcl-2 trans-
gene expression does not impede the generation of high affinity key mutation bearing
B cells, but rather averts their propagation [136]. Besides recirculating cells, also
naive follicular B cells may interfere in the global selection step, as they are shown
to represent incessant visitors to pre-existing GC [101]. Naive follicular B cells are
long-lived [137], which may compensate for their disadvantage in competition with
recirculating cells. Since GC formation is an ongoing process, recirculating B cells
as well as naive follicular B cells may additionally continuously give rise to new GC
within empty or recently vacated follicular niches, an event hereinafter referred to
as launching or relaunching, respectively. Whether recirculating B cells are capable
to induce formation of GC or if (re)launching solely attributes to naive follicular
B cells remains to be elucidated.
Albeit not explicitly depicted in the graphical illustration of the proposed model
(Figure 4.18), soluble antigen presumably plays a pivotal role in adjusting recircu-
lation of emigrant B cells. The phenomenon of soluble antigen induced cell death
of antigen-specific GC B cell is well-known and thought to reflect clonal deletion of
self-reactive B cells emerging within GC [138, 139, 140]. Interestingly, reduction in
the spleen is preceded by rapid elimination of antigen specific B cells from the blood
[140]. Therefore, soluble antigen may not only affect GC in a local but also in a
global fashion, in that it prevents recirculation of emigrant B cells by "killing" them.
Noteworthy, whereas single injections of soluble antigen do not significantly affect
cross-sectional numbers and size of GC, repeated injections cause a four- to fivefold
in size within 20 hours [138]. Consequently, recirculation of emigrant B cells may
contribute or even be required for the maintenance of GC. This circumstance might
also provide an explanation for the inconsistency of T cell independent (TI) GC
responses. The generation of GC emigrant B cells is likely to rely on CD40-CD40L
interactions in the presence of GC T cells, since blocking of this interaction grossly
impairs establishment of the memory compartment [141, 142, 143]. Since CD40-
CD40L signaling is not required for the initial induction of GC [142], TI antigens
can elicit the formation of GC - even in the absence of CD40L providing GC T cells.
Nevertheless, they presumably fail to maintain these GC since they are incapable
to generate emigrant B cells, which might explain the rapid disappearance of GC.
Taken together, adjusting the recirculation of emigrant B cells provides a potential
tool to affect the growth kinetics of GC. In this scenario, the onset and height of GC
responses are controlled by the amount of soluble antigen that defines the pool of
recirculating emigrant B cells. This idea is consistent with the delayed formation of
GC in response to Salmonella, in that GC become first detectable after the spread
of Salmonella is impeded by production of sufficient amounts of antibodies in an ex-
tensive extrafollicular response (unpublished, data were presented in a contributed
talk given by A.F. Cunningham at the BSI congress 2007).
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Figure 4.18: A revised model of affinity maturation. The proposed events involved in GC formation
and progression during affinity maturation are illustrated in a sketch of the spleen. A. B cells (b)
within already established GC undergo SHM and selection. B. B cells succeeding to pass this
local selection step leave GC as emigrant B cells (e), including memory B cells (m) and AFC (p).
The size of the emigrant pool is finite, hence survival is competitive and may lead to additional
cell death of emigrant B cells (δ). A fraction of surviving emigrant B cells becomes recirculating
B cells (+) that are permitted to reenter the spleen. C. Recirculating B cells can join already
established GC reactions (reentry) or D. occupy vacant follicular niches giving rise to new GC
((re)launch). Access to follicular niches involves a global selection step, including competition
among recirculating B cells and E. naive follicular B cells that may also continuously join pre-
existing or even (re)launch new GC.
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The crux of recirculation: oligoclonality of GC
The efficiency of affinity maturation is generally believed to attribute to the imple-
mentation of an iterative process, in that phases of diversification repeatedly alter-
nate with phases of selection. Briefly, if diversification is not interposed by multiple
rounds of selection, B cells are considered to loose their capability to bind antigen
on account of accumulation of deleterious mutations in their V genes. Although
iteration is reasonable, it lacks experimental validation, since tracing succession of
selection and subsequent resumption of diversification for individual B cells is, as
yet, unfeasible from the experimentally point of view. Nevertheless, two concepts
of implementation of iteration subsist, namely i) recycling within GC, also referred
to as internal iteration and ii) recirculation or external iteration, respectively. In
contrast to recycling, recirculation has been treaten as an orphant over the past
years, somehow fallen into oblivion. So why? - Because GC are oligoclonal! As-
suming recirculation of GC B cells immediately prompts the audience to point out
that recirculation is implausible because GC are oligoclonal (well-funded personal
experience). The oligoclonal composition (1-5 clones) of GC is well-documented by
two kinds of experiments including sequence analysis of individual GC [118, 121]
and immunohistological evaluation after seeding of GC with either two antigens or
two defined B cell populations [118, 121, 144, 24, 101]. While oligoclonality does
certainly attribute to established GC, initial seeding of GC is likely to be multiclonal
[121, 145] and clonal failures are rather common and inherent to the GC reaction
[145]. Consequently, only the minor (oligoclonal) population of clones that survive
the interclonal competition within GC at all become emigrant B cells, thereby giv-
ing rise to a selected repertoire [133]. The interclonal diversity is supposed to even
further decline in case the very emigrant B cells recirculate, since reentry into GC
is linked to an additional global selection process. In this scenario, the B cells that
previously came off victorious of each individual GC ("locally selected") now have to
compete globally with each other. This global selection process is likely to be again
accompanied by marked clonal failures.
One might argue that reentry should increase the local interclonal diversity of in-
dividual GC assessed in experiments, just because this process may add cells that
are quite unrelated to the currently propagating cells. That this is not necessarily
the case, is best reflected by naive follicular B cells that are recently shown to rep-
resent frequent visitors to pre-established GC [101] but strikingly never perturbed
oligoclonality in forerun studies. This phenomenon most likely attributes to the
transient nature of these visits, in that the retention time of naive follicular B cells
is low as indicated by higher motility and velocity compared to the physically re-
stricted GC B cells [101]. The minor proportion of naive follicular B cells [101]
further indicates that the rate of influx is rather low compared to the prolifera-
tion rate of GC B cells. If such behavior also accounts for recirculating emigrant
B cells, they are very unlikely to increase the interclonal diversity of GC, especially
as they also represent a restricted pre-selected pool of cells. Therefore, reentry of
recirculating emigrant B cells does not necessarily contradict oligoclonality.
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Kinetics of the cellular players of germinal
centers
Chapter 5
Kinetics of the cellular players of
germinal centers
5.1 Kinetics of germinal center T cells
For assessing the kinetics of GC T cells serial spleen sections of phOx-CSA immu-
nized mice, derived at different time points after immunization, were triple stained
for proliferating cells (mAb Ki-67), FDC-networks (mAb FDC-M2) and T cells (mAb
CD3). In the following, stained sections were analyzed by confocal microscopy for
the presence of GC that were identified as cell clusters of Ki-67+ proliferating cells
in the context of FDC-networks. The collectivity of all GC within individual sec-
tions was subsequently recorded by image acquisition (x400 magnification). Image
evaluation was performed as exemplary depicted for a GC image obtained at day 8
after immunization in Figure 5.1. In total, 1136 GC out of 45 sections derived from
23 mice were evaluated, a detailed survey of all analyzed sections and evaluated GC
is given in Table 5.1, the recorded parameters (direct and derived quantities) are
listed in Table 5.2.
days p.i. Σ (GC)/©
4 (14) (17) 	(4) 	(11) (46)/4
6 (12) (16) ⊗(19) ⊗(15) 	(16) 	(35) (15) (11) (139)/8
8 (18) (31) 	(35) 	(45) (27) (37) (193)/6
10 (27) ⊗(10) ⊗(19) 	(31) 	(41) (128)/5
12 (22) (16) 	(37) 	(52) (127)/4
14 (27) (25) ⊗(44) ⊗(12) (108)/4
16 (34) (26) 	(50) 	(38) (26) (25) (199)/6
18 	(21) 	(20) (30) (39) (110)/4
21 (17) (22) 	(19) 	(28) (86)/4
(1136)/45
Table 5.1: Survey of spleen sections analyzed for tracing the kinetics of GC T cells. Each ©
represents one analyzed spleen section at the given time point after immunization, identical ©
patterns ( ⊗ 	) reflect sections (interspace>500 µm) derived from the same animal. The
number of evaluated GC for each section is given in parentheses.
66
Figure 5.1: Data acquisition for assessing the kinetics of GC T cells exemplified by an image of a GC
obtained at day 8 after immunization. GC were identified as clusters of proliferating cells (mAb Ki-
67) within the context of FDC networks (mAb FDC-M2). GC T cells (T) were specified as CD3+
cells within the manually assigned boundaries of GC (ROIs), by further discriminating between the
FDC-rich light zone (FDC+) and the FDC-poor dark zone (FDC-) of GC. The subpopulation of
proliferating GC T cells (p+) was identified as CD3+ Ki-67+, accordingly non-proliferating T cells
(p-) were identified as CD3+ Ki-67−. Scale bar 50 µm.
Parameter Parameter description Calculation formula
(D) areat total area of GC
(D) areaFDC+ area of FDC-rich light zone
(D) nKit total number of Ki-67+ cells
(D) nKiFDC+ number of Ki-67+ cells within FDC-rich
light zone
(D) nTp+FDC+ number of proliferating T cells within
FDC-rich light zone
(D) nTp+FDC− number of proliferating T cells within
FDC-poor dark zone
(D) nTp-FDC+ number of non-proliferating T cells within
FDC-rich light zone
(D) nTp-FDC− number of non-proliferating T cells within
FDC-poor dark zone
(d) areaFDC− area of FDC-poor dark zone =areat - areaFDC+
(d) nKiFDC− number of Ki-67+ cells within FDC-poor
dark zone
=nKit - nKiFDC+
(d) nTp+t total number of proliferating T cells =nTp+FDC+ + nTp+FDC−
(d) nTp-t total number of non-proliferating T cells =nTp-FDC+ + nTp-FDC−
(d) nTFDC+,t total number of T cells within FDC-rich
light zone
=nTp+FDC+ + nTp-FDC+
(d) nTFDC−,t total number of T cells within FDC-poor
dark zone
=nTp+FDC− + nTp-FDC−
(d) nTt total number of T cells =nTFDC+,t + nTFDC−,t
Table 5.2: Survey of recorded parameters for assessing the kinetics of GC T cells. Listed are the
recorded direct (D) and derived quantities (d).
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5.1.1 The number of GC T cells reflects cross-sectional GC
size
The numbers of GC T cells detected per cross-sectional GC show pronounced inner-
section variation, thereby reflecting the already stated broad size distribution of
cross-sectional GC. Both, the total number of GC T cells and the numbers of GC
T cells in the two analyzed GC compartments (FDC-rich light zone and FDC-poor
dark zone) correlate with the corresponding cross-sectional GC areas throughout
all sampled time points. The left panels of Figure 5.2, A and B illustrate the
correlation of numbers of GC T cells and GC area for the peak (day 10) and the
decay phase (day 16) of the GC response, respectively. Correlations were rated by
performing simple linear regression. As demonstrated previously (Section 4.1.1), the
size of GC can be specified by either quoting cross-sectional GC areas or numbers
of Ki67+ cells of cross-sectional GC. Therefore, the recorded numbers of GC T cells
not only correlate with the cross-sectional GC area, but as well with the numbers of
Ki67+ cells per cross-sectional GC (right panel of Figure, 5.2, A and B ). However,
in-between day 8 to 21 after immunization, the correlation of GC T cells within
the FDC-rich light zone, tend to be more pronounced (R2=0.77-0.90), than the
correlation of numbers of GC T cells within the FDC-poor dark zone (R2=0.70-
0.80). As an aside, correlation coefficients obtained for the very early phase of GC
formation (day 4 to 6) have unsteady and lower values (R2=0.40-0.90). This is most
probably due to both, the low number and relatively small size of cross-sectional
GC, detected in the very period.
5.1.2 Very different correlation of proliferating and non-
proliferating GC T cells with cross-sectional GC size
The separation of the overall GC T cell population into proliferating and non-
proliferating GC T cells indicates divergent behavior of the two GC T cell subsets.
Whereas the recorded numbers of non-proliferating GC T cells feature distinctive
correlation with cross-sectional GC size (R2=0.8-0.9), proliferating GC T cells do not
correlate well (R2=0.3-0.6) (Figure 5.3, A). Likewise, the numbers of proliferating
GC T cells are not governed by the dimensions of either of the two GC compart-
ments or dark and light zone, respectively (Figure 5.3, B). Noteworthy, the recorded
numbers of proliferating cells show high variability with respect to GC of equivalent
cross-sectional size (Figure 5.3, B). Symptomatically, rather large GC harboring no
or only low numbers of proliferating GC T cells, are frequently observed from day
10 onwards, whereas very small GC often comprise unexpectedly high numbers of
proliferating T cells at about the same time (highlighted by merged day 10 data
in Figure 5.4). However, the numbers of proliferating T cells are rather nominal
and thereby prone to manual counting errors and statistical fluctuations. Therefore,
functional relevance of this finding is questionable.
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Figure 5.2: Inner-section correlation of numbers of GC T cells and cross-sectional GC size ex-
emplary depicted for spleen sections obtained at day 10 (A) and day 16 (B) after immunization.
The cross-sectional size of GC is given as both, cross-sectional GC area (left panel) and number
of Ki-67+ cells per cross-sectional GC (right panel). Correlations are rated applying simple linear
regression. Regression line (black) for total numbers of GC T cells and correlation coefficient (R2)
are specified for each scatter plot.
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Figure 5.3: Interrelation of GC T cell proliferation and cross-sectional GC size exemplary shown for
a spleen section obtained at day 10 after immunization. (A) The numbers of non-proliferating GC
T cells correlate with the total cross-sectional GC size, but numbers of proliferating GC T cells do
not. (B) The numbers of proliferating GC T cells are likewise not governed by the size of either of
the two GC compartments. Correlations are rated applying simple linear regression. The regression
lines for non-proliferating (black) and proliferating GC T cells (gray) as well as appendant squared
correlation coefficients (R2) are specified for each scatter plot.
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Figure 5.4: Illustration of highly variable numbers of proliferating GC T cells recorded for GC of
equivalent cross-sectional size. Data is representative of merged data obtained for day 10 after
immunization (128 GC out of 5 spleen sections). Note: GC of equivalent cross-sectional size
harbor variational numbers of proliferating GC T cells. Correlation is rated applying simple linear
regression. The regression line (black) and the squared correlation coefficient (R2) are specified for
the scatter plot.
5.1.3 Mean kinetics of GC T cells
The mean number of total GC T cells steeply increases from day 4 onwards and
reaches its maximum at day 8 after immunization. After peaking at day 8, the
mean number of total GC T cells marginally declines featuring an almost "steady
state level" from day 10 to 21 (Figure 5.5, A). The mean kinetics of total GC T cells
therefore resembles the overall growth kinetics of GC. The same applies to the ki-
netics of GC T cells within the two GC compartments, in which the mean number
of GC T cells in the FDC rich light zone is constantly higher compared to the FDC
poor dark zone (Figure 5.5, A). The comparison of images of B cell zones of naive
and immunized mice further indicates an antigen-driven influx of T cells into folli-
cular niches, in that accumulation of T cells in B cell zones is not observed until the
induction of GC formation (Figure 5.6).
The mean frequency of GC T cells in relation to numbers of Ki-67+ proliferating
cells ranges between 10-16% (Figure 5.7, A). Therefore, GC T cells constitute a mi-
nor fraction of the total GC cell population. The kinetics of the mean frequency of
GC T cells is characterized by two maxima (day 6 and days 16-21) seperated by an
intermediate minimum (day 12 after immunization) (Figure 5.7, A) . The chrono-
logically early maximum most probably reflects the strong influx of T cells observed
at the onset of GC formation, whereas the successional minimum and rather late
maximum are most likely due to a rather sustained mean number of T cells but
increasing/decreasing mean cross-sectional GC size. The kinetics of frequencies of
GC T cells with respect to dark and light zone - calculated as mean ratio of GC
T cells per number of Ki-67+ cells covered by the respective compartment - resemble
the overall kinetics (Figure 5.7, A). However, the density of GC T cells is increased
in the light zone compared to the dark zone about a factor of 1.5 between days 10
to 16 after immunization.
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Albeit the recorded mean numbers of proliferating GC T cells per GC are low (0.4-
4), an apparent peak is observed at day 8 after antigenic challenge (Figure 5.5, B).
The mean frequency of proliferating GC T cells in reference to total numbers of GC
T cells is characterized by a striking maximum at day 6 (16%) (Figure 5.7, B). Taken
together, the recorded data imply that proliferation of GC T cells is a feature of
the early phase of GC formation and becomes marginal thereafter. In this scenario,
rather stable mean numbers of GC T cells are attained in the early phase of GC
formation by migration and proliferation of T cells. Afterwards, the mean number
of GC T cells is sustained by either "long-term" residing or continuous circulation
of GC T cells.
Figure 5.5: Mean kinetics of GC T cells. Illustrated are the mean numbers and standard deviations
of GC T cells per cross-sectional GC. Each mean is representative of the entirety of analyzed
sections at the given time point (see Table 5.1). (A) Mean kinetics of the overall number of
GC T cells and numbers of GC T cells in the FDC- and FDC+ GC compartment (dark and light
zone). (B) Mean kinetics of non-proliferating and proliferating GC T cells.
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Figure 5.6: Antigen-driven influx of T cells into follicular niches due to GC formation. Whereas
follicular niches of naive mice typically lack notable numbers of T cells, GC show accumulation
of T cells, in particular within the FDC-rich light zone. Images are representative of triple im-
munofluorescent stainings of T cells (mAb CD3), FDC networks (mAb FDC-M2) and either B cell
zones of naive (A) or GC of immunized mice at day 10 after immunization (B). B cell zones of
naive mice were visualized applying mAb B220, GC of immunized mice were identified as clusters
of Ki-67+ cells within the context of FDC networks. Scale bar 50 µm.
Figure 5.7: Kinetics of frequencies of GC T cells. (A) Mean frequencies of GC T cells in relation
to Ki-67+ cells per cross-sectional GC. Illustrated are the frequencies of total GC T cells and GC
T cells within the FDC- and FDC+ GC compartment (dark and light zone). (B) Mean frequency of
proliferating GC T cells with regard to the total number of GC T cells. Data are each representative
of the entirety of evaluated GC at a given time point (see Table 5.1).
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5.2 Kinetics of germinal center Mφ
For assessing the kinetics of GC macrophages (Mφ) serial spleen sections of phOx-
CSA immunized mice, derived at different time points after immunization, were
triple stained for proliferating cells (mAb Ki-67), FDC-networks (mAb FDC-M2)
and Mφ (mAb CD68). In the following, stained sections were analyzed by confocal
microscopy for the presence of GC that were identified as cell clusters of Ki-67+
proliferating cells in the context of FDC-networks. The collectivity of all GC within
individual sections was subsequently recorded by image acquisition (x400 magnifi-
cation). Image evaluation was performed as exemplary depicted for a GC image
obtained at day 10 after immunization in Figure 5.8. In total, 1290 GC out of 52
sections derived from 26 mice were evaluated. A detailed survey of all analyzed
sections and evaluated GC is given in Table 5.3, the recorded parameters (direct
and derived quantities) are listed in Table 5.4.
days p.i. Σ (GC)/©
4 (15) (18) 	(6) 	(5) (44)/4
6 (11) (18) ⊗(13) ⊗(8) 	(14) 	(23) (15) (12) (114)/8
8 (25) (30) 	(31) 	(51) (32) (36) (205)/6
10 (23) (29) ⊗(16) ⊗(8) 	(32) 	(45) (153)/6
12 (18) (19) ⊗(13) ⊗(32) 	(41) 	(55) (178)/6
14 (23) (21) ⊗(41) ⊗(29) 	(21 	(12) (147)/6
16 (26) (27) 	(46) 	(38) (28) (28) (193)/6
18 ⊗(14) ⊗(47) 	(23) 	(23) (25) (46) (178)/6
21 (15) (20) 	(16) 	(27) (78)/4
(1290)/52
Table 5.3: Survey of spleen sections analyzed for tracing the kinetics of GC Mφ. Each © represents
one analyzed spleen section at the given time point after immunization. Identical © patterns
( ⊗ 	) reflect sections (interspace>500 µm) derived from the same animal. The number of
evaluated GC for each section is given in parentheses.
Parameter Parameter description Calculation formula
(D) areat total area of GC
(D) areaFDC+ area of FDC-rich light zone
(D) nKit total number of Ki-67+ cells
(D) nKiFDC+ number of Ki-67+ cells within FDC-rich
light zone
(D) nMFDC+ number of Mφ within FDC-rich light zone
(D) nMFDC− number of Mφ FDC-poor dark zone
(d) areaFDC− area of FDC-poor dark zone =areat - areaFDC+
(d) nKiFDC− number of Ki-67+ cells within FDC-poor
dark zone
=nKit - nKiFDC+
(d) nMt total number Mφ =nMFDC+ + nMFDC−
Table 5.4: Survey of recorded parameters for assessing the kinetics of GC Mφ. Listed are the
recorded direct (D) and derived quantities (d).
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Figure 5.8: Data acquisition for assessing the kinetics of GC Mφ exemplified by an image of a GC
obtained at day 10 after immunization. GC were identified as clusters of proliferating cells (mAb
Ki-67) within the context of FDC networks (mAb FDC-M2). GC Mφ (M) were specified as CD68+
cells within the manually assigned boundaries of GC (ROIs), by further discriminating between
the FDC-rich light zone (FDC+) and the FDC-poor dark zone (FDC-) of GC. Scale bar 50 µm.
days p.i. Σ (B cell zones)/©
naive (0) (69) (60) ⊗(53) ⊗(46) (228)/4
4 (39) (62) (101)/2
6 (52) (57) (109)/2
10 (36) (54) (90)/2
21 (43) (53) (96)/2
x (68) (79) (147)/2
(771)/14
Table 5.5: Survey of spleen sections analyzed for assessing the frequency of Mφ within B cell zones
of naive and immunized BALB/c. Each © represents one analyzed spleen section at the given
time point after immunization. Identical © patterns (⊗) reflect sections (interspace>500 µm)
derived from the same animal. The number of evaluated B cell zones for each section is given in
parentheses.
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5.2.1 The number of GC Mφ reflects cross-sectional GC size
Likewise to GC T cells, the recorded numbers of Mφ per cross-sectional GC feature
prominent inner-section variation based on the underlying broad size distribution of
cross-sectional GC. The total numbers as well as the numbers of Mφ within dark and
light zone of GC appear to be dependent on the size of the appendant compartments
(Figure 5.9). The strict correlation of numbers of Mφ and cross-sectional GC size is
observed throughout all sampled time points, irrespective of the delineation of cross-
sectional GC size in terms of either areas or numbers of Ki-67+ cells (Figure 5.9,
A and B). Notably, the regulation of numbers of macrophages appears to be very
tight, as the vast majority of evaluated spleen sections feature squared correlation
coefficients (R2) substantially above 0.9.
Figure 5.9: Inner-section correlation of numbers of GC Mφ and cross-sectional GC size exemplarily
depicted for spleen sections obtained at day 10 (A) and day 16 (B) after immunization. The cross-
sectional size of GC is given as both cross-sectional GC area (left panel) and number of Ki-67+
cells per cross-sectional GC (right panel). Correlations are rated applying simple linear regression.
Regression line (black) for total numbers of macrophages and squared correlation coefficient (R2)
are specified for each scatter plot.
5.2.2 Mean kinetics of GC Mφ
The mean kinetics of GC Mφ follows the overall GC growth kinetics, marked by an
increment of mean numbers of GC Mφ in the early phase of GC formation up to
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the peak (day 4 to 10 after immunization), followed by a gradually but moderate
decline until the last sampled time point (day 21 after immunization). The herein
described kinetics holds true for both, the total numbers of GC Mφ and the numbers
of GC Mφ in the two differentiated GC compartments (Figure 5.10, A). The mean
numbers of GC Mφ in the FDC-rich light zone and FDC-poor dark zone do not
differ significantly, at the utmost a trend towards slightly elevated numbers GC of
Mφ in the FDC devoid compartment can be anticipated.
The frequency of GC Mφ in relation to Ki-67+ cells ranges between 8-11% (Fig-
ure 5.10, B). Hence GC Mφ constitute a rather small GC cell population, if not the
smallest, given the recorded frequency of GC T cells (10-16%). As a hallmark, the
frequency of GC Mφ in relation to Ki-67+ cells additionally turns out to be sus-
tained in an almost fabulous fashion throughout the immune response, displaying
pronounced robustness (Figure 5.10, B). Taken together, the recorded, rather in-
variant mean frequency of numbers of GC Mφ per Ki-67+ cells and virtually absent
standard deviations with regard to the total GC as well as the two GC compart-
ments, indicate a very tight regulation.
Figure 5.10: Mean kinetics of GC Mφ. Illustrated are the mean numbers and standard deviations
of GC Mφ per cross-sectional GC. Each mean is representative of the entirety of analyzed spleen
sections at the given time point (see Table 5.3). (A) Mean kinetics of the overall number of GC
Mφ and numbers of GC Mφ in the FDC- and FDC+ GC compartment (dark and light zone) (B)
Mean frequencies of GC Mφ in relation to Ki-67+ cells per cross-sectional GC. Depicted are the
frequencies of total GC Mφ and GC Mφ within the FDC+ and FDC- GC compartment (dark and
light zone).
5.2.3 GC Mφ do not invade B cell zones due to GC forma-
tion but are already detectable in B cell zones of naive
mice
The course of the mean kinetics of numbers and frequencies GC Mφ highly suggests
an influx of GC Mφ into B cell zones due to the onset of GC formation, as do
T cells (Section 5.1.3). Indeed, influx of Mφ only as a consequence of GC formation
(simplified: first comes the GC, then the Mφ follow) is a current doctrine that is
taken up to allege that GC Mφ cannot play a role for initiation and the early phase
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of GC development at all [45]. Astonishingly, juxtaposing images of follicular niches
of naive to follicular niches of immunized mice explicitly refutes the "Mφ influx
doctrine". In contrary to T cells, Mφ are already frequently detected in B cell zones
of naive mice (Figure 5.11, A). The presence of Mφ in B cell zones was repeatedly
verified in naive mice that were checked for the absence of GC by PNA staining.
Based on this finding, Mφ have to be understood as a component of the primary
follicular niche that is a prerequisite for GC formation (simplified: first comes the
Mφ, then GC follow).
Figure 5.11: Mφ do not invade B cell zones due to GC formation but are already detectable in
B cell zones of naive mice. Images are representative of triple immunofluorescent stainings of B cell
zones of naive (A) and immunized mice at day 10 after immunization (B). B cell zones of naive
mice were visualized applying mAb B220, GC of immunized mice were identified as clusters of
Ki-67+ cells within the context of FDC networks (mAb FDC-M2). Scale bar 50 µm. Note: Images
are representative of both the same B cell zone and GC as shown for GC T cells (figure 5.6).
5.2.4 The frequency of Mφ per cross-sectional GC is regu-
lated in a superordinate fashion by the overall B cell
zone size
The comparison of images of follicular niches of naive to immunized mice gives the
impression that the frequencies of Mφ in the corresponding B cell zones are quite
equivalent (Figure 5.11). To further elucidate the regulation of numbers of Mφ, the
frequencies of Mφ per cross-sectional B cell zone size was assessed in naive and im-
munized mice. For this purpose spleen sections were triple stained for B cells (mAb
B220), T cells (mAb CD4) and macrophages (mAb CD68) and both the size of cross-
sectional B cell zones and associated numbers of Mφ were recorded (Figure 5.12, A).
Within individual sections the number of Mφ strictly correlates with cross-sectional
B cell zone size (R2 ≥0.9) (Figure 5.12, B). The quantitative analysis verifies the
prementioned qualitative impression. As illustrated in Figure 5.12, C, the frequen-
cies of Mφ within B cell zones of naive (35±6 Mφ/25,000 µm2) and immunized mice
(30±3 Mφ/25,000 µm2) are rather steady. The overall average frequency of Mφ
within follicles of BALB/c mice, ultimately adds up to 31±5 Mφ/25,000 µm2.
78
Besides affirming the involvement of Mφ in formation of primary follicular niches
(Section 5.2.3) this finding further implies that the frequency of Mφ is governed by
the overall B cell zone size. Therefore, the executing regulation mechanism does
not take charge of GC B cells in particular, but of B cells in general. Figuratively,
GC formation and growth lead to an expansion of the overall B cell zone that is
accompanied by an influx of Mφ because the number of B cells increases, not by
reason that there are "specialized" GC B cells. As an aside, the superordinate regu-
lation of the frequency of Mφ is not confined to naive and immunized BALB/c mice
but is also valid for other mouse strains, as well as its perturbation is potentially
associated with autoimmunity (Section 5.4.2).
Figure 5.12: Steady frequencies of Mφ within B cell zones of naive and immunized mice. (A)
Evaluation of the frequency of Mφ within B cell zones exemplarily shown for a spleen section
derived from a naive mouse. B cell zones were identified as B220+ areas (ROI, highlighted in
yellow) adjacent to T cell zones (mAb CD4). Mφ within B cell zones were identified and counted
by CD68 reactivity. Scale bar 50 µm. (B) The number of Mφ strictly correlates with cross-sectional
size of the B cell zone. Data is representative of a spleen section derived from a naive BALB/c
mouse. Correlation is rated applying simple linear regression. Regression line (black) and squared
correlation coefficient (R2) are specified for the scatter plot. (C) The frequency of Mφ within B cell
zones remains sustained upon immunization. Illustrated are the mean frequencies of Mφ within
B cell zones of two naive and five immunized mice at different time points after immunization. Data
is each representative of two evaluated sections per mouse. In order to improve interpretability,
frequencies are quoted as numbers of Mφ per 25,000 µm2, corresponding to the area comprised by
the white selection in (A).
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5.3 Kinetics of cell death and uptake of apoptotic
cells within germinal centers
For assessing the kinetics of apoptotic cells within GC, serial spleen sections of
phOx-CSA immunized mice were triple stained for GC B cells (PNA), macrophages
(mAb CD68) and apoptotic nuclei (TUNEL). In the following, stained sections were
analyzed by confocal microscopy for the presence of GC that were identified as cell
clusters of PNA+ cells. The collectivity of all GC within individual sections was
subsequently recorded by image acquisition (x400 magnification). Image evaluation
was performed as exemplary depicted for a GC image obtained at day 10 after
immunization in Figure 5.13. In total, 1038 GC out of 42 sections derived from 21
mice were evaluated, a detailed survey of all analyzed sections and evaluated GC is
given in Table 5.6.
Figure 5.13: Data acquisition for assessing the kinetics of cell death within GC exemplified by an
image of a GC obtained at day 8 after immunization. (A) GC were identified by PNA-reactivity
and apoptotic nuclei were specified as TUNEL+ signals within the manually assigned boundaries of
GC (ROIs). Scale bar 50 µm. (B) Automated detection and measurement of TUNEL+ nuclei for
the GC depicted in (A) applying an adapted version of the Nucleus Counter plugin of the ImageJ
software. Scale bar 50 µm.
5.3.1 Less pronounced inner-section correlation of numbers
of apoptotic nuclei and cross-sectional GC size
As expected by the underlying broad size distribution of cross-sectional GC, the
recorded numbers of apoptotic nuclei per cross-sectional GC show distinctive inner-
section variation. But whereas the numbers of GC T cells and in particular GC
macrophages turn out to well correlate with the underlying cross-sectional size of
GC, this dependency appears to be less pronounced with respect to the numbers of
apoptotic nuclei, reflected by lessened squared correlations coefficients (R2 ≤0.76).
The inner-section correlation is exemplarily depicted for day 10 and 16 in Figure 5.14.
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days p.i. Σ (GC)/©
4 (13) (12) 	(7) 	(5) (37)/4
6 (11) (17) 	(11) 	(17) (16) (8) (80)/6
8 (24) (36) 	(34) 	(48) (30) (42) (214)/6
10 (28) (31) 	(31) 	(37) (127)/4
12 (26) (22) 	(7) 	(20) (38) (57) (170)/6
14 (21) (18) (39)/2
16 (24) (29) 	(50) 	(22) (18) (29) (172)/6
18 	(20) 	(23) (34) (36) (113)/4
21 (20) (17) 	(21) 	(28) (86)/4
(1038)/42
Table 5.6: Survey of spleen sections analyzed for tracing the kinetics of apoptotic nuclei within
GC. Each © represents one analyzed spleen section at the given time point after immunization.
Identical © patterns (⊗	) reflect sections (interspace>500 µm) derived from the same animal.
The number of evaluated GC for each section is given in parentheses.
5.3.2 The number of apoptotic nuclei does not reflect cross-
sectional GC size
The aforementioned less-stringent correlation of numbers of apoptotic nuclei and
cross-sectional GC size becomes even more apparent by merging all data recorded
at a given time point. Noteworthy, GC of the same cross-sectional size harbor
arbitrary numbers of apoptotic cells, as exemplary illustrated for day 8 after im-
munization in Figure 5.15, A. At that time for instance, the numbers of apoptotic
nuclei, corresponding to a cross-sectional GC area of 27,000 µm2 (marked by the
gray dashed line in Figure 5.15, A), cover a range from 25 to 109. Figure 5.15, B il-
lustrates the automatic detection and measurement of apoptotic nuclei within three
GC of the very cross-sectional size. Besides differing in the actual number, those GC
also vary in the appearance of apoptotic nuclei, as increasing numbers effectuate a
shift from initially discrete to cumulative clusters of of apoptotic nuclei. The forma-
tion of clusters of apoptotic nuclei indicates multiple uptake by GC macrophages as
specified in Section 5.3.4. The high variance is not attributed to variation between
mice but constitute a decisive trait.
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Figure 5.14: Inner-section correlation of numbers of apoptotic nuclei and cross-sectional GC size
exemplary depicted for sections obtained at day 10 (A) and day 16 (B) after immunization. The
cross-sectional size of GC is given as cross-sectional GC area, as revealed by PNA-reactivity.
Apoptotic nuclei were visualized applying TUNEL.
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Figure 5.15: The number of apoptotic nuclei does not reflect cross-sectional GC size. (A) Less-
stringent correlation of numbers of apoptotic nuclei and cross-sectional GC size. Note: GC of the
same cross-sectional size harbor arbitrary numbers of apoptotic nuclei. Data is representative of
merged data obtained for day 8 after immunization (214 GC out of 6 spleen sections). GC were
identified by PNA-reactivity and apoptotic nuclei were visualized applying TUNEL. Correlation is
rated applying linear regression. The regression line (black) and the squared correlation coefficient
(R2) are specified for the scatter plot. (B) Automated detection and measurement of apoptotic
nuclei exemplified by a series of GC of the same cross-sectional size (27,000 µm2, highlighted
by the gray dashed line in (A)). Increasing numbers of apoptotic nuclei are reflected by a shift
from initially discrete (left panel) to cumulative clusters of signals (middle to right panel). GC
boundaries (yellow) were each assigned according to the source images.
5.3.3 Mean kinetics of apoptotic nuclei
The time course of the mean number of apoptotic nuclei per cross-sectional GC fol-
lows the overall growth kinetics of GC (Figure 5.16, A). Whereas apoptotic nuclei are
rather infrequently observed within follicles of naive mice (Figure 5.17, A), and are
only detected occasionally at the onset of GC formation (day 4), their mean number
steadily increases afterwards, reaching a maximum at day 10 after immunization.
At that time, also huge clusters of apoptotic nuclei are abound in cross-sectional
GC (Figure 5.17, B). After peaking at day 10, the mean number of apoptotic nuclei
per cross-sectional GC moderately decays.
The time course of the mean frequency of apoptotic nuclei relative to cross-sectional
GC area is characterized by a steep increase at the outset up to day 8 after im-
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munization. From day 8 to 21 after immunization, the mean frequency is retained
at a quasi steady state level. Nevertheless, it tends to slightly decrease between
day 10 to 16, giving rise to a less apparent second maximum at at day 18 after
immunization (Figure 5.16, B). Albeit not directly recorded, the mean frequency of
apoptotic nuclei with respect to the numbers of Ki-67+ cells was extrapolated using
the already assessed density of Ki-67+ cells per cross-sectional GC area (1 cell/86
µm2, Section 4.1.1). Expression of the mean frequency of apoptotic nuclei in rela-
tion to the number of Ki-67+ cells facilitates its comparison to frequencies of GC
T cells and macrophages. As aforementioned, starting from 0%, the frequency of
apoptotic nuclei in relation to Ki-67+ cells first increases and averages to 21 % at
its peak at day 10 after immunization. In the following, the mean frequency ranges
between 17-21 % (Figure 5.16, B, dashed line). Taken together, whereas apoptotic
nuclei represent a minor cellular constituent at the onset of GC formation, they
subsequently evolve to a major cellular constituent of GC (17-21%), as revealed by
comparison to frequencies of GC T cells (10-16%) and macrophages (8-11%).
Figure 5.16: Mean kinetics of apoptotic nuclei within GC. (A) Time course of the mean number
of apoptotic nuclei per cross-sectional GC. (B) Mean frequencies of apoptotic nuclei with respect
to cross-sectional GC area (solid line) and numbers of Ki-67+ cells (dashed line). Mean values
and standard deviations are each representative of the entirety of analyzed sections at the given
time point (see Table 5.6). The mean frequency of apoptotic nuclei in relation to Ki-67+ cells is
an extrapolated quantity, taking into account that one Ki-67+ cell corresponds to 86 µm2 cross-
sectional GC area (specified in Section 4.1.1).
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Figure 5.17: Apoptotic nuclei become a major cellular constituent of GC and entail the formation
of abundant clusters during the immune response. Whereas apoptotic nuclei are basically absent
from follicles of naive mice (A), they accumulate in GC and give rise to the formation of huge
clusters due to their multiple uptake by GC macrophages (B). Images are representative of triple
immunofluorescent stainings of apoptotic nuclei (TUNEL), macrophages (mAb 68) and B cell zones
of naive (A) and GC of immunized mice at day 10 after immunization (B), respectively. B cell
zones of naive mice were visualized applying mAb B220, GC of immunized mice were identified by
PNA-reactivity. Scale bar 50 µm.
5.3.4 Uptake of apoptotic cells by GC Mφ
The non-inflammatory removal of apoptotic cells generally requires their efficient
recognition and uptake by macrophages, since impaired clearance of dying cells ap-
parently involves the development of autoimmunity [146]. Among the individual
kinetics of apoptotic nuclei and GC macrophages, just the kinetics of uptake is a
matter of particular interest. Visually, the uptake of apoptotic cells by GC mac-
rophages is reflected by colocalization of TUNEL+ nuclei and CD68+ macrophages
in immunofluorescent stainings. Notably, within GC of immunized BALB/c the oc-
currence of TUNEL+ signals turns out to be exclusively restricted to macrophages,
as they were never detected in the absence of a dedicated macrophage. Moreover,
the observed formation of clusters of apoptotic nuclei attributes to multiple up-
take by macrophages, as illustrated in Figure 5.18. Noteworthy, multiple uptake of
apoptotic nuclei by GC macrophages accounts for profound changes regarding the
macrophage size. Hence, the number of apoptotic nuclei ingested by a macrophage
determine its size.
The uptake of apoptotic cells is first rated by examining the time course of the mean
number of apoptotic nuclei per GC Mφ. Since the frequency of GC Mφ per cross-
sectional GC area is fixed (see Section 5.2.4), and the kinetics of GC Mφ is already
known (Section 5.2.2), the numbers of GC Mφ are extrapolated from cross-sectional
GC areas for this purpose. Accordingly, the resultant time course of the mean
number of apoptotic nuclei per GC Mφ mimics the kinetics of the mean frequency
of apoptotic nuclei per cross-sectional GC area, albeit the ordinate scale differs.
The mean number of apoptotic nuclei per GC Mφ steeply increases until day 8 to
10 after immunization (1.8±0.3) but subsequently hardly decays (1.5±0.4, day 21)
(Figure 5.19, A). After all, the mean number of apoptotic nuclei per GC Mφ is a less
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informative measure of uptake of apoptotic cells within GC, because it misleadingly
implies that apoptotic nuclei are evenly distributed among GC, solely dependent on
their cross-sectional size. To factor in the given disparity in numbers of apoptotic
nuclei within GC of the same cross-sectional size, GC are first classified according
to their respective mean number of apoptotic nuclei per Mφ. Since the number of
inclosed apoptotic nuclei determines the size of Mφ, data thus obtained figuratively
qualify GC according to their mean size of Mφ, as exemplified in figure 5.18. Plotting
the distribution of GC comprising either small, medium, large or very large Mφ - in
the following referred to as the Mφ size distribution - reveals radical changes over the
observed time course (Figure 5.19, B). Whereas small Mφ prevail at the onset of the
formation of GC (100%, day 4), the Mφ size distribution afterwards incrementally
shifts towards larger Mφ till day 10 after immunization. At that time, the bulk
of GC comprises either medium (42%), large (34%) or even very large Mφ (9%).
Hence the once prevalent small Mφ (15%) just account for a small fraction of GC.
Subsequently, the frequencies of GC containing large and very large Mφ successively
decline. Thus, GC comprising very large Mφ are virtually absent at day 14 (2%)
and the vast majority of GC feature medium sized Mφ (74%). Noteworthy, albeit
the mean number of apoptotic nuclei per GC Mφ at day 12 and 14 stays equal to
1.6, the underlying Mφ size distributions are disparate (Figure 5.19, B). After day
14 the Mφ size distribution again shifts towards larger Mφ, wherein this second
shift strikingy resembles the already specified preceding shift between days 6 to 10
with respect to both general progression and attained frequencies. In conclusion,
the Mφ size distribution constitutes a key element for cross-sectional evaluation of
GC growth kinetics, as its particular shape may serve as an excellent marker for the
stage of the immune response. Moreover, it turns out to be the sole parameter that
succeeds in reflecting the underlying volume distribution of GC (Section 4.3.5).
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Figure 5.18: The disparity in numbers of apoptotic nuclei within GC of the same cross-sectional
size is reflected by the varying size of macrophages. Multiple uptake of apoptotic nuclei by GC
macrophages involves profound changes with respect to macrophage size. The mean size of GC
macrophages is equivalent to the ratio of numbers of apoptotic nuclei to numbers of macrophages
within an individual GC. Therefore, it allows for rating of uptake of dying cells within GC. To
facilitate evaluation, the mean size of macrophages of individual GC is confined to the provision
of four size classes: small (0-1), medium (1-2), large (2-3) and very large (>3 apoptotic nuclei
per macrophage). The frequencies of GC belonging to the four size classes give rise to a distri-
bution that is referred to as macrophage size distribution (Figure 5.19, B). Images illustrate the
colocalization of apoptotic nuclei (TUNEL) and GC macrophages (mAb CD68) for the same series
of GC as depicted in Figure 5.15. GC boundaries (yellow selection) were assigned according to
PNA-reactivity (hidden, in order to facilitate inspection). Scale bar 50 µm.
Figure 5.19: Mean kinetics of uptake of apoptotic cells by GC macrophages and underlying macro-
phage size distribution. The macrophage size distribution is subjected to radical changes over the
time course that are not necessarily reflected by the mean kinetics. (A) Time course of the mean
number of apoptotic nuclei per GC Mφ (green solid line). (B) Time course of the macrophage
size distribution that was acquired as illustrated in Figure 5.18. Data is representative of the
entirety of analyzed sections at a given time point (see Table 5.6). The mean number of apoptotic
nuclei per GC Mφ is an extrapolated quantity, allowing for the absolute frequency of GC Mφ per
cross-sectional GC area (31±5 Mφ/25,000 µm2, as specified in Section 5.2.4).
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5.3.5 The shape of the Mφ size distribution potentially acts
as an regulatory element - Implications of a phenome-
nological mathematical model
The cell kinetics in germinal centers are remarkably fast, as for instance GC B cells
have been shown to divide every 6 to 10 hours [144, 147]. But despite this high
proliferation rate, the total number of GC B cells grows much slower than expected.
So far, the mechanisms that control the growth behavior of GC are still ill-defined.
Apparently, the high proliferation rate has to be counterbalanced by a comparably
high apoptosis rate, but besides, GC macrophages are thought to play an important
role in the regulation of GC growth [45, 46]. The evaluation of the kinetics of GC
macrophages and uptake of apoptotic cells by GC macrophages suggests that instead
of the number, rather the size of GC macrophages might represent a regulatory
element. This working hypothesis was tested by devising a mathematical model
that assumes simple feedback mechanisms for the interaction between GC B cells
and macrophages. Mathematical modeling was assisted by Dr. Michal Or-Guil and
Dr. Johannes Schuchhardt.
The model
The model describes the kinetics of individual GC as illustrated in Figure 5.20
and as translated into a mathematical model (given below). The formation of GC
is accompanied by a brisk expansion phase characterized by pronounced GC B cell
proliferation. Consequently, the number of follicular B cells increases and macropha-
ges are attracted to the B cell follicles, respectively GC (superordinate regulation,
Section 5.2.4). Due to selection and competition for survival signals within GC, a
fraction of GC B cells becomes apoptotic. Apoptotic GC B cells are immediately
recognized and phagocytozed by GC macrophages. The size of GC macrophages is
influenced by two counteracting processes: uptake of apoptotic cells and degradation
of the very cells within macrophages. Whereas uptake of apoptotic cells increases
the size, the degradation of apoptotic material decreases the size of a macrophage.
The kinetics of GC B cells and macrophages are coupled by a negative feedback
mechanism that implies inhibition of GC B cell proliferation by large macrophages
loaded with several apoptotic cells.
Model equations
The interactions described in the Model section and in Figure 5.20 are specified by
the following set of ordinary differential equations:
b˙ = pt · b− φ
n−1∑
k=0
mk · b (5.1)
m˙0 = α · b− δ ·m0 − φ ·m0 · b+ θ ·m1 (5.2a)
m˙k = φ ·mk−1 · b− φ ·mk · b+ θ ·mk+1 − θ ·mk (5.2b)
m˙n = φ ·mn−1 · b− θ ·mn (5.2c)
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Figure 5.20: Model interactions of GC B cells and macrophages. The simulation starts with
the formation and expansion of GC by swiftly proliferating GC B cells (b). As the proliferation
of GC B cells increases the total number of B cells, macrophages (m) are attracted to B cell
follicles and thus to GC. The subscript of m indicates the number of engulfed apoptotic cells and
thereby reflects the size of GC macrophages. Due to selection within GC, a fraction of GC B cells
becomes apoptotic and is immediately engulfed and phagocytozed by GC macrophages. Uptake
of apoptotic cells gradually increases the size of GC macrophages, whereas the degradation of
apoptotic cells within GC macrophages decreases their size. On account of a simple feedback
mechanism, GC macrophages counteractively influence the expansion of GC B cell as large GC
macrophages suppress GC B cell proliferation.
GC B cells (b) proliferate with the actual proliferation rate pt but disappear with rate
φ due to apoptosis and uptake by GC macrophages (m) (Equation 5.1). The size of
macrophages is reflected by the index k that indicates the number of engulfed apop-
totic cells. The kinetics of macrophages belonging to any size class mk are specified
by each two influx and efflux terms (Equation 5.2b). Influx to mk is given by either
uptake of apoptotic cells by macrophages of size k-1 or by degradation of apoptotic
cells within macrophages of size k+1 that occurs at rate θ. Accordingly, the efflux
from mk is defined by either uptake or degradation of apoptotic cells by macropha-
ges of size k. In the particular case of macrophages that harbor no apoptotic cells at
all (m0) (Equation 5.2a), the influx is given by the initial attraction of macrophages
by B cells with rate α and the degradation of apoptotic cells within macrophages of
size k=1. The efflux from m0 is determined by the death rate δ of macrophages and
uptake of apoptotic cells by macrophages of size k=0. Consequently, the kinetics of
macrophages belonging to the maximal size class mn (Equation 5.2c) comprise only
each one influx (uptake of apoptotic cells by macrophages of size n-1) and efflux
term (degradation of apoptotic cells within macrophages of size n).
The influence of the macrophage size distribution on the actual proliferation rate pt
is implemented as:
pt =
pmax
1 + f
n∑
k=0
k ·mk
(5.3)
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In the absence of GC B cell apoptosis and uptake (k=0) proliferation occurs at max-
imal rate pmax. Uptake of apoptotic cells leads to a decline of the actual proliferation
rate pt, where the decline is proportional to the general negative feedback potency
of macrophages (f ) and their actual size distribution.
Parameter and initial conditions Value Reference
Maximum proliferation rate of GC B cells (pmax) 2.75 day−1 [144, 147]
Rate of uptake of apoptotic cells by GC macrophages (φ) 0.001 day−1
Degradation rate of apoptotic cells ingested by GC macro-
phages (θ)
0.7 day−1 [148]
Initial rate of attraction of GC macrophages by B cells (α) 0.015 day−1
Death rate of GC macrophages (δ) 0.5 day−1
Negative feedback potency rate of GC macrophages (f ) 0.01
Table 5.7: Parameter values and initial conditions.
The model succeeds in reproducing major characteristics of GC cell ki-
netics
The behavior of the model resembles the major characteristics of the experimentally
recorded cell kinetics of GC. In the simulation, GC first become detectable at around
day 4 and last for about three weeks. The maximum size of GC is attained at day 8
after immunization when the total population size of GC B cells amounts to about
12,000 cells. Thereafter, GC gradually vanish (Figure 5.21, top panel). Moreover,
the simulated time course of GC macrophages parallels GC growth as the numbers
of GC macrophages increase during the expansion but consequently decrease in the
decay phase of GC. The peak number of GC macrophages is detected at day 12
after immunization. At this time, the population size of GC macrophages is about
750 cells (Figure 5.21, bottom panel).
The simulation additionally succeeds in reproducing the kinetics of uptake of apop-
totic cells within GC, since the size of macrophages - reflected by the number of
apoptotic nuclei per GC macrophage - steeply increases up to day 10 and thereafter
slowly decays (Figure 5.22, left panel). Noteworthy, the simulation also provides a
fair prediction of the macrophage size distribution as exemplarily illustrated for day
4, 6 and 10 in Figure 5.22, middle panel. It accurately predicts that virtually all
GC macrophages are of small size at the onset of GC formation (day 4), but then
gradually shift towards larger size (day 6), finally resulting in a predominance of
large-sized GC macrophages at the peak of GC growth (day 10).
The herein outlined model has to be considered rather phenomenologically, since
several parameter values are not yet established experimentally (Table 5.7) and
were therefore tuned within reasonable limits to achieve a realistic behavior of the
simulation. Nevertheless, it provides strong evidence that the size distribution of
macrophages acts as a regulatory element with regard to GC growth kinetics.
90
Figure 5.21: The model phenomenologically reproduces the experimentally recorded kinetics of
GC B cells and macrophages. The simulated time plots of GC B cells and macrophages (gray-
shaded) are each opposed to the experimentally recorded kinetics. Parameter values and initial
conditions of the simulation were applied according to Table 5.7. The ordinate scales of simulations
and experimental data differ, as simulations are performed on GC volumes but experimental data
are derived from cross-sectional evaluation.
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Figure 5.22: The model reproduces the experimentally recorded kinetics of uptake of apoptotic
cells and predicts the macrophage size distribution. The simulated time plot of the uptake of
apoptotic GC B cells by macrophages as well as the resultant macrophage size distributions at day
4, 6 and 10 (gray-shaded) are opposed to the experimentally recorded data. Parameter values and
initial conditions of the simulation were applied according to Table 5.7.
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5.4 Excursus: Perturbed GCMφ compartment in
autoimmune NZB/W mice
The immunohistological detection of apoptotic cells applying the TUNEL techno-
logy was established in a series of pilot experiments using cryosections of spleen
tissue derived from lupus-prone (NZB/W)xF1 mice. The NZB/W strain exhibits
spontaneous GC formation in the spleen in the absence of purposeful immunization
and adventitious infection. The cells of these spontaneously developing GC were
reported to be phenotypically similar with respect to cell-surface markers to GC
that arise in response to immunization [149]. As an initially unanticipated result of
the pilot experiments, the morphology of GC Mφ and associated apoptotic cells of
NZB/W mice turned out to be obviously peculiar. Because the generation of high
titers of anti-DNA antibodies in autoimmune mice is generally ascribed to malfunc-
tion of GC and in particular to clearing defects of Mφ within GC [150], the NZB/W
model emerged as an eligible candidate to complement the analysis of the kinetics
of apoptotic cells and their uptake by Mφ assessed in BALB/c mice. Therefore, the
follicular Mφ of NZB/W mice were subjected to further analysis. The frequency
of Mφ within B cell zones was recorded for naive NZB/W of different age as de-
scribed before for naive and immunized BALB/c mice (Section 5.2.4). Naive NZB
and BALB/c mice served as controls and standards, respectively. A survey of all
analyzed tissue specimens is depicted in Table 5.8.
Specimen Σ (B cell zones)/©
NZB (6-8 w) (41) (40) ⊗(43) ⊗(41) (165)/4
NZB/W (6-8 w) (40) (49) ⊗(43) ⊗(43) (175)/4
NZB/W (14 w) (62) (53) ⊗(53) (168)/3
(508)/10
Table 5.8: Survey of spleen sections analyzed for assessing the frequency of Mφ within B cell zones
of NZB/W and NZB mice. Each © represents one analyzed spleen section at the given time point
after immunization, identical © patterns (⊗) reflect sections (interspace>500 µm) derived from
the same animal. The number of evaluated B cell zones for each section is given in parentheses.
5.4.1 Aberrant morphology of GC Mφ in NZB/W mice
As mentioned in the preface of this section, confocal imaging of fluorescence stained
GC Mφ and apoptotic cells discloses differences of NZB/W compared to BALB/c
mice with respect to morphology. These differences strikingly unveil by performing
z-scans accounting for the third dimension of Mφ (Figure 5.23, A and B, middle left
panel). Unlike z-scans, default xy-scans do not expose these alterations (Figure 5.23,
A and B, left panel). A great many of GC Mφ of NZB/W mice feature clear signs of
disintegration. The cell membrane of these Mφ ceases to exist as a whole framework,
but is fractionated into myriads of membrane particles (blebs, vesicles) (Figure 5.23,
A, middle right panel). As a concomitant feature, the accumulation of loads of
apoptotic nuclear debris is detected in conjunction with these Mφ (Figure 5.23, A,
right panel). This "exaggerated" morphology of NZB/W Mφ can be interpreted as a
decomposition phenomenon due to Mφ hyperactivity - finally resulting in Mφ death.
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Figure 5.23: Aberrant morphology of GC Mφ in NZB/W mice. Illustrated are stainings of GC Mφ
(mAb CD68) and apoptotic cells (TUNEL) of a 17 weeks old unimmunized NZB/W mouse (A)
and an immunized BALB/c mouse at day 10 after immunization (B). Whereas GC Mφ of NZB/W
and immunized BALB/c mice look rather similar in xy-scans at lower magnification (left panel),
maximum projections of z-scans at higher magnification reveal striking differences regarding the
morphology of GC Mφ (middle left panel). GC Mφ of NZB/W show clear signs of disintegration
of the cell membrane (middle right panel) accompanied by pronounced accumulation of loads of
apoptotic nuclear debris (right panel). Scale bar 50 µm.
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5.4.2 Decreased frequencies of follicular Mφ in NZB/Wmice
due to disease progression
Decomposing "dying" GC Mφ do not emerge occasionally but rather habitually in
NZB/W mice. Assuming progressional death of GC Mφ in NZB/W mice, the tightly
regulated equilibrium between follicular Mφ and B cells should get affected by the
time. In fine, the frequency of Mφ in B cell zones of NZB/W mice would drop along
disease progression. To verify this hypothesis, the frequency of Mφ within B cell
zones of NZB/W mice of different age was recorded and compared to frequencies
obtained for parental NZB and naive BALB/c mice.
Likewise BALB/c, NZB/W and parental NZB mice show stringent inner-section
correlation of numbers of Mφ and cross-sectional B cell zone size (R2 ≥0.9) (Figure
5.24). Moreover, the mean frequency of Mφ of young 6-8 weeks old NZB/W mice
(35±3/25,000 µm2) is the same as established for naive BALB/c mice (35±6/25,000
µm2), once more emphasizing the tight superordinate regulation of numbers of Mφ
by the overall B cell zone size (Section 5.2.4). In fact, the frequency of Mφ decreases
along disease progression, as it is significantly reduced of about one third in 14 weeks
old compared to 6-8 weeks old NZB/W mice (21±1/25,000 µm2) (Figure 5.25, A);
(p=0.0001, independent samples t-test). The decline in numbers of Mφ becomes
even more striking by opposing the distributions of frequencies of Mφ within B cell
zones. Whereas the distribution of frequencies of 6-8 weeks old NZB/W mice is
indistinguishable compared to naive BALB/c mice, it radically shifts towards lower
frequencies in 14 weeks old NZB/Wmice (Figure 5.25, B). Recapitulating, the herein
described results indicate an acquired imbalance of frequencies of follicular Mφ and
B cells due to disease progression in lupus-prone NZB/W mice.
In addition, the frequencies of Mφ within B cell zones of 6-8 weeks old parental NZB
(29±3/25,000 µm2) turn out to be slightly decreased compared to naive BALB/c
mice (35±6/25,000 µm2) (Figure 5.25). NZB mice are reported to develop autoim-
munity, but of a different kind and at a different age compared to NZB/W mice
[151]. If impairment of the follicular Mφ compartment also contributes to disease
progression in NZB mice has to be elucidated in follow-up experiments.
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Figure 5.24: Inner-section correlation of numbers of GC Mφ and cross-sectional B cell zone size in
NZB and NZB/W mice. Data is representative of each one spleen section derived from 6-8 weeks
old NZB, NZB/W and 14 weeks old NZB/W. The cross-sectional size of B cell zones is given as
cross-sectional area. Correlations are rated applying simple linear regression. Regression lines and
squared correlation coefficients (R2) are specified for each scatter plot.
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Figure 5.25: Age-dependent decline in numbers of follicular Mφ in NZB/W. The number of Mφ per
B cell zone area was determined as described previously (Section 5.2.4). (A) Illustration of mean
frequencies of Mφ within B cell zones of in each case two naive BALB/c, 6-8 weeks old parental
NZB as well as 6-8 and 14 weeks old NZB/W mice. Data is representative of two evaluated spleen
sections per mouse, values of individual mice are depicted as open circles. The frequency of Mφ of
6-8 weeks old NZB/W is in par with steady frequencies reported for naive and immunized BALB/c
mice, but explicitly drops in 14 weeks old NZB/W mice. Significant differences as calculated by
Student’s t test are indicated. (B) Striking shift towards lower frequencies of Mφ within B cell
zones of NZB/W mice due to disease progression. Displayed are the distributions of frequencies of
Mφ within B cell zones of the same mice as depicted in (A). Data is representative of all sections
analyzed per mouse strain and time point.
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5.5 Discussion
5.5.1 Kinetics of GC T cells
GC T cells are thought to represent an unique subset of antigen specific T cells [152],
also referred to as follicular helper T cells [41, 42, 27, 153], that plays a pivotal role
in affinity maturation, in that it is linked to proliferation, differentiation and in
particular memory formation [141, 142, 154, 143]. Only recently, in vivo imaging of
GC provided evidence that GC T cells may also drive the selection of high affinity
GC B cells [100]. Studies performed in this thesis for the first time address the
kinetics of this unique subset during the primary immune response.
In contrast to macrophages, T cells first selectively colonize B cell follicles upon anti-
genic challenge but are practically absent in primary follicles of naive mice (Figure
5.6). Although assessment of proliferating GC T cells is hampered by their generally
low frequency within the GC cell population (≤1%), the obtained results indicate
that proliferation of GC T cells is certainly not governed by the size of GC or one
of its compartments (Figure 5.3), but rather by the stage or age of the immune
response, respectively (Section 5.1.2). Marked GC T cell proliferation is restricted
to a short period of time following the migration and entry of T cells into follicular
niches, reaching its peak at day 6 (17 % of GC T cells are proliferating, Figure
5.7, B). Thereafter, proliferation of T cells is straight off reduced to a marginal
level (Figure 5.7, B). Together with the finding that initial colonization of B cell
follicles by T cells is not directed by B cells but rather controlled by dendritic cells
(DC) [155], these results suggest that the presence of T cells within the early phase
of GC formation is not soleley for the purpose of providing B cell help but may
also indicate regular T cell differentiation pathways as for instance clonal expansion
[156, 157] and formation of CD4 memory [158, 159]. Given the fact that the early
phase of GC formation also takes place in the absence of T cells [113, 37], B cells
and T cells are likely to act independently at this stage. Moreover, this early stage
of initial GC formation may serve to procreate pools of both, B cells and T cells
whose interaction becomes a prerequisite for affinity maturation only afterwards. In
the light of the revised model of affinity maturation (Section 4.4.4, Figure 4.18), it is
tempting to speculate that the very interaction involves a shift from local to global
acting processes in that it triggers mobilization of both, GC B cells and T cells, in
which the latter are already shown to extensively travel among white pulp regions
when GC are fully established [153].
After the initial phase of formation of GC, proliferating T cells are not absent but
rather sporadically detected within individual GC, in which the actual numbers are
highly variable for GC of equivalent cross-sectional size (Figure 5.4). Whether this
finding attributes to the ongoing new formation of GC (Section 4.3.2, Figure 4.11)
and thus reflects the age distribution of GC cannot be gathered from the present
data.
The kinetics of total numbers of GC T cells follows the time course of the overall
size kinetics of GC peaking at day 8 after antigenic challenge, as do the numbers of
GC T cells within dark and light zone of GC (Figure 5.5). Consistent to previous
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reports, the numbers of GC T cells are always higher for the FDC rich compartment
of GC, indicating preferential localization of GC T cells in the light zone [100, 154,
147]. GC T cells constitute a minor fraction of the GC cell population (10-16%)
(Figure 5.7, A), although recorded frequencies are slightly increased compared to
previous reports (5-10%) [155, 153], which most probably attributes to differences
in studied mouse models as well as antibodies used for detection of GC T cells.
Notably, the variable numbers of GC T cells among individual GC turn out to
reflect the underlying size distribution of GC, in that numbers are strictly governed
by the cross-sectional GC size (Figure 5.2). The strong correlation of numbers
of GC T cells with GC size further suggests that T cell retention within GC is
regulated by factors intrinsic to GC, most likely delivered by B cells or stromal cells
such as FDC and DC [155]. Nevertheless, the observations that T cells are often
found in close proximity to macrophages (not shown) and also carry apoptotic blebs
[100], may indicate a complex feedback system of GC cell homeostasis including
GC B cells, T cells and macrophages. With regard to the selection model proposed
by Allen et al. [100], the take over from macrophage derived apoptotic material to
T cells may not only drive selection by limiting T cell help but may concomitantly
promote GC B cell proliferation by effecting the suggested regulatory propensity of
macrophages (Section 5.3.5).
5.5.2 GC Mφ and uptake of apoptotic cells
The presence of characteristic macrophages within GC is recognized for about 125
years and was already described when GC were first discovered by Flemming [28].
Early light and electron microscopical studies revealed that these macrophages con-
tain many phagocytozed lymphocytes in their cytoplasm and thus specified them
as tingible body macrophages (TBM) [28, 160, 43]. Due to the observation that
the definition of TBM does not account for the collectivity, but rather describes a
marked subset of large macrophages (Figure 5.8, 5.17), macrophages within follicles
or GC are referred to as follicular and GC macrophages, respectively, in the current
thesis. The analysis of (GC) macrophages challenge the prevailing view, in that their
role turns out to be not restricted to sole removal of apoptotic cells but is likely to
also involve induction, homeostasis and regulation of GC. The study of uptake of
apoptotic cells within GC indicates that selection of BC B cells is not confined to
the the light zone but is likely to occur also in the dark zone of GC. Moreover, it
lends support to asynchronous growth and ongoing seeding of GC.
Presence and functions of Mφ within B cell follicles
In striking contrast to the work of Smith et al. [45], macrophages are shown not
to require antigenic stimulation to colonize follicles but already represent a con-
stituent cell population of B cell zones of naive mice (Figure 5.11), in which their
actual number strictly correlates with the underlying size of the B cell zone (35 ±
6 Mφ/25.000 µm2 or 9 ± 1 Mφ/100 B cells) (Figure 5.12). The differences between
Smith et al. [45] and the results presented here, attribute to the antibodies used
for detection of follicular macrophages (mAb Mac-2, mAb CD68) and underline the
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uniqueness and adaptability of this particular subset of macrophages. Since the
macrophage antigen Mac-2 has been reported to be expressed by mature macropha-
ges [161], its absence from macrophages of primary follicles [45] strongly suggests
maturation or differentiation of follicular macrophages upon antigenic stimulation.
Whether this maturation attributes to GC formation per se or intense uptake of
apoptotic cells within GC remains to be rigorously addressed, yet the latter is sup-
ported by the propensity of mAb Mac-2 to stain very large (TBM-like) macrophages
[45]. Noteworthy, the Mac-2 staining pattern is resembled by a further mature mac-
rophage marker, MOMA-2 (not shown). Besides their unknown ontogeny [162],
there is still controversy whether GC macrophages are resident [163] or migratory
macrophages [45], in which the former is recently encouraged by in vivo imaging of
GC. Nevertheless, the abundance of phenotypically indifferent macrophages within
T and B zones of primary follicles (Figure 5.11) suggest a common origin of these
macrophages, thereby favoring ongoing replenishment of GC macrophages by mac-
rophages from the T zone. The presence of macrophages in B zones of naive mice
further indicates that they may be involved in or even be required for the induc-
tion of GC responses. However, albeit GC macrophages were reported to possess
two requisite characteristics [44, 164], they are rather unlikely to contribute to the
induction of GC by functioning as critical antigen presenting cells [46].
As a hallmark, the strict correlation of numbers of macrophages in B cell zones
with the size of the B cell zone is even preserved upon antigenic challenge and
germinal center development (30 ± 3 Mφ/25,000 µm2 or 8 ± 1 Mφ/100 B cells)
(Figure 5.12). This tight balance most likely reflects an integral homeostatic inter-
dependency of follicular B cells and macrophages. Peripheral B cell homeostasis was
recently shown to primarily rely on B cell activation factor (BAFF) production by
radiation-resistant stromal cells [165]. Nevertheless, macrophages have been shown
to produce BAFF in vitro [166, 167, 168] and reconstitution of BAFF-deficient mice
with wild type bone marrow containing macrophages was proven to be sufficient to
induce maturation of some newly formed B cells to mature follicular B cells [165].
The close proximity of macrophages and B cells further suggests that locally high
concentrations of macrophage-derived BAFF may affect the homeostasis of B cell
zones by mediating B cell survival.
The importance of the 8:100 macrophage to B cell ratio for macrophage-B cell in-
teractions within B cell follicles is withal supported in that young NZB/W show the
same ratio (Figure 5.25). Noteworthy, the imbalance of this ratio (5:100) in older
NZB/W mice (Figure 5.25) coincides with the progression of autoimmune disease
in these mice, characterized by spontaneous formation of GC and elevated autoan-
tibody titers [169, 149, 170].
GC Mφ and uptake of apoptotic cells indicate that selection takes place
in the dark zone and light zone of GC
As expected, the number of GC macrophages turns out to be strictly dependent on
the underlying size of GC (Figure 5.9), as indicated by marked inner-section correla-
tions and the almost invariable 1:10 GC macrophage to B cell ratio (Figure 5.10, B).
The striking difference of the macrophage to B cell ratio reported here and the one
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previously assessed by Smith et al. [45] (1:350) attributes to the incomplete coverage
of GC macrophages by means of Mac-2 reactivity, as discussed above.
The time course of total numbers of GC macrophages follows the overall size kinetics
of GC and macrophages are found evenly distributed within both GC compartments
throughout the response (Figure 5.10, A). Mentionably, GC macrophages are often
found at both, the transition of dark and light zone and the very the basal part of
GC adjoining to the T cell zone (Figure 5.8). Nevertheless, costaining of apoptotic
cells reveals that cell death occurs throughout GC, showing no preferential bias to-
wards the very macrophages or either of the two GC compartments (Figure 5.13,
5.18). Taken together, this results strongly suggest that selection of GC B cells
is not restricted to the FDC rich light zone as generally believed [147], but does
also take place in the dark zone of GC. Selection of GC B cells within the dark
zone is also supported by sequence analysis of single GC performed by Camacho
[118], that revealed low inter- and intraclonal diversity of GC B cells within the
dark zone. However, because the irreversible steps of apoptosis, namely caspase-3
activation and DNA-fragmentation, first occur only when GC B cells are attached to
macrophages [171], it cannot be excluded that the decisive death signal is delivered
exclusively within the light zone of GC.
Although GC are detectable as early as day 4 after antigenic challenge, GC B cell
apoptosis is hardly detectable until day 6, but afterwards phenomenally increases up
to day 8-10 (Figure 5.16, A), causing apoptotic cells to henceforth become a major
population of GC as reflected by a 1:5 apoptotic nuclei to GC B cell ratio (Figure
5.16, B, Figure 5.17). The skyrocketing time course of cell death most probably
reflects the transition of GC from an initial formation phase to a "function phase",
in which the transition is characterized by massive cell death of GC B cells due to
the onset of SHM between days 7 to 8 [121] and subsequent failures in selection.
Evaluation of cell death within GC supports asynchronous GC growth
and ongoing seeding of GC
Unanticipated, cross-sectional evaluation of uptake of apoptotic cells within GC
supports the proposition of asynchronous GC growth and ongoing seeding of GC
(Section 4.3.2). In striking contrast to GC T cells (Figure 5.2) and GC macropha-
ges (Figure 5.9), the number of apoptotic nuclei per GC obviously does not well
correlate with the underlying size of GC (Figures 5.14-5.15, A), as GC of equivalent
size are constantly shown to comprise arbitrary numbers of apoptotic nuclei within
a broad range (e.g. 0-100), (Figure 5.15, B). Since the observed disparity in num-
bers of apoptotic nuclei is also well reflected on the level of macrophage size (Figure
5.18) it is considered a relevant finding, most likely reflecting the coexistence of GC
of different age or volume, respectively. Indeed, quantification of the disparity by
grading GC into 4 classes by means of their mean size of macrophages (referred to
as macrophage size distribution) (Section 5.3.4, Figures 5.18-5.19) leads to a picture
that resembles the kinetics of the volume distribution of GC (Figure 4.17).
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Regulation of the GC reaction by shifts in GC Mφ phenotypes
As discussed above, the analysis of GC macrophages performed by [45] was incom-
plete in that they only detected a particular subpopulation, namely Mac-2+ GC
macrophages which are typically large due to multiple uptake of apoptotic cells and
follow the traditional definition of TBM [28, 160, 43]. The data presented in this
thesis, however, show that the actual number of GC macrophages is much higher,
and thereby indicate the existence of at least one more subpopulation of GC macro-
phages, that are Mac-2− and smaller in size. Indeed, this is a finding of importance,
since shifts in phenotypes of macrophages subpopulations (Mac-1, Mac-2, Mac-3)
are associated with immunosuppressive activity [172]. In this context, macrophages
expressing the Mac-2 antigen are suggested to possess suppressive activity due to
the production of prostaglandin E2 (PGE2), that can be counteracted by Mac-2−
macrophages [172, 173]. Prostaglandins, in particular PGE2, are capable to repress
lymphokine production by T cells and are also believed to mediate local suppressive
activity directly on B cells [174, 175]. The presence of Mac-2+ and Mac-2− macro-
phages within GC and the observation that Mac-2+ GC macrophages (TBM) are
actually rich in PGE2 [46], therefore gave rise to the hypothesis that shifts between
macrophage phenotypes may apply for the homeostasis, longevity or intensity of
the GC reaction. The hypothesis was approached by a mathematical model (Sec-
tion 5.3.5, Figure 5.20) that has to be considered rather phenomenologically, since
several parameter values are not yet established experimentally and were therefore
tuned within reasonable limits to achieve a realistic behavior of the simulation (Table
5.7). The central proposition of the model is that the phenotype of each macrophage
is specified by the number of engulfed apoptotic cells and thereby by its size at a
given time, in which large macrophages (TBM) act suppressive by repressing pro-
liferation of GC B cells. The model succeeded in reproducing major characteristics
of the GC reaction, such as recorded mean time courses of GC B cells, GC macro-
phages and uptake of apoptotic cells (Figure 5.21-5.22). Noteworthy, it also fairly
predicted the experimentally recorded macrophage size distribution (Figure 5.22).
Taken together, the model provides strong evidence that the shift between macro-
phage phenotypes or sizes, respectively, may indeed account for a central regulatory
element of GC reactions.
5.5.3 An acquired imbalance of follicular Mφ and B cells
contributes to progression of autoimmunity in NZB/W
mice
The literature provides profound evidence for a strong link between impaired clear-
ance of apoptotic cells within GC and the pathogenesis of autoimmunity in mice
[85, 86, 176, 177] and men [83, 178, 82, 87, 179]. According to an elegant model pro-
posed by Gaipl et al. [82], that has become the general conception, clearing defects
of macrophages within GC lead to the accumulation of apoptotic cells that undergo
secondary necrosis and thereby release autoantigens that afterwards become accessi-
ble due to binding to FDC. In the following, presentation of autoantigens on FDCs,
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promotes positive selection of autoreactive B cells that may exit GC and become
autoantibody secreting plasma cells. Nevertheless, the nature of the triggering clear-
ance defect remains ambiguous, in that it is not clear whether it attributes to an
intrinsic/acquired macrophage defect or is serum dependent, i.e. associated with
decreased levels of complement [180, 181, 85, 86, 182]. Based on the analysis of
macrophages from different SLE patients Gaipl et al. [82] even suggest heteroge-
neous clearance defects.
However, the results of the current thesis indicate that the disease progression in
lupus-prone NZB/W mice not necessarily implies a "qualitative" clearance defect
of macrophages, but rather correlates with an acquired "quantitative" imbalance
of follicular macrophages and B cells due to marked macrophage death (Figures
5.23, 5.25). These findings further lead to the proposal of a revised model for
the pathogenesis of autoantibodies in NZB/W mice, that is illustrated in Figure
5.26. In this scenario, an increased apoptotic load within GC, most likely due to
hyperactive B cells [183, 184, 185] and/or accelerated apoptosis rates of NZB/W
spleen cells [186], jeopardizes the ability of local macrophages to efficiently clear
cell corpses. The high apoptotic load involves increased phagocytic activity of lo-
cal macrophages, that are thus subjected to sustained stress. If the apoptotic load
finally exceeds the local capacity of macrophages for clearance, macrophages col-
lapse and undergo cell death, most probably in form of apoptosis (Figures 5.23).
Phagocytosis-induced apoptosis of macrophages has already been shown to occur
in the course of intracellular destruction of bacteria and is assumed to constitute
a mechanism for the disposal of terminally differentiated macrophages [187]. As
discussed before, uptake and digestion of apoptotic cells within GC most likely in-
volves differentiation of macrophages (Section 5.5.2), which lends support to the
proposition that phagocytosis-induced apoptosis of macrophages may represent a
general phenomenon during GC reactions. Whereas such macrophage death may
be modest and balanced by attraction of new macrophages under normal "healthy"
conditions, the sustained high apoptotic load within GC of NZB/W mice is likely
to prevent compensation of macrophage death, thereby causing the experimentally
observed imbalance of follicular macrophages and B cells (Figure 5.25). Noteworthy,
unbalanced macrophage death within GC creates a vicious circle scenario in that
dropping numbers of macrophages act as an feedback amplifier by further increasing
the apoptotic load.
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Figure 5.26: Model for the pathogenesis of autoantibodies in GC of NZB/W mice. Hyperactivity
and/or an accelerated apoptosis rate of GC B cells causes an increased apoptotic load within GC of
NZB/W mice. The high apoptotic load effects increased phagocytic activity of local macrophages
that are thereby subjected to sustained stress. When the apoptotic load exceeds the local capacity
of macrophages for clearance, macrophages collapse and undergo cell death. In the following, un-
balanced macrophage death acts as an feedback amplifier in that it further increases the apoptotic
load within GC. 1Apoptotic cells accumulate, enter the state of secondary necrosis and release
modified autoantigens, that become accessible by presentation on FDC. Autoreactive GC B cells
are positively selected due to engagement of their BCR and autoantigen bound to FDC. Finally,
positively selected autoreactive GC B cells exit GC and become autoantibody secreting plasma
cells. 1This part of the model is adopted from Gaipl et al. [82].
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Comparison of B cell receptor light chain
sequences derived from living and
apoptotic germinal center B cells
Chapter 6
Comparison of B cell receptor
light chain sequences derived from
living and apoptotic germinal
center B cells
Peripheral selection within GC is generally believed to occur in a B cell receptor
dependent fashion. The fate of individual GC B cells is assumed to rely on their
antigen binding properties and competence to interact with accessory cells, including
FDC and GC T cells. Consequently, the primary sequence of B cell receptor variable
regions (BCR V region) should act as an indicator of survival fate of GC B cells. To
test this hypothesis, B cell receptor sequences derived from either living or apoptotic
GC B cells were compared to each other. Since the comparison was performed at
different time points after immunization, this type of analysis further aimed at
revealing dynamical aspects of selection.
6.1 Strategy for identification and recovery of liv-
ing and apoptotic GC B cells
Prior to actual isolation, an approach strategy for identification of living and dying
GC B cells was mapped out. Whereas living GC B cells are easily identified as
B220+ PNAhigh cells among viable lymphocytes [96] (example shown in Figure 6.1),
detection of dying GC B cells is much more complex. At first, dying GC B cells were
assessed applying Annexin V (AnV) as primary cell death marker. Albeit AnV has
been reported to permit reproducible identification of early apoptotic GC B cells
(B220+ PNAhigh AnV+ PI−) [188, 189], this approach was subsequently rejected
for the following reasons: i) low frequency of early apoptotic GC B cells (∼ 5%
of GC B cells and ∼ 0.2% of total lymphocytes, respectively, data not shown), ii)
ambiguous origin, as AnV reactivity is not neccessarily due to the in situ GC mi-
croenvironment but is as well likely to be acquired during cell preparation.
Since direct detection of GC B cells that are unequivocally undergoing apoptosis
is currently unrealizable, the initial strategy was revised as to indirect recovery of
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rather late apoptotic GC B cells from macrophages. Therefore, splenic macrophages
were stained with an antibody to CD68 (macrosialin) and subsequently analyzed by
flow cytometry. As macrosialin is only exposed at low levels on the cell surface but is
abundant within cells, extracellular staining of CD68 was compared to intracellular
staining following permeabilization of cells using saponin. Such analysis reveals that
permeabilization of cells and intracellular staining of CD68 explicitly improve the
identification of splenic macrophages, as regards recorded frequencies and separation
of stained cells (Figure 6.2). However, CD68 staining results in the detection of the
entirety of splenic macrophages, including red pulp and marginal zone macrophages.
As in particular red pulp macrophages are not involved in the clearance of apoptotic
GC B cells but are rather likely to engulf dying plasma cells, additional macrophage
markers were screened in order to further restrict the macrophage population iden-
tified by CD68. Immunohistological staining reveals that, whereas the macrophage
marker F4/80 is ubiquitously expressed by red pulp macrophages, macrophages of
the white pulp completely lack F4/80 expression (Figure 6.3). Therefore, additional
staining of macrophages with an antibody to F4/80 allows the identification of the
subset of macrophages restricted to the splenic white pulp (CD68+ F4/80−), in the
following referred to as follicular macrophages (example shown in Figure 6.4).
Figure 6.1: Identification of GC B cells by flow cytometry. Splenocytes from phOx-CSA challenged
BALB/c were isolated 12 days after immunization, stained with B220:PE and PNA:FITC and were
subsequently analyzed by flow cytometry. Splenocytes are gated first on lymphocytes (left panel)
and then on viable cells (PI−) (middle panel). GC B cells are identified as the B220+ PNAhigh
subpopulation (blue tinted box) of total B cells (blue box, right panel). Flow cytometry profiles are
given as dot plots, numbers within the dot plot specify the frequencies [%] of B cells and GC B cells
within viable lymphocytes, respectively.
6.2 Isolation of GC B cells and follicular Mφ
For the comparative analysis of BCR sequences of living and apoptotic GC B cells,
both GC B cell and follicular macrophage populations were collected at days 8 and
12 following phOx-CSA challenge using a FACSAria cell sorter. To ensure recovery
of sufficient numbers of GC B cells and follicular macrophages, splenocytes from
two immunized mice were pooled for each time point. In order to prevent continual
uptake of apoptotic B cells by macrophages during cell handling, B cells and macro-
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Figure 6.2: Implications of intracellular staining of CD68. As the CD68 transmembrane protein
(macrosialin) is predominantly located within the cells, permeabilization of cells improves staining
in respect of recorded frequencies and separation of stained cells. (A) Extracellular staining of
CD68 (w/o saponin). (B) Intracellular staining of CD68 after saponin treatment. Flow cytometry
profiles are given as dot plots (left panel) and histograms (right panel). In histograms, filled curves
illustrate CD68 detection, dotted curves show the isotype control. Data illustrates the analysis
of splenocytes (gated on lymphocytes) of a representative immunized BALB/c at day 12 after
immunization.
Figure 6.3: Follicular macrophages are distinguished from splenic macrophages by absence of
the macrophage marker F4/80. (A) Double immunofluorescence labeling of splenic macrophages
reveals colocalization of CD68 (green) and F4/80 (blue) staining regarding red pulp macrophages,
whereas F4/80 expression is absent from macrophages located in T and B cell zones of the white
pulp. (B) Higher magnification view of the detail boxed in (A). Image is representative of a stained
spleen section at day 10 after immunization. Scale bar 250 µm.
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Figure 6.4: Identification of follicular macrophages by flow cytometry. Splenocytes from phOx-
CSA challenged BALB/c were isolated 12 days after immunization, stained with F4/80:Cy5 and
CD68:A488 and were subsequently analyzed by flow cytometry. Splenocytes are gated on lympho-
cytes (left panel) and follicular macrophages are identified as the CD68+ F4/80− subpopulation
(green tinted box) of total splenic macrophages (green box, right panel). Flow cytometry pro-
files are given as dot plots, numbers within the dot plot specify the frequency [%] of total splenic
macrophages and follicular macrophages (fol. Mφ), respectively, within the lymphocyte gate.
phages were henceforth rapidly separated by magnetic negative depletion of B cells
from spleen cell suspensions. Subsequently, GC B cells and follicular macrophages
were identified within the B cell fraction and B cell depleted fraction, respectively
(exemplary depicted for day 12 after immunization in Figure 6.5, A and B). The ini-
tial frequency of B cells within spleen cell suspensions was about 50% at all sampled
time points. After MACS seperation, B cells were enriched up to 96% in the B cell
fraction and the frequency of B220+ PNAhigh GC B cells for each time point was as
follows: day 8 (7.8%), day 12 (7.7%) (Figure 6.5, A). By contrast, B cells and thus
also GC B cells were virtually absent from the B cell depleted fraction (Figure 6.5,
B).
CD68+ macrophages constituted of about 6 to 8% of total splenocytes at all sam-
pled time points. As a consequence of passive enrichment due to B cell depletion
their frequency increased up 11%, whereas CD68+ F4/80− follicular macrophages
accounted for about 1.5 to 7% of splenocytes within the B cell depleted fraction
(Figure 6.5, B). Nevertheless, macrophages were not strictly confined to the B cell
depleted fraction but were also detected with minor frequencies within the B cell
enriched fraction (Figure 6.5, A). Macrophages within the B cell fraction account
for CD68+ B220+ double positive macrophages that gained B220 reactivity due to
partially engulfed B cells. However, the depletion of CD68+ B220+ double positive
macrophages during MACS seperation does not interfere with the strategy for re-
covery of apoptotic cells. To ensure the isolation of B cells that are unequivocally
undergoing apoptosis, sorting was restricted to follicular macrophages that stain
negative for extracellular B cell markers (B220− F4/80− CD68+). The number of
collected cells was about 106 in case of GC B cell samples and 105 for the samples
of follicular macrophages, respectively.
109
Figure 6.5: Isolation of GC B cells and follicular Mφ exemplarily illustrated for phOx-CSA chal-
lenged BALB/c following day 12 after immunization. First, B cells and macrophages were sep-
arated by magnetic negative depletion of B cells from spleen cell suspensions. (A) Identification
of GC B cells and splenic macrophages within the B cell enriched fraction. (B) Identification of
follicular macrophages in the B cell depleted fraction. Flow cytometry profiles are given as his-
tograms or dot plots. Numbers within dot plots specify the frequencies [%] of the respective cell
populations. In histograms, the dotted and filled curves indicate B220 detection before and after
MACS seperation, respectively.
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6.3 IgL repertoire analysis of live and phagocy-
tozed B cell fractions
GC B cells and follicular macrophages were sorted from spleens of phOx-CSA immu-
nized BALB/c mice at days 8 and 12 using the gating scheme shown in Figure 6.5.
IgL chains of live and phagocytozed B cells were amplified by RT-PCR from total
RNA of sorted populations using a primer mix covering the whole spectrum of κ
and λ light chain gene families (Section 3.10.2). Transcripts of the VκOx1 gene
(IGKV4-59 according to the new IMGT nomenclature), that dominates the phOx
response, were amplified in separate RT-PCR reactions using gene specific primers
(Section 3.10.2). For identification of Vκ and Jκ genes as well as mutation analysis,
amplificates were directly sequenced after cloning and compared against the IMGT
database (http://imgt.cines.fr/IMGT_vquest/vquest) [90]. Clones that were iden-
tical on the cDNA level were counted once. Potential clonal relatedness of sequences
was determined by means of shared VL and JL gene segment use and identical VJ
joins (LCDR3s). Rather occasionally, out of frame LCDR3s are observed among
both, overall and phOx specific IgL sequences of phagocytozed B cell fractions.
These out of frame LCDR3s are unlikely to represent a priori unproductive IgL
rearrangements, but rather seem to be a byproduct of somatic hypermutation (dele-
tion/insertion) [190], since i) amplifications were performed on RNA preparations,
in which a priori unproductive IgL rearrangements are unlikely to be transcribed
into mRNA, ii) the appearance of such out of frame LCDR3s correlates with the
increasing average mutation frequency from day 8 to 12 after immunization, iii) the
belonging V genes show additional mutations (ranging from 2 to 7). On this ac-
counts, phOx specific sequences featuring out of frame LCDR3s are included in the
analyses, but are specially indicated () in sequence alignments.
6.3.1 Equivalent V gene family and J gene segment use
among IgL of live and phagocytozed B cell fractions
IgL chain diversity in the mouse mainly attributes to the Igκ locus in that the
observed Igκ:Igλ ratio of B cells is as high as 95:5 [191]. Whereas the Igκ locus
comprises 91 functional Vκ genes belonging to 19 subgroups (VL gene families) [90],
the Igλ locus is thought to include only three functional Vλ genes. Although the
murine Igκ locus is well explored, data regarding the adult functional repertoire of
mice is both fragmentary and contradictory. Nevertheless, Vκ gene family use is
considered to be non-random, showing predominance of the Vκ families IGKV1,
IGKV4 and IGKV6 [192].
The frequencies of VL gene family expression in live and phagocytozed B cell frac-
tions were quantitatively compared using the χ2 test. For both time points ana-
lyzed the frequencies of VL gene family expression in live and phagocytozed B cell
fractions are found to be statistically equivalent (p>0.10). Thus, the level of ex-
pression of a given VL gene family within the live B cell fraction seems to di-
rectly affect the level of expression within the corresponding phagocytozed B cell
fraction. The overall hierarchical pattern of VL gene family expression (IGKV10,
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12>IGKV4>IGKV1>IGKV6, 8, 9 and IGKL1) does not correlate to genomic com-
plexity and remains unchanged between day 8 to 12 after phOx-CSA challenge
(Figure 6.6). The obvious dominance of IGKV10, IGKV12 and IGKV4 expression
is very unlikely to be due to a primer bias since the adapted primer mix was shown to
amplify the here missing VL gene families (e.g. IGKV7) - when subjected to RNA of
total splenic B cells (data not shown). In addition, members of gene families known
to be rather slightly expressed, are occasionally identified, as for instance IKVL-1.
Identified Vκ genes are scattered about the entire Igκ locus (Appendix A.1). The
overall response to phOx-CSA is predominated by B cells bearing the Igκ V genes
IGKV10-94, 10-96, 12-41, 12-44, 12-46 and 4-59 (appendix Figure A.4). Whereas
the prevalence of IGKV4-59 (VκOx1) may be readily explained by its major role in
the phOx response, the reason for overrepresentation of IGKV10 and IGKV12 genes
is currently unclear.
JL gene segment use by live and phagocytozed B cells was quantitatively compared
as described above. At day 12 post immunization, JL usage is both equivalent in
the live and phagocytozed B cell fraction (p>0.20) (Figure 6.6) and its hierarchical
pattern (Jκ1, Jκ2»Jκ5>Jκ4>Jλ1) reflects previously reported JL usage of splenic
murine B cells [193]. Jκ1 and Jκ2 are the predominant genes segments, each ac-
counting for about 35 to 50% of IgL rearrangements. By contrast, JL usage is
significantly different in the live and phagocytozed B cell fraction at day 8 after
phOx-CSA challenge (p≤0.001). Whereas JL usage in the live B cell fraction re-
sembles the hierarchical pattern observed at day 12, JL usage in the phagocytozed
B cell fraction is characterized by a marked overrepresentation of Jκ5 (50%) and
underrepresentation of Jκ2. The reason for the deviant Jκ use in the phagocytozed
B cell fraction is unclear.
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Figure 6.6: IgL repertoire analysis among live and phagocytozed B cell fractions. Illustrated are
the distributions of VL gene family and JL gene segment use for live (GC, gray) and phagocytozed
B cell (Mφ, black) fractions derived from phOx-CSA challenged BALB/c mice at days 8 (A) and
12 (B). VL gene families and JL gene segments were identified using the IMGT/V-Quest database
[90]. VL gene family usage is additionally compared to expected frequencies according to the
genomic complexity of VL gene families.
6.3.2 Variational kappa J gene segment use among phOx
specific IgL of live and phagocytozed B cell fractions
In addition to IGK4-59 (VκOx1) rearrangements, five IGKV4-74 (128.con) rear-
rangements and one rearrangement of IGKV4-78 (H1) were observed among the
pool of analyzed sequences. Since IGKV4-74 and IGKV4-78 most likely repre-
sent additional phOx specific gene segments in that they have been previously iso-
lated from phOx specific GC [118] and share high sequence homology to IGKV4-59
(>94%), they were included in the analysis. For transparency reasons, IGKV4-74
and IGKV4-78 rearrangements are each identified by respective labels. Integration
of IGKV4-74 and IGKV4-78 rearrangements did not interfere with the analysis,
since their exclusion did not alter the results.
The analysis of JL gene segment use phOx specific rearrangements reveals highly sig-
nificant differences regarding live and phagocytozed B cell fractions at days 8 and 12
(p<0.001) (Figure 6.7). The live B cell fraction features marked overrepresentation
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of Jκ5 (>50%) that is counteracted by complete absence of Jκ1 expression. In turn,
phagocytozed B cell fractions are highly enriched for Jκ1 expression (60-80%) but
nearly lack Jκ2 and Jκ5 rearrangements. For one, this result affirms the dominance
of IGKV4-59/Jκ5 rearrangements in the immune response against phOx [124], but
most interestingly, it reveals that such dominance goes at the expense of Jκ1 usage.
The strict absence of Jκ1 rearrangements from live B cell fractions further suggests
that such rearrangements hold features that categorically cause negative selection,
which might explain their overrepresentation in phagocytozed B cell fractions.
Figure 6.7: Jκ gene segment use of phOx-specific IgL among live and phagocytozed B cell fractions.
Illustrated are the distributions of Jκ gene segment use among phOx specific IgL sequences of live
(GC, gray) and phagocytozed (Mφ, black) B cell fractions at days 8 (A) and 12 (B). Jκ gene
segments were identified using the IMGT/V-Quest database [90].
6.3.3 Differences in interclonal diversity of phOx specific
IgL between live and phagocytozed B cell fractions
The interclonal diversity of phOx specific IGK4-59 (VκOx1), IGKV4-74 (128.con)
and IGKV4-78 (H1) rearrangements among live and phagocytozed B cell fractions
was determined based on shared Vκ gene segments and identical nucleotide se-
quences of VJ joins and LCDR3s, respectively. At both time points analyzed, the
interclonal diversity among the phagocytozed B cell fraction exceeds the diversity of
the live B cell fraction (Table 6.2). Noteworthy, LCDR3s that are different on the
nucleotide level but become identical when translated into protein, are repeatedly
observed among phOx specific IgL sequences of live B cell fractions during analysis,
thus suggesting that interclonal diversity is even more diminished on the translated
or protein level. On this account, LCDR3s of live and phagocytozed B cell fractions
were compared by multiple alignment of their amino acid sequences (Figure 6.8). In
the first instance, amino acid sequence alignments of phOx specific IgL reveal dif-
ferences regarding the spectrum of LCDR3s detected among live and phagocytozed
B cell fractions. Whereas live B cell fraction appear to be interclonally restricted
(6-8 different LCDR3s), interclonal diversity is markedly pronounced in the phago-
cytozed B cell fractions (15-20 different LCDR3s). The overall interclonal diversity
(live+phagocytozed) of phOx specific IgL is the same at day 8 and 12 (26 and 23
different LCDR3s, respectively).
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The comparison of LCDR3s of live and phagocytozed B cell fractions furthermore
suggests that the texture of the LCDR3 is substantially important to the outcome
of selection of phOx specific GC B cells, in that even key mutation bearing Igκ re-
arrangements are found in the phagocytozed fraction at both time points analyzed
(Figure 6.8). Among phOx specific IgL sequences of phagocytozed B cell fractions,
a group of "odd-looking" LCDR3s leaps to the eye which is rather phenomenolog-
ically characterized by an increased occurrence of histidine (H), arginine (R) and
tryptophan residues (W) (Figure 6.8). The observation that this group primarily
consists of Jκ1 rearrangements suggests that use of Jκ1 is prone to formation of
LCDR3s that are detrimental to phOx binding, which might explain the aforemen-
tioned strict absence of of Jκ1 rearrangements from live B cell fractions (Figure 6.7).
Figure 6.8: Comparison of LCDR3s of phOx specific IgL sequences among live and phagocytozed
B cell fractions. The amino acid sequence spectrum of observed κ light chain rearrangements
among live (GC) and phagocytozed (M) phOx-specific B cell fractions obtained at days 8 (A) and
12 (B) is illustrated. Boxed sequences refer to κ light chain rearrangements that were exclusively
found in context of Jκ1 usage. ⊕ indicate rearrangements of key mutation (H34Q/N) bearing κ
light chains. Alignments include LCDR3s that become out of frame () due to deletions/insertions
in the cause of somatic hypermutation (discussed in Section 6.3).
6.3.4 Phagocytozed B cell fractions are generally not en-
riched in LCDR3s showing characteristics related to
autoreactivity
Autoreactivity and, in particular, anti-DNA reactivity of antibodies is generally
ascribed to the emergence of long, positively charged HCDR3s which are otherwise
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negatively selected in normal "healthy" circumstances [194, 195]. However, studies
by Park et al. [196] indicate that positive charged LCDR3s also contribute to DNA
binding. To account for this, LCDR3s of live and phagocytozed B cell fractions were
compared in order to assess whether nonstandard lengths and positive charge are
enriched among the latter fraction. The average length of LCDR3 is 8.9±0.3 aa.
This value is similar for live and phagocytozed B cell fractions at day 8 (8.9±0.4 aa
vs. 8.9±0.3 aa) and day 12 (8.9±0.3 aa vs. 9.0±0.4 aa) (data not shown). Alike,
the average length of LCDR3 of phOx specific B cells (9.1±0.5 aa) is invariant with
respect to live and phagocytozed fractions at day 8 (8.9±0.5 aa vs. 9.0±0.5 aa) and
day 12 (9.3±0.6 aa vs. 9.1±0.5 aa), respectively (data not shown). Potential signs of
autoreactivity owing to LCDR3 charge were assessed by quantifying the incidence
of positively charged amino acid residues (R, K, H) in this region. Overall IgL
sequences of live and phagocytozed B cell fractions do not significantly differ with
respect to LCDR3 charge at either of the time points analyzed (p>0.20) (Figure
6.9). Between 75 to 90% of all LCDR3s bear either one (50-75%) or no positively
charged amino acid residue (15-30%). In fact, the frequency of LCDR3s with 3 or
more positively charged residues never exceeds 3.3%. Thus, phagocytozed B cell
fractions are generally not enriched in LCDR3s showing characteristics related to
autoreactivity.
Figure 6.9: Frequency of overall clones bearing positively charged amino acids (aa) within their
LCDR3. The frequency of clones bearing a given number of positively charged amino acids (R,
K, H) within their LCDR3 is graphically illustrated for live (GC, gray) and phagocytozed (Mφ,
black) B cell fractions derived from phOx-challenged BALB/c mice at days 8 (A) and 12 (B).
6.3.5 Accumulation of positively charged LCDR3s among
phOx specific IgL sequences of phagocytozed B cells
The quantification of charged amino acid residues in LCDR3s of phOx specific rear-
rangements reveals striking differences in relation to overall IgL sequences, in that
the live B cell fractions are nearly void of positively charged residues (>95% in
phOx specific vs. 15-30% in overall LCDR3s) (Figure 6.10). Accordingly, charged
phOx specific LCDR3s accumulate within phagogytosed B cell fractions as already
phenomenologically observed during sequence alignment (Figure 6.8). PhOx spe-
cific IgL rearrangements of live and phagocytozed B cell fractions cannot directly
be compared statistically with each other, since the formers each comprise only one
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single charged LCDR3 and thereby fall beneath the minimum frequency threshold
required for the statistical test. However, since charged phOx specific LCDR3s are
virtually absent from live B cell fractions, the observed differences are highly prob-
able significant. Coupled with the observation that positively charged LCDR3 are
usually not enriched among phagocytozed B cell fractions (Section 6.3.4, Figure 6.9),
LCDR3 charge appears to have crucial impact on predicting survival fate of phOx
specific B cells.
Figure 6.10: Frequency of phOx-specific clones bearing positively charged amino acids (aa) within
their LCDR3. The frequency of phOx-specific clones bearing a given number of positively charged
amino acids (R, K, H) within their LCDR3 is graphically illustrated for live (GC, gray) and
phagocytozed (Mφ, black) B cell fractions at days 8 (A) and 12 (B).
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6.4 Hypermutation among live and phagocytozed
B cell fractions
The frequency of somatic hypermutation was determined for overall and phOx spe-
cific IgL sequences amplified from live and phagocytozed B cells by comparison
against the IMGT database [90]. Sequences that were identical on the cDNA level
were only counted once. Potential clonal relatedness did not compromise mutation
analysis as clonally related groups principally contained sequences that were dif-
ferent in their mutation pattern, thereby indicating that they were derived from
distinct B cells (see sequence alignments in the appendix). The results of mutation
analyses of overall IgL and phOx specific IgL sequences are summarized in Table
6.1 and Table 6.2, respectively.
6.4.1 Hypermutation of overall IgL sequences from live and
phagocytozed B cell fractions
Live and phagocytozed B cell fractions always include germline sequences, though
the proportion of unmutated sequences is consistently reduced about a factor of
2-3 among phagocytozed B cells (Table 6.1). The proportion of germline sequences
among live B cell fractions decreases from day 8 (35.6%) to day 12 (21.7%), thereby
indicating the progression of affinity maturation. On the other hand, the propor-
tion of unmutated sequences among phagocytozed B cell fractions turns out to be
rather stable over time (9.4 7→ 10.0%) (Table 6.1). Since variational proportions
of germline sequences have an biasing effect on the calculation of average mutation
frequencies and statistical analyses, germline sequences were excluded for this parts
of the analysis. For transparency reasons, average mutation frequencies resulting
from calculations when unmutated sequences were included, are additionally quoted
in Table 6.1. Mutation frequencies were statistically compared using Wilcoxon rang
sum test. Noteworthy, IgL sequences from live and phagocytozed B cell fractions
at day 8 post immunization differ neither in average mutation frequencies (2.83 vs.
2.48) nor the range of detected mutations (0-10 vs. 0-7) (Table 6.1). The dis-
tributions of mutations look very similar, except for the proportion of unmuated
sequences as stated above (Figure 6.11, A). Statistical comparison using Wilcoxon
rank sum test finally approves that live and phagocytozed B cell fractions are not
significantly different from each other regarding mutation frequency (p=0.6951) at
day 8 post immunization. The picture at day 12 post immunization remains rather
unchanged against day 8, in that average mutation frequency (2.97 vs. 2.44), the
range of mutations (0-6 vs. 0-7) and the distribution of mutations among IgL of live
and phagocytozed B cells look very similar (Table 6.1, Figure 6.11, B). Likewise, dif-
ferences in mutation frequency at day 12 turn out to be not significant (p=0.0872).
The calculated average mutation frequency within live B cell fractions does not
increase over time (2.837→2.97) and differences are shown to be not significant
(p=0.4312). The same applies for the average mutation frequency of phagocytozed
B cell fractions (2.48 7→2.44, p=0.5032). The rather fixed average mutation frequen-
cies observed among overall IgL sequences are somewhat surprising considering that
the progression of the GC reaction is usually accompanied by the accumulation of
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mutations. However, since this analysis was performed on overall IgL sequences of
GC B cells, it pools different responses, namely the carrier-specific, hapten-specific
and mixed hapten-carrier specific responses, thus providing an "average picture"
of somatic hypermutation after phOx-CSA challenge. Still more surprising than
its constancy, the average mutation frequency is unexpectedly high, even early in
the response, which mainly attributes to high numbers of mutations within IgL re-
arrangements of IGKV10 and IGKV12 genes that dominate the overall response
(Section 6.3.1, Figure 6.6, sequence alignments are shown in the appendix). The
reason for the increased accumulation of mutations within this particular genes is
currently unclear but may reflect differences in the rate of somatic hypermutation
in dependence of the initial affinity of GC B cells as suggested by Dal Porto et al.
[197].
Day Sample
No. of
cells thru
cDNA
(% gl)1
No.
unique
LCDR3
Average
no. of
mut.2
Range of
mut.
FW
R/S
CDR
R/S
08 GC 45 (35.6) 35 2.83(1.82) 0 - 10 3.1 4.3
Mφ 32 (9.4) 18 2.48(2.28) 0 - 7 3.9 13.5
12 GC 46 (21.7) 31 2.97(2.33) 0 - 6 2.6 5.5
Mφ 30 (10.0) 21 2.44(2.20) 0 - 7 2.6 >23
Table 6.1: Comparison of IgL sequences of live (GC) and phagocytozed B cell fractions (Mφ)
post immunization. 1Sequences that were identical on the cDNA level were counted once, values
in brackets signify the proportion of germline (gl) sequences. 2Calculated excluding germline
sequences, values in brackets indicate average mutation frequency when germline sequences were
included.
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Figure 6.11: Distribution of the frequencies of mutations within IgL sequences of live and phago-
cytozed B cell fractions. The frequency of clones bearing a given number of mutations in the
IgL sequence is graphically illustrated for live (GC, gray) and phagocytozed (Mφ, black) B cell
fractions derived from phOx-challenged BALB/c mice at days 8 (A) and 12 (B).
A further criterion for assessment of somatic hypermutation is the distribution of
mutations along V genes, generally referred to as mutation pattern, that provides
information on where mutations are located. Under the assumption that somatic
hypermutation is random, the distribution of mutations should reflect the size of the
respective regions. In case of overall IgL sequences, the size ratio of FR to CDR is
rather similar for detected VL genes, ranging between 79%:21%(IGKV1, IGKV8 and
IGLV1 gene family members) and 83%:17% (IGKV4, IGKV10 and IGKV12 gene
family members). Likewise, the sizes of individual FR and CDR regions are quite
consistent for the identified VL genes and the mean pattern resembles the pattern of
the phOx specific IGKV4-59 gene (FR1:CDR1:FR2:CDR2:FR3:CDR3=27:8:18:3:38:6 [%]).
Therefore, observed mutation patterns among overall IgL sequences are compared
to the random mutation pattern expected for IGKV4-59, where 83% and 17% of IgL
mutations are expected to occur within FR and CDR regions of IgL, respectively.
(The difference to previous publications that often quote a 65%:35% ratio is due to
the use of the Kabat nomenclature instead of the IMGT nomenclature[90] used in
the current thesis.) Traditionally, divergence of experimentally observed from ex-
pected mutation patterns were considered an indication of selection [198]. This view
is challenged in that mutations pattern were shown to be non-random but intrinsic
to the coding sequences of V genes [199, 200].
The overall mutation pattern (FR:CDR) of live (74%:26%) and phagocytozed B cell
fractions (60%:40%) isolated at day 8 after immunization looks rather similar, and
differences are not significant (p=0.0883 in χ2 test) (Figure 6.12, A). The same
accounts for day 12 after immunization, in that the distribution of mutations is
64%:36% for live and 65%:35% for phagocytozed B cell fractions (p=0.9601) (Fig-
ure 6.12, B). Furthermore, neither the overall mutation pattern of live (74%:26% 7→
64%:36%) nor phagocytozed B cell fractions (60%:40% 7→ 65%:35%) significantly
changes over the time course (p=0.1530 and p=0.6760, respectively).
Nevertheless, considering the mutation pattern relevant to the individual FR and
CDR regions (segmental mutation pattern), live and phagocytozed B cell fractions
show significant differences at day 8 (p=0.0001) (Figure 6.12, A) that mainly at-
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tribute to variations in FR1 (31% vs. 12%), CDR1 (7% vs. 27%) and FR3 (18%
vs. 33%). The segmental mutation pattern of live B cell fractions at day 8 is ad-
ditionally significantly different from the one observed at day 12 (p=0.0001). Since
segmental mutation patterns of live and phagocytozed B cells are indifferent at day
12 (p=0.6528) (Figure 6.12, B) and the patterns of phagocytozed B cells do not
significantly change over time (p=0.1325), the observed difference at day 8 most
likely attributes to peculiarities of the live cell fraction.
The analysis of mutation patterns is usually complemented by calculation of re-
placement to silent mutations ratios (R/S), in which the deviation of experimen-
tally observed from theoretically predicted R/S values is construed as evidence for
selection. In this context, CDRs are thought to acquire higher R/S values because
they make up the main part of the antigen binding site and replacement mutations
therefore should have strong influence on antibody affinity. In contrary, replacement
mutations within FRs are believed to be selected against since they are detrimental
to antibody structure - resulting in R/S values falling below the expected.
As overall IgL sequences comprise a variety of different VL genes, distinct values
for expected R/S ratios in CDR and FR are not available. Nevertheless, compar-
ison of R/S values of live and phagocytozed B cell fractions should provide some
clues regarding selection. Unexpectedly, R/S values of live and phagocytozed B cell
fractions turn out to be rather similar in that R/S ratios in CDRs consistently ex-
ceeded R/S ratios of FRs at both time points analyzed (Table 6.1). In fact, R/S
ratios calculated for CDRs of phagocytozed B cell fractions are strikingly higher as
compared to live cells at day 8 (13.5 vs. 4.3) and even further increase up to day 12
(>23 vs. 5.5) after immunization (Table 6.1, Figure 6.12, A and B). The high R/S
ratios of overall CDRs of phagocytozed B cell fractions result from high frequencies
of replacement mutations in any of the individual CDRs as graphically illustrated
by means of the proportions of replacement mutations within CDR1, CDR2 and
CDR3 at days 8 and 12 after immunization (Figure 6.12, A and B). Noteworthy,
IgL sequences of the phagocytozed B cell fraction isolated at day 12 after immuniza-
tion show exclusively replacement mutations within CDRs, thus the proportion of
replacement mutations is 100% for CDR1, CDR2, CDR3 and overall CDR (Figure
6.12, B).
On the contrary, the R/S ratios calculated for the FR of phagocytozed and live B cell
fractions show only minor differences at day 8 (3.9 vs. 3.1) and even further decrease
until day 12, in which differences are nullified (2.6 vs. 2.6) (Table 6.1, Figure 6.12,
A and B). In addition, replacement mutations apparently do not accumulate within
individual FRs of phagocytozed B cell fractions over the time course as given by the
proportions of replacement mutations at day 8 and 12 (FR1: 89 7→ 50, FR2: 91 7→
75, FR3: 71 7→ 83) (Figure 6.12, A and B).
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Figure 6.12: Pattern of mutations within IgL sequences of live and phagocytozed B cell fractions.
The mean frequencies of mutations within individual FRs and CDRs as well as overall FR and CDR
are illustrated for live (GC, gray) and phagocytozed (Mφ, black) B cell fractions derived from phOx-
challenged BALB/c mice at days 8 (A) and 12 (B) after immunization, respectively. The pattern
of frequencies expected for equivalent randomly mutated IGKV4-49 (VκOx1) sequences (random,
white) is shown for comparison. Pie charts signify the proportion of observed replacement to silent
mutations, in which the depicted numbers specify the percentage of replacement mutations.
122
6.4.2 Hypermutation of phOx specific IgL sequences from
live and phagocytozed B cell fractions
Similar to overall IgL sequences (Table 6.1), phOx specific IgL sequences of live
B cell fractions comprise a considerable proportion of germline sequences, that only
slightly decrease from day 8 (36.8%) to day 12 (33.3%) (Table 6.2). Unmutated
phOx specific IgL sequences are strikingly less frequent among phagocytozed B cell
fractions at day 8 (13.2%) and even decrease over time, in which only one single
germline sequence is identified at day 12 (4.5%) (Table 6.2). As argued before (Sec-
tion 6.4.1), germline sequences were excluded when calculating average mutation
frequencies or performing statistical tests. Mutation frequencies were statistically
compared using Wilcoxon rang sum test. PhOx specific IgL sequences of live and
phagocytozed B cell fractions differ in average number (1.33 vs. 2.39), range (0-
3 vs. 0-5) and distribution of mutations at day 8 post immunization (Table 6.2,
Figure 6.13, A), in which the differences are shown to be significant (p=0.0171).
In contrast, average mutation frequency (3.00 vs. 2.29), range (0-5 vs. 0-7) and
distribution of mutations (Table 6.2, Figure 6.13, B) look rather similar for live and
phagocytozed B cell fractions at day 12 post immunization and differences turn out
to be not significant (p=0.4230). Whereas the increase in the average number of
mutations among phOx specific IgL sequences of live B cell fractions from day 8 to
12 (1.33 7→ 3.00) is highly significant (p=0.0020), the average mutation frequency
observed for phagocytozed B cell fractions is rather invariant (2.39 7→ 2.29) and
differences are not significant (p=0.6985). Thus, phagocytozed B cell fractions do
not necessarily comprise excessively mutated phOx specific IgL sequences.
The overall mutation pattern (FR:CDR) of phOx specific IgL sequences looks rather
similar for live (75%:25%) and phagocytozed B cell fractions (85%:15%) at day 8 and
differences are shown to be not significant (p=0.5553 in χ2 test) (Figure 6.14, A).
Likewise, live and phagocytozed B cell fractions do not significantly differ in the
pattern of mutation within individual FRs and CDRs (p=0.5923) (Figure 6.14, A).
The same accounts for phOx specific sequences isolated at day 12, in that live and
phagocytozed B cell fractions turn out to be neither significantly different regarding
their overall mutation patterns (FR:CDR) (62%:38% vs. 77%:23%) (p=0.1812) nor
regarding their pattern of mutations within individual FRs and CDRs (p=0.2880)
(Figure 6.14, B). Although, the overall mutation patterns (FR:CDR) of both live
and phagocytozed B cell fractions seem to change in favour of higher frequencies
of mutations in the CDR of phOx specific IgL over the time course, differences are
not significant (p=0.5295 and p=0.3905, respectively). Similarly, the variations ob-
served in the patterns of mutations within individual FRs and CDRs over the time
course, are not significant, in case of live as well as phagocytozed B cell fractions
(p=0.7618 and p=0.4054, respectively).
In case of the phOx specific IGKV4-59 (VκOx1) gene, expected R/S ratios were
calculated in a model of random mutation, resulting in R/S values of 3.4 for the FR
and 4.6 for the CDR (expected R/S values for IGKV4-59 according to the IMGT
nomenclature were calculated by Armin Weiser, a fellow-member of the Systems
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Immunology Group; expected R/S values according to Kabat nomenclature are 3.3
for FR and 3.5 for CDR, respectively [29]). With the sole exception of the live
B cell fraction at day 8, all other populations - irrespective of live or phagocytozed
- feature the generally contended signs of selected populations, in that R/S values
within FRs are lower (1.6-2.7) but R/S values within CDRs are higher (4.5-11.0)
than the expected (Table 6.2). However, the scenario is reversed in context of the
live B cell fraction at day 8 that shows higher R/S values in FRs (11.0) but lower
R/S values in CDRs (3.0) (Table 6.2). The divergence of this live B cell population
from both the expected and other B cell populations mainly attributes to the high
proportions of replacement mutations in FR1 (100%) and FR3 (100%) (Figure 6.14,
A), whose origin is unclear. Whereas R/S ratios in CDRs of live B cells increase
over the time course (3.0 7→ 7.0), the very of phagocytozed B cells decrease (11.0
7→ 4.5). R/S values within FRs of live B cells decrease from day 8 to day 12, in
which the observed decrease is most likely due to the unusually high R/S value at
day 8. Similar to overall IgL sequences, phagocytozed B cell fractions show a rather
constant R/S ratio over the time course (2.7 7→ 2.7) (Table 6.2), that even constantly
falls below the expected. With respect to replacement mutations in the individual
FRs, phagocytozed B cell fractions show rather similar or even lower proportions
than live B cells at both time points analyzed (Figure 6.14, A and B). The FR2 may
constitute an exception to this, since the proportions of replacement mutations are
consistently higher for phagocytozed compared to live B cell fractions (89%:75% and
86%:60% at days 8 and 12, respectively) (Figure 6.14, A and B). Such phenomenon,
may attribute to the importance of FR2 for the binding to phOx, in that it comprises
both key mutation sites.
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Day Sample
No. of
cells thru
cDNA
(% gl)1
No.
unique
LCDR3
Average
no. of
mut.2
Range
of mut.
H34Q/N
[%]3
FW
R/S
CDR
R/S
08 GC 19 (36.8) 8 1.33(0.84) 0 - 3 0 11.0 3.0
Mφ 38 (13.2) 23 2.39(2.08) 0 - 5 6.1 2.7 11
12 GC 21 (33.3) 10 3.00(2.00) 0 - 5 4.8 1.6 7
Mφ 22 (4.5) 17 2.29(2.00) 0 - 7 20.0 2.7 4.5
Table 6.2: Comparison of phOx specific IgL sequences of live (GC) and phagocytozed B cell frac-
tions (Mφ) post immunization. 1Sequences that were identical on the cDNA level were counted
once, values in brackets signify the proportion of germline (gl) sequences. 2Calculated exclud-
ing germline sequences; values in brackets indicate average mutation frequency when germline
sequences were included. 3The proportion of key mutation (H34Q/N) bearing sequences was cal-
culated excluding germline sequences.
Figure 6.13: Distribution of the frequencies of mutations in phOx specific IgL sequences of live
and phagocytozed B cell fractions. The frequency of phOx-specific clones bearing a given number
of mutations in the VL region is graphically illustrated for live (GC, gray) and phagocytozed (Mφ,
black) B cell fractions at days 8 (A) and 12 (B).
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Figure 6.14: Pattern of mutations among phOx specific IgL sequences of live and phagocytozed
B cell fractions. The mean frequencies of mutations within individual FRs and CDRs as well
as overall FR and CDR are illustrated for phOx specific IgL sequences of live (GC, gray) and
phagocytozed (Mφ, black) B cell fractions at days 8 (A) and 12 (B) after immunization. The
pattern of frequencies expected for equivalent randomly mutated IGKV4-49 (VκOx1) sequences
(random, white) is shown for comparison. Pie charts signify the proportion of observed replacement
to silent mutations, in which the depicted numbers specify the percentage of replacement mutations.
6.4.3 Special mutational events: Translational stop codons,
frameshifts/deletions and key mutations
The frequencies of special mutational events such as frameshifts/deletions, transla-
tional stop codons and key mutations are listed in Table 6.3. Frameshifts/deletions
are most frequent in both, overall and phOx specific IgL sequences of phagocy-
tozed B cell fractions at day 12 after immunization (5/30 and 6/22, respectively).
With respect to mutation sites, frameshifts/deletions are observed in FR1, FR3 and
LCDR3, in which most events rate among the latter. Translational stop codons are
found in overall/phOx specific IgL sequences of both live and phagocytozed B cell
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fractions, though they are commonest in the latter fraction (3/5). True to type,
due to the early time points analyzed, the frequency of key mutation bearing phOx
specific IgL sequences of live GC B cells is very low, in that only a single out of 21
sequences is detected at day 12 after immunization. As much astonishing, not only
the frequency of key mutation bearing phOx specific IgL turns out to be higher in
the phagocytozed fraction (4/22 at day 12 after immunization) but the key muta-
tion is even identified among phagocytozed B cell fractions as early as day 8 after
immunization.
Sample
No. of
cells thru
cDNA1
Frame shifts/deletions Translationalstop codons H34Q/N
day 08 GC 45 - 1 (FR2)
day 08 Mφ 32 - 1 (FR2)
day 12 GC 46 - 1 (FR2)
day 12 Mφ 30 5 (LCDR3) 1 (FR1)
day 08 phOx GC 19 1 (LCDR3) 1 (FR2) -
day 08 phOx Mφ 18 1 (LCDR3) 1 (LCDR3) 2
day 12 phOx GC 21 - - 1
day 12 phOx Mφ 22 6 (4 LCDR3, 1 FR1, 1 FR3) 2 (FR1, FR2) 4
Table 6.3: Survey of special mutational events. Illustrated are the numbers of frameshifts/deletions,
translational stop codons and key mutations observed in overall/phOx specific IgL sequences of
live (GC) and phagocytozed (Mφ) B cell fractions post immunization. Mutation sites are specified
in parentheses. 1Sequences that were identical on the cDNA level were counted once.
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6.5 Discussion
The way of how - and especially by which criteria - B cells are selected within GC is
a thrilling question as it is quite fragmentary understood. This is particularly due
to the fact that comprehensive assessment of evolutionary processes generally relies
on two strands of information, that of survivors and losers. Such a demand proves
elusive regarding the micro-evolutionary GC reaction, in that loosing B cells just do
not fossilize in the fashion of dinosaurs but rapidly disappear. However, a reliable
method for recovery of apoptotic "loser" GC B cells could be established during the
current thesis that for the first time allowed for tracing of winners and losers during
a hapten-carrier elicited immune response.
6.5.1 Reliability of recovery of live and apoptotic GC B cell
fractions
To revisit the dinosaur simile, holding the fossile in hands inevitable implies that
the belonging dinosaur is dead. Unfortunately, things are not that obvious in case
of GC B cells which are fragile and designated to undergo apoptosis [201, 202] un-
less they receive rescue signals provided by surrounding FDC [203]. Detachment
of GC B cells from their microenvironment, as for instance during preparation of
cell suspensions, readily actuates the apoptotic machinery and within 5 h about
40-50% of the cells express phospatidylserine (PS), one of the earliest markers of
apoptotic cells [66]. Consequently, direct detection of apoptotic GC B cells within
cell suspensions (e.g. by annexin V reactivity) is unreliable in that it is not capa-
ble to distinguish between cells that died under physiological conditions and cells
becoming apoptotic due to cell handling ex vivo. Under physiological conditions,
externalization of PS on the surface of apoptotic GC B cells leads to their rapid
clearance by proximally positioned GC macrophages [204, 205, 85], which makes
GC macrophages the most reliable reservoir of apoptotic GC B cells arising in vivo.
Since there is no marker specific to GC macrophages, a protocol for identification
and isolation of follicular or white pulp macrophages (CD68+ F4/80−), respectively,
was developed and established instead (Sections 6.1-6.2, Figures 6.3-6.5). To pre-
vent systemic distortion of the results owing to uptake of ex vivo evoked apoptotic
GC B cells, B cells were immediately separated from spleen cell suspensions and
follicular macrophages showing partially engulfed B cells (CD68+ F4/80− B220+)
were excluded from FACS sorting. The developed protocol turns out a success,
since overall IgL sequences of phagocytozed B cell fractions are shown to be related
but not identical to live GC B cell fractions (Sections 6.3.1, 6.4, Table 6.1, Figures
6.11-6.12). Moreover, phOx specific IgL sequences of live and phagocytozed B cell
fractions are shown to strictly classify according to Jκ gene segment use and differ
in interclonal diversity (Figures 6.7-6.8). Noteworthy, the key mutation is identified
among phOx specific IgL sequences of phagocytozed B cells as early as day 8 post
immunization and its frequency is always higher compared to live GC B cells there-
after (Table 6.2). This lends experimetal support to the blocking model proposed
by Kleinstein and Singh [206] that attributes the late occurence and low frequencies
of key mutations among live phOx specific GC B cells [118, 122] to the existence of
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a large number of detrimetal mutations whose presence can prevent the ability of
the key mutation to confer high affinity.
6.5.2 Live and phagocytozed GC B cells carry the gener-
ally accepted molecular signatures of antigen-driven
selection
In previous studies, affinity selection among Ig sequences is often rated by means
of the mutation patterns of V genes, in which variation of the distribution of mu-
tations in FR and CDR to the values expected for random mutation is considered
evidence for (positive) selection [127, 32, 207]. In this context, affinity maturation
is thought to lead to the accumulation of replacement mutations in CDRs (antigen
binding sites), thus resulting in R/S ratios exceeding the values expected on the
basis of random mutation within CDRs. On the other hand, replacement mutations
in the FRs are believed to be (negatively) counterselected as they harm the overall
structure of Ig molecules. Consequently, the ratio of R/S substitutions within FRs
of positively selected GC B cells should fall below the values expected for random
mutation.
However, the here performed comparative IgL sequence analysis of live (positively
selected "winners") and phagocytozed (negatively selected "losers") challenges
this conception in that both, winners and losers turn out to be in agreement
with the abovementioned criteria of positively selected GC B cells. Phagocytozed
B cells are shown to not necessarily comprise excessively mutated sequences (Ta-
bles 6.1-6.2, Figures 6.11, 6.13) and both, live and phagocytozed B cell fractions
show variations of the distribution of mutations in FR and CDR to the expected
values for random mutation over the time course, in which mutations usually ac-
cumulate in CDRs (summarized in Table 6.4). The fact, that these changes in the
overall mutation pattern are rated as not significant in statistical tests most likely
attributes to generally low numbers of overall mutations. Since the vast majority of
analyzed sequences have a range of 1-4 mutations (Figures 6.11, 6.13), large num-
bers of sequences may be needed to reach statistical significance. Nevertheless, most
importantly, such analysis reveals that there is apparently no difference regarding
the distribution of mutations between winners and losers of selection (Figures
6.12 and 6.14).
Likewise, the comparison of R/S ratios among IgL sequences of winners and
losers shows that both populations are characterized by accumulation of replace-
ment mutations within CDRs, but not FRs (Tables 6.1, 6.2). Neither phagocytozed
overall IgL nor phOx specific IgL sequences are characterized by excessive replace-
ment mutations within FRs as anticipated by the general conception of selection.
In fact, R/S ratios among phOx specific IgL sequences of phagocytozed B cells con-
sistently fall below the expected value of 3.4 (Table 6.2). (Expected R/S values for
IGKV4-59 according to the IMGT nomenclature were calculated by Armin Weiser, a
fellow-member of the Systems Immunology Group. Expected R/S values according
to Kabat nomenclature are 3.3 for FR and 3.5 for CDR, respectively [29]). Together
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these findings indicate that R/S ratios fail to specify antigen driven selection but
rather reflect differences in intrinsic mutability among CDRs and FRs as already
argued by Dunn-Walters et al. [208].
In addition, the acquisition of key mutations does not predict the survival fate of
GC B cells, as key mutation bearing phOx specific IgL sequences are commonly
observed among phagocytozed B cell fractions (Table 6.3). In conclusion, the tradi-
tionally proposed molecular signatures fail to demarcate winners and losers and
therefore do not allow for determining antigen driven selection.
Distribution of mutations
Sample FR:CDR [%]1
day 8 7→ day 12
overall IgL
live 74:26 7→ 64:36
phagocytozed 61:39 7→ 65:35
phOx specific IgL
live 75:25 7→ 62:38
phagocytozed 85:15 7→ 77:23
Table 6.4: Survey of changes regarding the distribution of mutations in FRs and CDRs post
immunization. 1Expected proportion for IGKV4-59 (VκOx1) according to IMGT nomenclature is
83%:17%.
6.5.3 Positive selection of GC B cells relies on the absence
of adverse mutations within CDRs
The comparative IgL sequence analysis of live and phagocytozed B cells not only
emphasizes the failing of previously proposed molecular signatures to determine anti-
gen driven selection (Section 6.5.2), but additionally admits a revised conception of
selection, in which the survival of GC B cells particularly relies on the "quality"
and cumulative effect of mutations. The high frequencies of replacement mutations
within CDRs of phagocytozed B cells (Tables 6.1-6.2), that actually often exceed
those of live GC B cells (Figures 6.12 and 6.14), controvert the generally proposed
positive or "affinity-enhancing" effects of replacement mutations within CDRs. In-
deed, excessive replacement mutations within CDRs rather seem to have a profound
negative, deleterious effect. Thus, survival or positive selection of GC B cells seems
to be determined by the absence of excess mutations within CDRs that have an
adverse effect with respect to antigen binding.
6.5.4 Low interclonal diversity of phOx specific GC B cells
is due to continual massive clonal failures
The comparison of phOx specific IgL sequences of live and phagocytozed B cell frac-
tions further reveals striking differences regarding the interclonal diversity between
winners and losers. Whereas live GC B cells are interclonally restricted, inter-
clonal diversity turns out to be markedly pronounced among phagocytozed B cell
fractions (Section 6.3.3, Figure 6.8). Thus, the generally observed oligoclonality of
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"live" GC has to be considered only the tip of the iceberg regarding the diversity
of the phOx response, just emerging as a consequence of massive clonal failures.
The overall interclonal diversity (live+phagocytozed) of phOx-specific GC B cells
is shown to remain constant over the time course (Figure 6.8). Consequently, the
domination of the GC response by few clones does not attribute to progressive re-
duction of interclonal diversity due to successive elimination of unfit clones, as both
generally believed and taken as the main argument for local antigen-driven selection.
In fact, the high interclonal diversity of phagocytozed B cell fractions suggests that
interclonal competition is sustained throughout the GC response, most probably
incited by ongoing replenishment of the pool of interacting B cells (schematically
illustrated in Figure 6.15).
Figure 6.15: Traditional and revised explanation for the domination of GC responses by few clones.
(A) Schematic illustration of the traditional conception. The domination of GC responses by few
clones is the result of progressive reduction of interclonal diversity due to successive elimination
of unfit clones over the time course. (B) Schematic illustration of the revised conception. The
domination of GC responses by few clones is the result of sustained interclonal competition that
includes massive clonal failures.
6.5.5 Some closing remarks
The comparative analysis of live and phagocytozed B cells presented in the current
thesis strongly suggests that the survival fate of GC B cells cannot be predicted
by means of general molecular signatures of primary BCR sequences, which
is partly in line with results reported by Jackson and Capra [209] who followed a
similar approach in that they compared IgH sequences of living and dying human
tonsillar GC B cells. However, whereas Jackson and Capra [209] do not find con-
sistent differences of living and dying GC B cells at all, the comparative analysis
131
of live and phagocytozed B cell fractions following phOx-CSA challenge performed
during this thesis quite does, as for instance variational Jκ gene segment usage (Fig-
ure 6.7), LCDR3 charge (Figure 6.10) and interclonal diversity of LCDR3s (Figure
6.8). As highlighted in the opening paragraph, these differences are unlikely to
represent generally or universally valid features, respectively, but rather have to be
considered special to the GC response to phOx-CSA. Differences between the work
of Jackson and Capra [209] and the results presented here, certainly attribute to the
circumstance that Jackson and Capra [209] analyze an overall immune response to
an unknown mixture of antigens, whereas the analysis reported here is based upon
examination of an immune response elicited by a single known antigen (phOx-CSA).
Moreover, Jackson and Capra [209] report the repeated identification of identical se-
quences in both, living and dying B cell fractions, a finding that is not reproduced by
the analysis performed here, in that identical sequences in both fractions represent
extremely rare exceptional cases. This divergence most likely reflects differences
regarding the strategies of recovery of primary BCR sequences of dying GC B cells,
in which the study of Jackson and Capra [209] is largely based upon identification
of dying GC B cells by Annexin-V reactivity.
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Chapter 7
Conclusions and perspectives
The revised model of affinity maturation - emigration, recirculation and
global selection
Although this was not the initial intention of the current thesis, the presented results
unanimously challenge the general conception of evolution of B cells within GC. This
finally lead to the proposal of a revised model of affinity maturation that includes
asynchronous formation and ongoing seeding of GC, recirculation of emigrant GC
B cells and the implementation of a global selection process. This model strikingly
differs from the traditional conception in that it postulates an external (recircula-
tion) instead of an internal iterative (recycling) process, that is, vital mutation-free
phases are not installed by migration of B cells within, but by emigration from GC.
Noteworthy, external iteration is indirectly supported by vivo imaging of GC, which
just recently revealed that recycling within GC is doubtful, because the observed
exchange of B cells between dark and light zone of GC falls below the "traffic" re-
quired for efficient affinity maturation as predicted by theoretical modeling (Hauser
et al., personal communication). However, although the in vivo imaging and transfer
experiments performed by Schwickert et al. [101] demonstrate that GC are dynamic
open structures, and seeding of GC is likely to be ongoing, direct experimental
proof for both emigration and recirculation of GC B cells is still missing. Thus far,
Schwickert et al. [101] have shown that antigen-specific B cells that are applicated
at the height of the GC response can be detected within pre-existing GC afterwards.
The next step would be to proof that these B cells do indeed join pre-existing GC
reactions, in that they start to hypermutate and are subjected to selection. Inter-
estingly, Schwickert et al. [101] point out that joining of pre-existing GC does rely
on a competitive advantage in antigen binding affinity of transfered B cells, thereby
lending indirect support to a global selection process acting on the level of reentry
into GC. It will be challenging to see what happens after transfer of B cells that
have a lower affinity towards the antigen than B cells within pre-existing GC, in
particular regarding the following questions: Where do they go and in particular
where do they get outcompeted? Do they enter pre-existing GC but then rapidly
die within the same GC due to their disadvantage in local competition with B cells
of higher affinity? or Are they excluded from joining pre-existing GC a priori due
to a globally acting selection process? Regarding the emigration of GC B cells, it
133
does not require a fortune teller to predict that new insights will be available very
soon, as it has already drawn the attention of the groups performing in vivo imaging
of GC. In this context, the exploration of emigration of GC B cells is particularly
incited by 5-bromo, 2’-deoxyuridine (BrdU) pulse labeling experiments that revealed
rapid disappearance of BrdU labeled proliferating cells from the light zone of GC
(within 2 to 4 h) [100].
Signatures of selection
The herein performed comparative analysis of IgL sequences of live and phagocy-
tozed B cell fractions following phOx-CSA challenge demonstrates the failing of
previously proposed molecular signatures to determine antigen driven selection. In
addition, it signalizes that selection and therewith survival of GC B cells may be es-
pecially determined by the "quality" of mutations (i.e. effected changes on the amino
acid level) as well as the cumulative effect of mutations. Thus, the identification of
signatures of selection during the response to phOx-CSA may require the compari-
son of large pools of IGKV4-59 (VκOx1) sequences of both live and phagocytozed
B cell fractions on the amino acid level, an approach currently being developed
together with Armin Weiser, a fellow member of the Systems Immunology group.
Such analysis might reveal patterns of amino acid substitutions that either favor
or handicap survival of phOx specific GC B cells, which may contribute to the un-
derstanding of their selection process. In addition, further criteria of selection may
be attained by assessing the binding properties of antigen-specific BCRs/antibodies
of live and phagocytozed GC B cells in ELISAs or BIAcore binding studies, which
requires their expression as (Fab)2 fragments first.
Tickling macrophages
Admittedly, macrophages became a personal obsession during the current thesis,
very much inspired by the "story of Jekyll and Hyde", a splendid article published
by Duffield [210] in 2003, that portrays the dueling personalities of macrophages in
inflammation. According to the "Jekyll and Hyde" scenario, engulfment of apoptotic
cells leads to a reprogramming of macrophage function, that is once "angry" cell-
killing proinflammatory macrophages become calming "anti-inflammatory" healing
macrophages. Duffield [210] points out, that the "Jekyll 
 Hyde" transition works
in both directions and that the "right amount of Mr Hyde and Dr Jekyll" is vital
to the resolution of inflammation. Interestingly, the results presented in the current
thesis indicate that such a "Jekyll and Hyde" scenario does also apply to macropha-
ges within GC and may be crucial to the regulation/homeostasis of GC. Moreover,
the analysis of macrophages within GC of NZB/W mice suggests that the observed
phagocytosis-induced death of macrophages may effect a "Jekyll and Hyde" imbal-
ance, in that the dampening function of Mr Hyde is lost. Thus, the "Jekyll and
Hyde" scenario may have to be extended for a third personality e. g. "Jekyll 

Hyde→ ?". It will be of great interest to assess the transitions between macrophage
states as they seem to represent a key regulatory element regarding GC homeosta-
sis. As differences in cytokine expression most likely translate into differences in
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function, a first approach could be to compare the cytokine expression profiles of
Mac-2+ and Mac-2− follicular/GC macrophages, in which the former are likely to
represent "Mr Hyde" in that they represent macrophages carrying many engulfed
apoptotic cells [45]. Moreover, "macrophage personalities" may be identified and
specified by profiling the gene expression of microdissected subsets of follicular/GC
macrophages.
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Appendix A
Supplemental material
A.1 Absorption and emission maxima of Alexa
dyes
Dye Amax [nm] Emax [nm]
A488 494 519
A546 556 573
A555 555 565
A594 590 617
A647 650 668
Table A.1: Absorption and emission maxima (Amax, Emax) of Alexa dyes.
A.2 Confocal microscope and image acquisition
settings
Image acquisition applying Leica DM Ire2 confocal microscope
Objectives HC PL APO 10x0.40 IMM UV
HPX PL APO CS 40x1.25 OIL PH
HCX PL APO CS 63x1.40 OIL UV
Zoom 1
Pinhole 1 Airy
Format 1024 × 1024 pixel
Frame average 8
Ar (50 mW): 488 nm (ch0: FITC, A488; green RGB pseudocolor)
GreenHeNe (1.2 mW): 543 nm (ch1: A546; red RGB pseudocolor)
RedHeNe (10 mW): 633 nm (ch2: Cy5, APC, A647; blue RGB pseudocolor)
xy-scan sequential, between frames
Table A.2: Applied settings for image acquisition using the Leica DM Ire2 confocal laser scanning
microscope. Listed settings are valid for images if not otherwise annotated.
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Image acquisition applying Leica TCS SP2 confocal microscope, IFN Magdeburg
Objectives HC PL APO CS 10.0x0.40 UV
HPX PL APO CS 40x1.25 OIL PH
Zoom 1.2
Pinhole 1 Airy
Format 512 × 512 pixel
Frame average 4
Ar (50 mW): 488 nm (A488)
GreenHeNe (1.2 mW): 543 nm (A555, A594)
RedHeNe (10 mW): 633 nm (A647)
xy-scan sequential, between frames
overlap 50 pixel
alignment moving block alignment
Table A.3: Applied settings for image acquisition using the Leica TCS SP2 confocal laser scanning
microscope, IFN Magdeburg. Listed settings are valid for images if not otherwise annotated.
A.3 Survey of ImageJ based macros
Macro ID Action Output
GC area assignment and measurement of GC
boundaries, referred to as regions of in-
terest (ROIs)
areas of ROIs [µm2]
Count Ki all automated detection, segmentation
and measurement of Ki-67+ cells
within assigned ROIs
number of Ki-67+ cells
FitEllipse parametrization of ROIs by an ellipse
fitting algorithm
major and minor radii
of fitted ellipses
GC count cells facilitation of manual counting of GC
macrophages and T cells
MacroROIVolumes binarization of segmented outlines
(ROIs) of GC
aligned and unaligned
binary 8-bit images of
individual ROIs, coor-
dinates of ROIs
Table A.4: Survey of ImageJ based macros.
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A.4 Supplemental figures
Figure A.1: Murine Igκ locus representation [2].
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Figure A.2: The 3-D shape of GC as assessed by 3-D alignment of whole spleen sections. Illustrated
is the interrelation of shape and size of GC as revealed by 3-D reconstruction of in each case three
spleens at day 6, 10 and 14 after immunization. In contrast to figure 4.16 alignment of sections
was not performed slicewise for individual GC but for whole sections. The radii of fitted GC
ellipsoids (R1E , R2E and R3E) are plotted separately against the underlying volumes of the very
GC. Best-fit curves resulting from power regression analysis (RE=a·Vb) are depicted as solid lines.
The respective values of constants (a), exponents (b) and squared correlation coefficients (R2) are
shown next to the curves.
157
Figure A.3: Penetration depths of follicular niches. (A) Illustrated are the frequencies of empty
follicular niches and niches occupied by GC permeating a given number of spleen sections at day
6, 10 and 14 after immunization. (B) Comparative illustration of frequencies of GC permeating a
given number of spleen sections at day 6, 10 and 14.
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Figure A.4: VL gene segment usage among live (GC, grey) and phagocytosed (Mφ, black) B cell
fractions derived from phOx-CSA challenged BALB/c mice at days 8 (A) and 12 (B). VL gene
segments were identified using the IMGT/V-Quest database [90].
A.5 IgL sequence alignments
The IgL sequence alignments are documented on the appendant CD-ROM. Se-
quences are aligned according to their VL gene and are compared to germline se-
quences. Only the nucleotides differing from the germline sequence are presented:
dashes represent identity, capital letters indicate mutations. The label "GC" al-
ways refers to IgL sequences derived from live B cell fractions, whereas "M" refers to
phagocytozed B cell fractions. The label "77" indicates sequences that were obtained
by amplification with the IGKV4-59 (VκOx1) gene specific primer Vκ77 (Section
3.10.2).
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A.6 Manufacturer listing
Manufacturer Location, State
Alexis Grünberg, Germany
Ambion Austin, TX, USA
Amersham Biosciences Freiburg, Germany
Arcturus Sunnyvale, CA, USA
Becton Dickinson Pharmingen San Jose, CA, USA
Bio101 Carlsbad, CA, USA
Biometra Göttingen, Germany
Biorad München, Germany
Biozym Diagnostics Hessisch Oldendorf, Germany
Corning Corning, NY, USA
Costar Cambridge, MA, USA
Dako Glostrup, Denmark
Eppendorf-Netheler-Hinz Köln, Germany
FMC Bioproducts Rockland, USA
Gibco BRL Life Technologies Gaithersburg, MD, USA
Greiner Bio-One Frickenhausen, Germany
Heraeus Hanau, Germany
ICN Biomedicals Eschwege, Germany
ImmunoK, AMS Biotechnology Abingdon, UK
Invitrogen Hamburg, Germany
Leica Microsystems GmbH Wetzlar, Germany
Macherey-Nagel Düren, Germany
Menzel Braunschweig, Germany
Merck Darmstadt, Germany
Microm Walldorf, Germany
Millipore Bedford, MA, USA
Miltenyi Biotech Bergisch Gladbach, Germany
Molecular Probes, Invitrogen Eugene, OR, USA
MWG Ebersberg, Germany
Perkin Elmer Apllied Biosystems Forster City, USA
Pierce Rockford, IL, USA
Promega Mannheim, Germany
Qiagen Hilden, Germany
R&D Systems Minneapolis, MN, USA
Roche Mannheim, Deutschland
Roth Karsruhe, Germany
Sakura Finetek Europe Zoeterwoude, The Netherlands
Schärfe System Reutlingen, Germany
Serotec Düsseldorf, Germany
Sigma-Aldrich Taufkirchen, Germany
TibMolBiol Berlin, Germany
Vector Burlingame, CA, USA
Vogel Berlin, Germany
Table A.5: List of manufacturers.
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Appendix B
Abbreviations
A488 Alexa Fluor 488
A546 Alexa Fluor 546
A555 Alexa Fluor 555
A594 Alexa Fluor 594
A647 Alexa Fluor 647
Ab antibody
APC antigen presenting cell
Ar argon laser
BCR B cell receptor
bp base pair
BSA bovine serum albumin
C constant region
CD cluster of differentiation
CDR complementary determining region
CGG chicken gamma globulin
CSA chicken serum albumin
CR complement receptor
Cy5 cyanine 5
D diversity gene segment
DNA deoxyribonucleic acid
DNP 2,4-dinitrophenol
dNTP deoxynucleotide triphosphate
DZ dark zone
EDTA ethylene diamine tetraacetate
Fab fragment antigen binding
FACS fluorescence activated cell sorting
Fc fragment crystallizable
FDC follicular dendritic cells
FITC fluorescein isothiocyanate
FR framework region
GC germinal center
HSA human serum albumin
HeNe helium neon laser
Ig immunoglobulin
IgH immunoglobulin heavy chain
IgL immunoglobulin light chain
IHC immunohistochemistry
i.p. intraperitoneal
IPTG isopropyl-beta-D-thiogalactopyranoside
J joining gene segment
161
kDa kilo dalton
LCDR3 light chain CDR3
LZ light zone
M molar
Mφ macrophage
mAb monoclonal antibody
MHC major histocompatibility complex
MSH spider crab hemocyanin
NP (4-hydroxy-3-nitrophenyl)acetyl
ORF open reading frame
PALS periarteriolar lymphoid sheath
PBA PBS containing 0.5% bovine serum albumin
PBS phosphate buffered saline
PCA principal component analysis
PCR polymerase chain reaction
PE Phycoerythrin
PFA paraformaldehyde
phOx 2-phenyloxazolone
PI propidium iodide
PNA peanut aggutinin
RA rheumatoid arthritis
RF rheumatoid factor
Rho rhodamine
RNA ribonucleic acid
rpm rounds per minute
RT-PCR reverse transcription PCR
SA streptavidin
SLE systemic lupus erythematosus
SHM somatic hypermutation
SRBC sheep red blood cells
Taq thermus aquaticus
TCR T cell antigen receptor
TdT terminal deoxynucleotidyl transferase
TUNEL TdT-mediated dUTP nick-end labeling
V variable gene segment/region
X-Gal 5-bromo-4-chloro-3-indolyl-[β]-D-galactopyranoside
Table B.1: Abbreviations.
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